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Abstract
Cell state is established and maintained through the combined action of
transcription factors, chromatin regulators and signaling pathways, which all
contribute to a transcriptional regulatory circuitry. Embryonic stem (ES) cells are
capable of self-renewal and can give rise to nearly all differentiated cell-types,
making them an ideal system in which to address the challenges of
understanding gene expression and cell state. Valuable insights into the control
of cell state have been revealed by recent studies of the ES cell transcriptional
regulatory circuitry. Here I present work contributing to the understanding of
transcriptional regulatory mechanisms that control ES cell state, specifically
signaling pathways and proteins that affect chromatin structure.
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Regulation of Gene Expression and Cell State
Abstract
Regulation of gene expression in eukaryotes occurs in the context of a confined nuclear
structure where DNA is tightly wrapped into nucleosomes and packaged into higher
order chromatin. DNA-binding regulators must therefore work together with chromatin
regulators to generate a gene expression program that is specific to each cell state.
The gene expression program of each cell is influenced by the extracellular environment
through signaling pathways that can connect directly to DNA-binding and chromatin
regulators. Here I describe the key concepts that emerged from early studies of gene
regulation and chromatin, discuss the use of embryonic stem (ES) cells as a model in
vitro system to study control of cell state, and review our understanding of ES cell
transcriptional regulatory circuitry. I highlight recent work that reveals how signaling
pathways connect to the key DNA binding regulators of ES cells. I also highlight recent
studies that have led to the model that Mediator and Cohesin physically and functionally
connect the enhancers and core promoters of a key subset of active genes in ES cells,
thus generating cell-type specific chromatin structure.
Key Concepts in Gene Regulation from Prokaryotes and Eukaryotes
The DNA fiber of the human genome is approximately two meters in length. The
genome is packaged into a highly compacted form in order to fit inside the nucleus of a
human cell with a diameter of only 10 [tm (Mohd-Sarip and Verrijzer, 2004). Genome
compaction also occurs in bacteria; the E. coli genome measures 2 mm in length and
must fit into a space of only 0.5 [tm 3. Accurate transcriptional regulation must occur in
the context of these compacted genomes. In fact, evidence from early studies of gene
regulation argues that gene regulators are involved in generating DNA loops that
apparently contribute to genome compaction (Finch and Klug, 1976; Olins and Olins,
1974; Ris and Kubai, 1970).
Gene regulation by Transcription Factors
DNA-binding transcriptional regulators are key to specific gene control. Early studies
into the transcriptional control of the E. coli lac operon created a framework for
understanding gene control in all of biology (Jacob and Monod, 1961). In the absence
of lactose, the lac operon is repressed by the Lac repressor, a DNA binding protein that
binds specifically to a DNA element just downstream of the transcription start site called
the lac operator. When the repressor is bound to the lac operator, transcription initiation
by RNA polymerase is inhibited. If lactose is present, it is metabolized into an isomer,
allolactose, which binds the lac repressor protein and alters its conformation, thus
preventing it from binding to the lac operator, and allowing transcription to occur. A
second control mechanism, which involves sensing of the nutrient environment and a
second DNA binding transcriptional regulator, can contribute to further activation of the
lac operon in the absence of glucose. Cyclic adenosine monophosphate (cAMP) is a
signaling molecule whose prevalence is inversely proportional to that of glucose. It
binds to Catabolite Activator Protein (CAP), which undergoes a conformational change
that allows it to bind a DNA element called the CAP binding site, located upstream of
the transcription start site, from which it recruits RNA polymerase, thus activating
transcription. Specific DNA-binding repressors and activators, and the specific
sequence elements they recognize in the genome, are the fundamental components of
gene control in all of biology.
DNA-binding transcription factors make up the largest single class of proteins
encoded in the human genome, representing approximately 10% of all protein-coding
genes (Babu et al., 2004; Lander et al., 2001; Levine and Tjian, 2003). Most DNA-
binding transcription factors that have been well-studied appear to function as
transcriptional activators, but can be bound by other proteins that cause the multiprotein
complex to act as a repressor. Transcription factors bind to both promoter-proximal
DNA elements and to distal regions 1-100 kb away from the promoter (D'Alessio et al.,
2009; Narlikar and Ovcharenko, 2009; Pan et al., 2010). The distal elements that are
involved in positive gene regulation are generally called enhancers, and these elements
are typically bound by multiple transcription factors. The best characterized of these
enhancers is that of the INF-p promoter, where eight transcription factor molecules
occupy a 50 bp segment of DNA (Agalioti et al., 2000; Maniatis et al., 1998; Panne,
2008). Additional DNA elements exist that can prevent the activity of enhancers at
nearby genes; elements called insulators fall into this class.
The activity of transcription factors in eukaryotes can be affected by the
environment surrounding the cells, just as it is in bacteria. For example, metabolic
ligands can bind specific transcription factors and alter their activity. In yeast, Leu3 can
only initiate transcription of the amino acid biosynthesis genes it regulates after
interacting with a leucine metabolic precursor which changes Leu3 from a repressor to
an activator (Kirkpatrick and Schimmel, 1995). In addition, there are complex signaling
pathways that employ both protein kinases and transcription factors to bring signals
from the extracellular environment to specific genes throughout the genome (Browning
and Busby, 2004; Martinez-Antonio and Collado-Vides, 2003). The gene expression
program of any one cell is thus dependent on both the population of transcription factors
expressed in the cell and the environment in which the cell resides.
Nucleosomes and Gene Requlation
Nucleosomes represent the fundamental unit of chromatin and are made up of an
octamer of four core histone proteins around which 147 bp of DNA are wrapped (Davey
et al., 2002; Finch and Klug, 1976; Kornberg and Klug, 1981; Luger et al., 1997; Olins
and Olins, 1974; Ris and Kubai, 1970). Nucleosomes compact the mammalian genome
by roughly 100,000-fold (Goetze et al., 2007). Genomic regions that are densely
populated by nucleosomes and highly compacted are generally more transcriptionally
silent than regions that have lower nucleosome density. Nucleosomes are distributed
throughout the genome, but are depleted from active promoter regions (Bernstein et al.,
2004; Gilbert et al., 2004; Jiang and Pugh, 2009; Mavrich et al., 2008; Schones et al.,
2008; Segal et al., 2006; Tirosh and Barkai, 2008; Yuan et al., 2005). The presence of
transcription factors and the transcription initiation apparatus at active promoters is
thought to influence the local density and positioning of nucleosomes.
Two classes of nucleosome regulators have been described. ATP-dependent
chromatin remodeling complexes are able to mobilize nucleosomes, which can enhance
or reduce access to DNA sequences by transcription factors with consequent effects on
gene activity (de la Serna et al., 2006a; de la Serna et al., 2006b; Ho and Crabtree,
2010; Kingston and Narlikar, 1999; Narlikar et al., 2002; Saladi and de la Serna, 2010;
Sif, 2004; Tsukiyama et al., 1995; Tsukiyama and Wu, 1995). There are also a large
number of histone modifying enzymes whose activities contribute to local gene activity
(Kouzarides, 2007). Transcription factors and components of the transcription
apparatus can bind and recruit ATP-dependent chromatin remodeling complexes and
histone modifying enzymes to specific sites in the genome (Cairns, 2009; Panne, 2008;
Roeder, 2005; Segal and Widom, 2009). In this manner, most nucleosome regulators,
which have no sequence-specific binding properties of their own, are brought to specific
sites to facilitate gene activity or repression.
The histone modifying enzymes contribute to gene control by chemically
modifying lysine, arginine, serine and other residues in the N-terminal "tails" of histone
proteins, which then form binding sites for other proteins that contribute to positive or
negative regulation of gene expression. For example, histone acetyltransferases
(HATs) can acetylate specific lysine residues, which form sites for binding by regulatory
proteins that contain bromodomains (Kouzarides, 2000; Phillips, 1963; Roth et al., 2001;
Yang and Seto, 2007). Histone methyltransferases (HMTs) can methylate specific
lysine and arginine residues, forming sites for binding by regulatory proteins that contain
chromodomains (Berger, 2002; Gerber and Shilatifard, 2003; Trievel, 2004; Yeates,
2002). There are also enzymes that can remove these modifications from histones,
thus having the opposite effect on gene control (Agger et al., 2008; Hassig and
Schreiber, 1997; Kim et al., 2009; Thiagalingam et al., 2003; Verdin et al., 2003).
DNA Looping and Gene Regulation
In addition to DNA packaging at the level of the nucleosome, DNA looping contributes to
further chromatin compaction (Finch and Klug, 1976; Olins and Olins, 1974; Ris and
Kubai, 1970). Recent studies have identified a variety of looping interactions in the
genomes of eukaryotes (Dostie et al., 2006; Hadjur et al., 2009; Kurukuti et al., 2006;
Levasseur et al., 2008; Lieberman-Aiden et al., 2009; Nativio et al., 2009; Spilianakis
and Flavell, 2004; Tolhuis et al., 2002; Vakoc et al., 2005), but the mechanisms involved
in formation of loops are poorly understood. Some of this DNA looping is under the
control of transcription factors and the transcription apparatus at active genes and some
involves proteins that bind insulators involved in gene repression.
Studies in bacteria first provided evidence that DNA looping is a key feature of
transcriptional activation. Transcription factors called enhancer binding proteins
(EBPs), which bind to the enhancer element, can interact with the a54 RNA polymerase,
which is bound to the transcription start site, thus creating a defined DNA loop (Popham
et al., 1989; Sasse-Dwight and Gralla, 1988). The a54 holoenzyme cannot actively
transcribe genes until the enhancer elements are occupied and the enhancer-bound
proteins physically interact with 54 . These prokaryotic enhancers are typically located
70-150 bp from the promoter but can also act from distances as great as several
kilobases. For example, the nitrogen regulatory protein C (NtrC) transcription factor
creates a loop between its binding sites and the G54-RNA polymerase -occupied gInA
promoter (Reitzer and Magasanik, 1986; Rippe et al., 1997; Su et al., 1990). The NtrC
binding sites are located approximately 100 bp from the gInA promoter, but NtrC can
bind enhancer elements and activate gene transcription from as far as 3 kb from the
promoter. Thus, specific DNA loop formation between enhancers and core promoter
sites is a consequence of the mechanism of transcriptional regulation and has been
shown to be critical for activation of at least some genes transcribed by a54-RNA
polymerase. (Figure 1A)
Studies with bacterial systems also first established that proteins dedicated to
DNA bending play important accessory roles in DNA looping and gene activity.
Bacterial proteins with DNA bending functions include histone-like nucleoid structure
proteins (H-NS), integration host factors (IHF) and factors for inversion stimulation (Fis)
(Luijsterburg et al., 2008). Each of these proteins can create a significant bend in the
DNA, which range from a 90* bend created by the Fis proteins (Pan et al., 1996) to a
1600 bend mediated by H-NS and IHF (Dame et al., 2000; Dorman et al., 1999;
Ellenberger and Landy, 1997; Gerstel et al., 2003; Goodrich et al., 1990; Hochschild
and Ptashne, 1988; Huo et al., 1988; Luijsterburg et al., 2006; Popham et al., 1989; Xu
and Hoover, 2001). Some of these DNA bending proteins, such as IHF, have been
shown to facilitate loop formation and gene activity at promoters where enhancer
binding proteins interact with a54-RNA polymerase (Claverie-Martin and Magasanik,
1991; Hoover et al., 1990). In summary, the study of gene expression in these bacterial
systems led to the concept that transcription factors bound at enhancers bind to RNA
polymerase at the transcription start site, thus forming a specific DNA loop, and that this
loop is facilitated and stabilized by the binding of DNA bending factors, which thereby
contribute to gene expression. (Figure 1A)
In eukaryotes, enhancer elements are typically located at substantial distances
from the core promoter where the transcription initiation apparatus is bound (Banerji et
al., 1981; Benoist and Chambon, 1981; Levine and Tjian, 2003; Maniatis et al., 1987;
Visel et al., 2009; Wasylyk et al., 1983). Transcription factors bind cofactors that can
bind RNA polymerase 11 and are thus thought to bridge the enhancers to which they are
bound and the transcriptional machinery located at the promoter (Fuda et al., 2009;
Hampsey and Reinberg, 1999; McKenna and O'Malley, 2002; Naar et al., 2001;
Spiegelman and Heinrich, 2004; Thomas and Chiang, 2006). Among the cofactors are
Mediator and p300, which have been shown to bind both transcription factors and the
transcription initiation apparatus (Conaway et al., 2005; Kornberg, 2005; Malik and
Roeder, 2005, 2008; Roeder, 1998; Taatjes and Tjian, 2004; Visel et al., 2009). It thus
seems likely that specific DNA loop formation is a natural consequence of the
mechanism of transcriptional activation in eukaryotes. (Figure 1 B)
Like prokaryotes, eukaryotes posses a family of proteins capable of bending
DNA and facilitating interactions between proteins that are bound at distant DNA sites.
This class of proteins includes the high mobility group box (HMGB) proteins. HMG box
domain-containing proteins bend DNA 80-130* depending on the number of HMG box
proteins present (Bustin and Reeves, 1996; Thomas and Travers, 2001). HMG box
proteins do not recognize specific DNA sequences, but by altering DNA structure, these
proteins aid in transcription either by stabilizing protein interactions or by promoting the
recruitment of other proteins to a site of transcriptional activity (Bianchi and Agresti,
2005; Thomas and Chiang, 2006). Sox2, a key transcription factor in the transcriptional
regulatory circuitry of embryonic stem cells, is a member of the HMG box domain
protein family and functions in ES cells by forming a heterodimer with the POU-domain
protein family member Oct4 (Pevny and Lovell-Badge, 1997; Wegner, 1999). This
makes it tempting to speculate that Sox2 is essential for ES cell state both because of
its interaction with Oct4 and its physical impact on DNA structure.
DNA loop formation has recently been implicated in insulator activity. The
insulator binding protein CTCF (CCCTC-binding factor) is thought to block the
interaction between enhancer-bound proteins and the transcriptional machinery to
prevent inappropriate expression as well as the spread of repressive chromatin
(Ohlsson et al.; Ohlsson et al.; Phillips and Corces, 2009). CTCF can dimerize, thus
bringing together two CTCF-bound DNA sites. It has been implicated in the control of
gene expression through knockout studies and may play a role in certain cancers (Dunn
and Davie, 2003; Filippova et al., 2002; Kim et al., 2007). Whole genome studies have
revealed that there are nearly 20,000 CTCF-bound sites across the genome of any
given cell-type. Most CTCF binding sites are not cell-type specific, although the
contribution of CTCF to the control of gene expression is specific (Barski et al., 2007;
Kim et al., 2007; Xie et al., 2007). Several examples of CTCF's involvement in DNA
looping at cell-type specific loci have recently been identified using chromosome
conformation capture (3C) (Kurukuti et al., 2006; Lewis and Murrell, 2004; Li et al.,
2008; Majumder et al., 2008; Splinter et al., 2006). The evidence for CTCF's
involvement in cell-type specific transcriptional activity suggests it is interacting with
other cell-type specific factors. The other factors that may be contributing to these long-
range looping interactions remain unknown.
In summary, accurate transcriptional regulation must occur in the context of
highly compacted genomes. In bacteria, transcription factors bound to regulatory DNA
elements also bind to the transcription apparatus at the core promoter, thus forming a
DNA loop, and this loop can be facilitated or stabilized by DNA bending proteins. In
eukaryotes, it seems likely that a similar process takes place, although in the context of
nucleosomal DNA. Transcription factors bound to regulatory DNA elements recruit
chromatin regulators that mobilize and modify nucleosomes, thus creating a chromatin
environment favorable to further regulation. The transcription factors also bind to
cofactors, which in turn bind to the transcription apparatus at the core promoter, thus
forming a DNA loop. We imagine that a variety of proteins may aid in the formation or
stability of this loop, and thus contribute to gene regulation in eukaryotes.
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Figure 1. Features of prokaryotic and eukaryotic transcription initiation.
(A). Prokaryotic transcription requires DNA sequence-specific binding elements called
enhancer binding proteins (EBPs) that occupy the enhancer elements located upstream
of the promoter and transcriptional start site. RNA polymerase a5 holoenzyme occupies
the promoter and is activated upon interaction with EBPs. A DNA bending factor is
often involved in facilitating this interaction. The integration host factor (IHF), histone-
like nucleoid structure (H-NS) proteins and factors for inversion stimulation (Fis) are
examples of proteins that bend the DNA. These proteins are responsible for altering the
DNA in order to bring enhancer-bound proteins in proximity to the polymerase occupied
promoter.
(B). In many ways, eukaryotic transcription resembles prokaryotic transcription. The size
of eukaryotic genomes and the number of cell-type specific expression profiles required
by multicellular organisms require more complex mechanisms to regulate gene
expression. RNA polymerase II occupies the promoter along with the transcriptional
apparatus and a number of cofactors including TATA binding protein (TBP). Upstream
of the promoter are sequence-specific enhancer elements. These elements can be
anywhere from 1-100 kb from the promoter and are commonly occupied by cell-type
specific transcription factors. In order to activate transcription of the genes they
regulate, transcription factors must interact with the transcriptional machinery at the
promoter. Mediator is a multisubunit complex that helps to bridge this interaction by
interacting at one end with enhancer-bound transcription factors and at the other with
RNA polymerase 11 and the transcription apparatus.
ES Cells as a Model System to Study Transcriptional Control of Cell State
Embryonic stem cells posses the unique ability to self-renew, propagating almost
indefinitely in culture under the appropriate conditions. ES cells are also pluripotent,
capable of giving rise to any of the over 200 fully differentiated cell-types found in adult
mammals (Pera and Trounson, 2004; Rossant, 2008; Silva and Smith, 2008; Wobus
and Boheler, 2005; Yamanaka, 2008) (Figure 2). Before the isolation and culture of
embryonic stem cells, cells derived from teratocarcinomas (P9 and F10) and embryonic
carcinomas (EC) were used to study self-renewal and differentiation (Kahan and
Ephrussi, 1970; Martin, 1980; Pardal et al., 2003; Stevens, 1978; Stevens et al., 1977).
Cancer cells resemble ES cells in that they have the ability to self-renew and
differentiate into a number of cells types, but differ in that they are not generally
pluripotent and directed differentiation is not as cleanly controlled. The mutations that
immortalize cancer cells also make cancer cell lines difficult in vitro systems from which
to derive a reliable understanding of development (Chambers and Smith, 2004;
Downing and Battey, 2004). Embryonic stem cells, on the other hand, provide a
primary, pluripotent, self-renewing cell line that can be used to investigate many of the
questions surrounding early mammalian development.
Waddington's model of the epigenetic landscape provides a useful concept to
describe the progression of ES cells from their undifferentiated state to a more defined
terminal cell state (Waddington, 1957) (Figure 2). A pluripotent stem cell is positioned at
the top of the landscape, poised to begin traveling towards a differentiated cell-type. As
the cell adopts a new cell identity, it loses those properties of pluripotency. The cell first
passes through a stage of multipotency where it is committed to one of three cell
lineages - endoderm, mesoderm or ectoderm - but maintains the ability to become any
cell-type within that lineage. Ultimately, the cell reaches a state of unipotency where its
identity is maintained as a fully differentiated cell. The study of embryonic stem cells
has led to the identification of factors that promote self-renewal, pluripotency or direct
cellular differentiation to any number of multipotent progenitor cells or fully differentiated
cells. Several cell states can now be reproduced in culture, including beating
cardiomyocytes, muscle cells, and neurons (D'Amour et al., 2006; Graichen et al., 2008;
Joannides et al., 2007; Kubo et al., 2004; Laflamme et al., 2007; Murry and Keller,
2008; Ng et al., 2005; Nostro et al., 2008; Wichterle et al., 2002; Ying and Smith, 2003).
The progression of normal cellular differentiation was long thought to be
irreversible, progressing only in the direction of pluripotency to unipotency, but studies
in the last 13 years have shown that this is not necessarily the case. Nuclear
transplantation and the generation of Dolly the sheep provided powerful evidence that
cell fate could be reversed (Wilmut et al., 1997). Dolly was a clone, created by the use
of somatic cell nuclear transfer (SCNT). SCNT involves the introduction of a somatic
nucleus into an enucleated oocyte. The genome contained in that somatic nucleus is
reprogrammed by factors within the oocyte to resemble the gene expression program of
an embryonic stem cell, which can give rise to all cell-types required for an adult
organism (Gurdon and Byrne, 2003; McGrath and Solter, 1983). Cellular
reprogramming techniques have since improved in efficiency and safety, providing
greater value to the potential application of reprogrammed cells in areas of biomedical
research.
To further our understanding of development, and to facilitate discoveries that
advance the new field of regenerative medicine, it is important to understand the
regulatory mechanisms that control pluripotency, self-renewal and differentiation. To
gain this understanding, it is useful to discover how transcription factors, signaling
pathways and chromatin regulators contribute to control of the gene expression
program that is necessary to maintain ES cell state.
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Embryonic stem cells are derived during the blastocyst stage of
embryogenesis.
At this stage cells are pluripotent and can proliferate this way in culture
indefinitely under the right conditions. As ES cells differentiate during
development they are fated for particular lineages and take on a multipotent cell
state. Within each lineage a cell can continue to differentiate into any of the over
200 defined cell-types of an adult mammal. Examples of these fully
differentiated, unipotent cell states are depicted here.
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Embryonic Stem Cell Transcriptional Regulatory Circuitry
Transcription factors, signaling pathways, chromatin regulators and noncoding RNAs
play key roles in establishing and maintaining cell-type specific gene expression
programs. Recent studies of these regulators have led to a model of the transcriptional
regulatory network for embryonic stem cells and concepts that may provide a foundation
for further understanding the control of cell state (Boyer et al., 2005; Boyer et al., 2006;
Cole et al., 2008; Lee et al., 2006; Loh et al., 2006; Marson et al., 2008b). A version of
this model is shown in Figure 3 and its key features are discussed below.
Transcription Factors
Oct4, Sox2 and Nanog are three core transcription factors required for
determining and maintaining the state of embryonic stem cells. The critical role of the
transcription factors Oct4 and Nanog was initially established based on their unique
expression in ES cells and the impact that their loss of expression had on cell state
(Chambers et al., 2003; Chambers and Smith, 2004; Hart et al., 2004; Mitsui et al.,
2003; Nichols et al., 1998; Scholer et al., 1990). The high mobility group protein, Sox2,
was added to the list of key regulators of ES cell state when it was discovered that Sox2
forms a heterodimer with Oct4 (Ambrosetti et al., 1997; Ambrosetti et al., 2000; Avilion
et al., 2003; Masui et al., 2007).
The study of genes occupied and regulated by Oct4, Sox2 and Nanog has led to
three key concepts in transcriptional control of ES cell state. First, the master regulators
collaborate to regulate each of their own promoters, forming an interconnected
autoregulatory loop (Boyer et al., 2005) (Fiugre 3A). This regulatory feature probably
contributes to the ability to jump-start the ES cell gene expression program during
reprogramming by forced expression of exogenous reprogramming factors (Jaenisch
and Young, 2008). It is also thought to generate a bi-stable state for ES cells; a stable,
positive feedback controlled gene expression program when the master transcription
factors are adequately expressed, and a stimulus to enter a differentiation program
when any one of the master transcription factors is no longer fully functional. A second
concept is that the master regulators collaborate to regulate their target genes because
all three factors are found at these genes (Boyer et al., 2005). A third concept is that
they function to activate expression of genes necessary to maintain ES cell state, while
contributing to silencing of genes whose repression is essential to maintaining that
state. These silenced genes encode developmental regulators whose expression is
required for the appropriate differentiation of ES cells, and whose repression is critical
for maintaining the self-renewing and pluripotent properties of ES cells. (Boyer et al.,
2005; Lee et al., 2006; Loh et al., 2006) (Figure 3B)
Additional transcription factors contribute to the transcriptional control of ES cells.
Sall4 and Tcf3 have recently been shown to occupy most of the same genes bound by
Oct4, Sox2 and Nanog (Chen et al., 2008a; Cole et al., 2008; Wu et al., 2006; Zhang et
al., 2006). The transcription factors c-Myc, Esrrb and Trim28 are also important for
control of proliferation and maintenance of ES cell state (Chen et al., 2008b; Hu et al.,
2009; van den Berg et al., 2008; Zhang et al., 2008). It is likely that there will be
additional transcription factors among the hundreds that are expressed in ES cells that
will emerge as making important contributions to the larger gene expression program of
these cells.
Some transcription factors have the ability to reprogram cell fates. Weintraub and
colleagues (Davis et al., 1987) first showed that a single transcription factor (MyoD) can
reprogram fibroblasts into muscle-like cells. Takahashi and Yamanaka (2006) more
recently showed that the forced expression of Oct4, Sox2, Klf4 and c-myc can
reprogram fibroblasts into induced pluripotent stem (iPS) cells. Many groups have
reproduced Yamanaka's findings and have demonstrated reprogramming to iPS cells
with Oct4 and other ES cell transcription factors in a variety of cell-types (Maherali and
Hochedlinger, 2008; Maherali et al., 2007; Park et al., 2008a; Park et al., 2008b; Silva et
al., 2008; Wernig et al., 2007; Wernig et al., 2008). Reprogramming is now being used
to generate patient-specific iPS cells. These patient-specific iPS cells have the ability to
differentiate into any number of desired cell-types, which hold the potential to treat a
number of diseases and eliminate the complications caused by the introduction of
foreign donor cells to affected individuals (Dimos et al., 2008; Ebert et al., 2009; Kiskinis
and Eggan; Soldner et al., 2009; Trounson, 2009). Further understanding of ES cell
transcriptional regulatory mechanisms and circuitry should improve our knowledge of
the underlying mechanisms that control cell state and will almost certainly continue to
improve reprogramming methods.
Chromatin Requlators
Polycomb group (PcG) proteins and SetDB1 are among the chromatin regulators that
play roles in the maintenance of embryonic cell states. Genetic studies established that
PcG genes are key regulators of early development in metazoans (Breiling et al., 2007;
Faust et al., 1998; O'Carroll et al., 2001; Pasini et al., 2004). Later studies revealed that
PcG proteins repress gene expression, in part by methylating and ubiquitylating histone
tails (Orlando, 2003; Pirrotta, 1998; Ringrose and Paro, 2004; Schuettengruber et al.,
2007; Schwartz and Pirrotta, 2007). In ES cells, PcG proteins occupy and silence genes
encoding developmental regulators (Bernstein et al., 2006; Boyer et al., 2006; Lee et al.,
2006; Pan et al., 2007; Yeap et al., 2009; Zhao et al., 2007).
SetDB1 knockdown causes loss of ES cell state (Bilodeau et al., 2009; Lohmann
et al., 2010; Yuan et al., 2009). SetDB1 is among the histone H3 lysine 9
methytransferases, which have roles in gene repression (Ayyanathan et al., 2003;
Schultz et al., 2002; Wang et al., 2003). SetDB1 occupies and methylates nucleosomes
at many of the same silent developmental genes that are occupied by PcG proteins
(Bilodeau et al., 2009; Yuan et al., 2009). It thus appears that both chromatin regulators
contribute to repression of this key set of developmental regulators, whose expression
leads to loss of ES cell state (Figure 3B).
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Figure 3. Transcription factors and chromatin modifiers determine gene
expression.
(A). Oct4, Sox2 and Nanog are part of an interconnected autoregulatory loop. Oct4,
Sox2 and Nanog each regulate their own expression as well as the expression of the
other two proteins.
(B). Oct4, Sox2 and Nanog are key transcription factors in determining embryonic stem
cell state. Studies have demonstrated a pairing of these transcription factors with marks
of activation including an elongating form of RNA polymerase II (Pol2), the chromatin
modifying complexes trithorax, the enzyme complex responsible for H3K4me3, Dot1,
the enzyme responsible for H3K36me3 and Set2, the enzyme responsible for
H3K79me2. The genes occupied by this combination of factors encode proteins
required for the maintenance of ES cell state including key ES cell-specific transcription
factors and inhibitors of differentiation (Id1). Oct4, Sox2 and Nanog have also been
found at silent genes with a nonproductive form of RNA polymerase II, the repressive
chromatin modifying complex Polycomb, the enzymatic complex responsible for
H3K27me3 and SetDB1, the enzyme responsible for H3K9me3. The genes occupied
by this combination of factors encode proteins required for early differentiation and
lineage commitment during development.
Signal Transduction Pathways
The culture of ES cells initially required a layer of irradiated fibroblasts in order to obtain
the necessary factors for proliferation and pluripotency. These fibroblasts produce
cytokines and growth factors necessary for ES cell pluripotency and self-renewal (Smith
and Hooper, 1983). The key factors secreted by fibroblasts have been identified, so ES
cells can now be grown in chemically defined medium in the absence of irradiated
fibroblasts. LIF, Wnt, BMP4 and TGF-p were among the factors supplied by the
fibroblasts and found to impact murine ES cell state (Okita and Yamanaka, 2006; Sato
et al., 2004; Smith et al., 1998; Williams et al., 1988; Ying et al., 2003). Thus, the LIF,
Wnt, BMP4 and TGF-p signaling pathways can contribute to maintenance of ES cell
state (Figure 4).
Leukemia inhibitory factor (LIF), which was originally identified through its ability
to inhibit growth of myeloid leukemia cells, has been implicated in growth promotion and
differentiation of various cell types (Hilton, 1992). LIF, a member of the IL-6 family of
cytokines, is expressed in the trophectoderm of the developing embryo, with its receptor
LIFR expressed throughout the inner cell mass. ES cells are derived from the inner cell
mass of blastocysts, so removing them from blastocysts also removes their source of
this cytokine. LIF binding to LIFR leads to phosphorylation and activation of the
JAK/STAT and MAPK cascades. In ES cells, activated STAT3 is translocated to the
nucleus where it acts as a transcription factor (Auernhammer and Melmed, 2000; Stahl
et al., 1995). STAT3 interacts with the core transcription factors Oct4, Sox2 and Nanog,
explaining how LIF signaling connects to the core regulatory circuitry and thus
contributes to maintainenance of murine ES cell state (Chen et al., 2008b). LIF has
been demonstrated to activate STAT3 in human ES cells but is unable to maintain their
pluripotency (Daheron et al., 2004; Humphrey et al., 2004). In mouse embryogenesis
LIF is produced to allow a pregnant female to maintain her embryos in an embryonic
stem cell state until her environment is appropriate for development and birth (Nichols et
al., 2001). This is likely the reason why LIF has a profound impact on mES cell state
but has no effect in the maintenance of hES cells.
Wnt signaling also contributes to the maintenance of ES cell state (Aubert et al.,
2002; Kielman et al., 2002; Sato et al., 2004; Yoshikawa et al., 1997). Wnt signaling is
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mediated by the intracellular signaling protein p-catenin. In the absence of Wnt
signaling, p-catenin is phosphorylated and subsequently degraded by the axin/GSK-
3/APC complex. When Wnt proteins bind to cell-surface receptors of the Frizzled
family, the receptors activate Dishevelled proteins, which inhibit the axin/GSK-3/APC
complex. Thus, when the Wnt signaling pathway is activated, unphosphorylated forms
of p-catenin accumulate in the cytoplasm and are shuttled into the nucleus (Reya and
Clevers, 2005). Within the nucleus, p-catenin interacts with DNA bound co-factors of
the lymphoic enhancer factor (LEF)/T-cell factor (TCF) family of proteins. The key
LEF/TCF factor expressed in ES cells is TCF3, which co-occupies promoters with Oct4,
Sox2 and Nanog. In the absence of p-catenin, TCF3 acts as a transcriptional repressor,
whereas when bound by p-catenin, it acts as an activator. Thus, Wnt signaling
connects directly to the core regulatory circuitry of ES cells by converting TCF3 from a
repressor to an activator (Cole et al., 2008). This study is the subject of Chapter 2.
The bone morphogenic protein 4 (BMP4) signaling pathway is a member of the
TGF-p superfamily of signaling pathways (Shi and Massague, 2003). Activation of the
BMP4 pathway stimulates the phosphorylation of Smad proteins 1, 5 and 8.
Phosphorylation of the Smads leads to an interaction with the co-Smad, Smad4. Once
together in a complex with Smad4, the Smad proteins are shuttled to the nucleus where
they act to regulate gene expression. BMP4 has been shown to maintain pluripotency
of ES cells by activating genes encoding inhibitors of differentiation proteins (Graichen
et al.) and can function together with LIF in the absence of serum to maintain ES cell
state (Ying et al., 2003). As with the transcription factors targeted by the LIF and Wnt
signaling pathways, Smad1 often occupies genes with the ES cell master transcription
factors Oct4, Sox2 and Nanog (Chen et al., 2008b). In addition to BMP4 signaling, the
TGF-p family of signaling pathways can also be activated by Activin/Nodal signaling.
Here, signaling goes through Smad2 and Smad3 (James et al., 2005; Ross and Hill,
2008; Rossant, 2008). Upon activation, Smad2/3 is phosphorylated, interacts with
Smad4 and is translocated to the nucleus. In mES cells the activation of this pathway
can lead to differentiation, where as in hES cells this pathway has a role in maintaining
ES cell state. A recent study identified the gene targets of Smad2/3 in both mouse and
human ES cells as well as differentiated cell types. This study, presented here in
Chapter 3, highlights the specificity and interaction of signaling pathways with critical
transcription factors. A high overlap is observed between the sites occupied by ES cell
master transcription factors Oct4, Sox2 and Nanog with Smad3. Although similar genes
are occupied in mouse and human ES cells their role at those genes is likely different.
In addition, Smad3 was bound to a different set of genes in muscle cells and in proB
cells but in each cell type Smad3 demonstrated a significant degree of co-occupancy
with the master transcription factors, MyoD in muscle cells and PU.1 in proB cells,
suggesting a relationship between transcription factors and signaling pathways that is
critical for regulating cell-type specific gene expression (Mullen et al., 2010).
New knowledge of the contributions of signaling pathways to the control of ES
cell state have led to advances in cellular reprogramming. A role for Wnt signaling in
the core regulatory circuitry of ES cells led Marson and colleagues to show that Wnt3a
conditioned media dramatically improves the efficiency of cellular reprogramming in the
absence of the proto-oncogene c-Myc (Marson et al., 2008a). Similarly, by inhibiting
TGF-p signaling using an inhibitor specific for part of the Activin/Nodal signaling
pathway, a pathway known to promote differentiation of murine ES cells,
reprogramming efficiency was improved in the absence of c-myc (Maherali and
Hochedlinger, 2009). The inhibition of this signaling pathway likely blocked other
signals of differentiation and so lowered the threshold for the expression of genes
necessary to regain the pluripotent state. These results are important because of the
interest in eliminating exogenous proto-oncogenes from reprogramming protocols.
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Figure 4. Signaling pathways interact with the transcriptional regulatory circuitry
of embryonic stem cells.
(A). Signaling pathways have a critical role in the interaction with transcription factors
and chromatin modifiers to direct gene expression in ES cells. The Wnt, LIF, TGF-p
and BMP4 signaling pathways are known to contribute to ES cell state. Genome-wide
profiling of the terminal component of each of these signaling pathways shows a direct
involvement with Oct4, Sox2 and Nanog to control gene expression and cell state.
(B). Terminal signaling components co-occupy parts of the genome with transcription
factors Oct4, Sox2, Nanog and Sa114. Nucleosome position is shifted and chromatin is
opened by histone modifiers including histone acetyltransferases (HATs) that increase
accessibility of DNA through the addition of acetyl groups to histones. Specific DNA
sequences are subsequently recognized and bound by transcription factors and
members of signaling pathways. The terminal components of signaling pathways are
likely recruited to these sites by the transcription factors that control cell state.
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Genetic Screens Reveal Novel Regulatory Factors of ES Cell State
The pioneering studies that identified Oct4 and Nanog as key regulators of embryonic
stem cells came from studies of differential gene expression and genetic manipulation.
The discovery that Oct4 was necessary for the maintenance of ES cell state came from
a series of studies that first identified the differential expression of Oct4 in embryonic
stem cells. These studies used cloning and sequencing techniques to identify Oct4 as a
novel member of the POU domain family of proteins (Okamoto et al., 1990; Rosner et
al., 1990; Scholer et al., 1990). Along with the identification of Oct4 as a novel protein,
its expression was determined to be limited to embryonic cells and was undetectable in
adult, differentiated cells (Okamoto et al., 1990). These studies were followed by
experiments that revealed the significant impact on cell state following the loss of Oct4.
The loss of Oct4 leads to a loss of pluripotency and a commitment to a trophectoderm
lineage (Nichols et al., 1998). Overexpression of Oct4 has also been discovered to lead
to differentiation, suggesting that the level of Oct4 expression is critical to the proper
maintenance of ES cell state (Niwa et al., 2000).
More recently, large-scale genetic screens have identified additional transcription
factors, chromatin modifiers, transcriptional coactivators, and chromosome scaffolding
proteins that contribute to maintenance of ES cell state (Bilodeau et al., 2009; Fazzio et
al., 2008; Hu et al., 2009; Ivanova et al., 2006; Zhang et al., 2006). Each of the screens
identified known ES cell regulators such as Oct4, Nanog and Stat3, indicating that other
genes identified in the screen were good candidates for novel ES cell regulators. The
novel transcription factors include Trim28, Cnot3, Zfp42/Rex-1, Esrrb, Tbx3 and Tcll
(Hu et. al., 2009; Ivanova et al., 2006; Zhang et al., 2006). The novel chromatin
regulators include Tip-60 and SetDB1 (Bilodeau et al., 2009; Fazzio et al., 2008). The
novel transcriptional coactivators and chromosome scaffolding proteins include
Mediator and Cohesin (Kagey et al., 2010).
The observation that reduced levels of Mediator and Cohesin cause loss of ES
cell state led us to further investigate their functions in ES cells (Kagey et al., 2010), and
this study is the subject of Chapter 4. Both Mediator and Cohesin were found to occupy
the enhancers and core promoters of a key subset of actively transcribed genes and to
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be necessary for normal transcriptional activity in ES cells. The Cohesin loading factor
Nipbl was found at the sites co-occupied by Mediator and Cohesin, providing a
mechanism for Cohesin loading at these sites. Mediator and Cohesin were found to
physically interact, further explaining how the recruitment of Mediator by a transcription
factor could lead to association with Cohesin. Chromosome conformation capture
experiments revealed that the enhancer and core promoter sites occupied by Mediator
and Cohesin are brought into close physical proximity, confirming DNA loop formation.
Mediator and Cohesin co-occupancy of the genome was found to be cell-type specific
due to cell-type specific gene activity. These and other results led us to propose that
Mediator and Cohesin contribute to a looped and reinforced chromatin structure at
active promoters genome-wide, thus generating a cell-type specific chromatin
architecture associated with the transcriptional program of each cell.
Concluding Remarks
Embryonic stem cells provide a valuable system in which to study mechanisms of gene
regulation, cell state, and differentiation. The ability to maintain ES cells and iPS cells
indefinitely in a pluripotent state in culture are properties unique to these cells that have
facilitated experimental investigation of the control of cell state. Consequently, much
has been learned about the roles of specific transcription factors, signaling pathways,
chromatin modifiers and microRNAs in controlling the gene expression program
responsible for the pluripotent state of these cells (Bernstein et al., 2007; Boyer et al.,
2005; Boyer et al., 2006; Chen et al., 2008b; Chew et al., 2005; Cole et al., 2008; Endoh
et al., 2008; Jiang et al., 2008; Kim et al., 2008; Lee et al., 2006; Loh et al., 2006;
Marson et al., 2008b; Tam et al., 2008).
The study of the key ES cell transcription factors has led to three key concepts in
transcriptional control of ES cell state: 1) the master regulators collaborate to regulate
each of their own promoters, forming an interconnected autoregulatory loop, 2) the
master regulators co-occupy and collaborate to regulate their target genes, and 3) the
master regulators function to activate expression of genes necessary to maintain ES
cell state, while contributing to silencing of genes whose repression is essential to
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maintaining that state (Boyer et al., 2005; Lee et al., 2006; Loh et al., 2006). The central
theme that emerged from the study of ES cell signaling pathways is that the
transcription factors that serve as effectors of these pathways can occupy and function
at the genes regulated by the master transcription factors Oct4, Sox2 and Nanog. This
suggests that master transcription factors -those that are key to control of cell state -
have properties that facilitate binding of the signaling transcription factors to adjacent
sites at enhancers.
Continued study of ES cell transcriptional regulatory mechanisms and circuitry is
almost certain to continue to provide important new insights into the control of gene
expression and cell state. Genetic screens have identified a large number of novel
candidate regulators of ES cell state. Our own studies of Mediator and Cohesin, two
complexes that emerged from these screens, have provided new insights into the
mechanisms involved in gene control, DNA looping and control of cell state (Kagey et
al., 2010). These studies argue that DNA loop formation between enhancers and core
promoters occurs as a consequence of the interaction between enhancer-bound
transcription activators, Mediator and promoter-bound RNA polymerase II. When the
transcription activators bind Mediator, the Mediator complex undergoes a
conformational change, and this form of Mediator binds Cohesin. The Cohesin loading
factor Nipbl is located at the sites co-occupied by Mediator and Cohesin, providing a
mechanism for Cohesin loading at these sites. The subset of genes occupied by
Mediator and Cohesin is cell-type specific, thus indicating that cell-type specific loops
exist in the chromosomes of vertebrate cells as a consequence of active gene
regulation.
Further understanding the control of ES cell state will also provide new insights
into human disease. For example, mutations in ES cell transcription factors (Myc) and
signaling pathways (Wnt, TGFb) can lead to cancer. Mutations in the genes encoding
Mediator and Cohesin components can cause an array of human developmental
syndromes and diseases. Mediator mutations have been associated with Opitz-
Kaveggia (FG) syndrome, Lujan syndrome, schizophrenia and some forms of congenital
heart failure (Ding et al., 2008; Philibert et al., 2007; Philibert and Madan, 2007; Risheg
et al., 2007; Schwartz et al., 2007). Mutations in Nipbl are responsible for most cases of
Cornelia de Lange syndrome (CdLS), which is characterized by developmental defects
and mental retardation and appears to be the result of mis-regulation of gene
expression rather than chromosome cohesion or mitotic abnormalities (Borck et al.,
2004; Musio et al., 2006; Strachan, 2005; Zhang et al., 2007). More detailed
understanding of these diseases and syndromes, and potential therapeutics, will almost
certainly emerge from further study of ES cells and from PS cells derived from patients
with these diseases.
My Research
My work in graduate school has focused on understanding how transcriptional
regulatory mechanisms function in the control of gene expression in embryonic stem
cells. The chapters presented in this document reflect this work and my contributions to
expanding the regulatory network of embryonic stem cells to include signaling pathways
and structural proteins.
Chapter 2 describes how Wnt signaling is mediated through Tcf3 and directly impacts
the core transcriptional regulatory circuitry of embryonic stem cells. I contributed to this
work by establishing our lab's mouse ES cell culturing approach. I used knockdown
studies to examine the functional role of Tcf3 and Wnt signaling in ES cells. I also
studied expression changes following stimulation of ES cells with Wnt3a conditioned
media.
Chapter 3 describes the discovery that the TGF-p terminal signaling factor Smad3 co-
occupies genes with the master transcription factors of embryonic stem cells (Oct4),
myotubes (Myod) and ProB cells (PU.1). My contributions to this project include the
initiation of the culture and study of human embryonic stem cells in the lab. I also
contributed to key concepts, experimental design and conducted experiments for this
project, including the perturbations of signaling pathways. I also conducted experiments
to demonstrate the active recruitment of Smad3 following the over-expression of
specific transcription factors.
Chapter 4 describes a role for the Mediator and Cohesin protein complexes in
maintaining embryonic stem cell state through the formation of DNA loops at active
genes. I participated in screening the transcription factor short hairpin library and
followed up on the role of Mediator in embryonic stem cells. I performed knockdown
experiments and ChIP-seq following the screen, leading to the discovery that Mediator
and Cohesin have a critical, cell-type specific role in DNA looping at active genes.
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Chapter 2
Tcf3 is an Integral Component of the Core Regulatory Circuitry
of Embryonic Stem Cells
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My contribution on this project
The work to study the role of Tcf3 and Wnt signaling in embryonic stem cells was
initiated by graduate student Megan Cole but quickly became a close, equal
collaboration with graduate student Sarah Johnstone and myself. I led the efforts
to establish the embryonic stem cell tissue culture room for the lab that was used
to do a majority of this work. I worked out cell culture conditions for the
embryonic stem cells and contributed a significant amount conceptually and
experimentally to the cell culture aspects of this project, including Tcf3
knockdowns and Wnt3a stimulation.
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Abstract
Embryonic stem cells have a unique regulatory circuitry, largely controlled by the
transcription factors Oct4, Sox2 and Nanog, which generates a gene expression
program necessary for pluripotency and self-renewal (Boyer et al. 2005; Loh et
al. 2006; Chambers et al. 2003; Mitsui et al. 2003; Nichols et al. 1998). How
external signals connect to this regulatory circuitry to influence embryonic stem
cell fate is not known. We report here that a terminal component of the canonical
Wnt pathway in embryonic stem cells, the transcription factor Tcf3, co-occupies
promoters throughout the genome in association with the pluripotency regulators
Oct4 and Nanog. Thus Tcf3 is an integral component of the core regulatory
circuitry of ES cells, which includes an autoregulatory loop involving the
pluripotency regulators. Both Tcf3 depletion and Wnt pathway activation cause
increased expression of Oct4, Nanog and other pluripotency factors and produce
ES cells that are refractory to differentiation. Our results suggest that the Wnt
pathway, through Tcf3, brings developmental signals directly to the core
regulatory circuitry of ES cells to influence the balance between pluripotency and
differentiation.
Introduction
Embryonic stem (ES) cells provide a unique opportunity to study early
development and hold great promise for regenerative medicine (Thomson et al.
1998; Reubinoff et al. 2000; Pera and Trounson 2004). ES cells are derived from
the inner cell mass of the developing blastocyst and can be propagated in culture
in an undifferentiated state while maintaining the capacity to generate any cell
type in the body. Discovering how signaling pathways and transcriptional
regulatory circuitry contribute to self-renewal and pluripotency is essential for
understanding early development and realizing the therapeutic potential of ES
cells.
A model for the core transcriptional regulatory circuitry of ES cells has
emerged from studying the target genes of the ES cell transcription factors Oct4,
Sox2 and Nanog (Boyer et al. 2005; Loh et al. 2006). These master regulators
occupy the promoters of active genes encoding transcription factors, signal
transduction components and chromatin modifying enzymes that promote ES cell
self-renewal. They also occupy the promoters of a large set of developmental
transcription factors that are silent in ES cells, but whose expression is
associated with lineage commitment and cellular differentiation. Polycomb
Repressive Complexes co-occupy the genes encoding these developmental
transcription factors to help maintain a silent transcriptional state in ES cells
(Boyer et al. 2006; Lee et al. 2006; Wilkinson et al. 2006; Rajaskhar and
Begemann 2007; Stock et al. 2007).
External signals can promote ES cell pluripotency or cause these cells to
differentiate, but precisely how these pathways are connected to the ES cell
regulatory network has not been determined. These signals are produced by the
stem cell niche in the developing blastocyst or, for cultured ES cells, can be
produced by added factors or serum to maintain stem cell identity or promote
differentiation. Recent studies have demonstrated the importance of several
signaling pathways in maintaining or modifying ES cell state, including the
Activin/Nodal, Notch, BMP4 and Wnt pathways (Rao et al. 2004; Kristensen et al.
2005; Friel et al. 2005; Boiani and Scholer 2005; Valdimarsdottir and Mummery
2005; Dreesen and Brivanlou 2007; Pan and Thomson 2007). By understanding
how these signaling pathways influence the gene expression program of ES
cells, it should be possible to discover how they contribute to embryonic stem cell
identity or promote specific differentiation programs.
The Wnt/p-catenin signaling pathway has multiple roles in embryonic stem
cell biology, development and disease (Logan and Nusse 2004; Reya and
Clevers 2005; Clevers 2006). Several studies have shown that activation of the
Wnt pathway can cause ES cells to remain pluripotent under conditions that
induce differentiation (Kielman et al. 2002; Sato et al. 2004; Singla et al. 2006;
Hao et al. 2006; Ogawa et al. 2006; Miyabashi et al. 2007; Takao et al. 2007),
while other studies have shown that the Wnt pathway has an important role in
directing differentiation of ES cells (Otero et al. 2004; Lindsley et al. 2006).
Recent studies have shown that T Cell Factor-3 (Tcf3), a terminal component of
the Wnt pathway, acts to repress the Nanog gene in ES cells (Pereira et al.
2006), providing an important clue for at least one mechanism by which the Wnt
pathway regulates stem cell state. Nonetheless, we have an incomplete
understanding of how the pathway exerts its effects, in part because few target
genes have been identified for its terminal components in ES cells.
Stimulation of the canonical Wnt signaling pathway causes the
transcriptional co-activator p-catenin to translocate to the nucleus, where it
interacts with constitutively DNA-bound Tcf/Lef proteins to activate target genes
(Behrens et al. 1996; Brantjes et al. 2001; Cadigan 2002). Tcf3, a member of the
Tcf/Lef family, is highly expressed in murine embryonic stem (mES) cells and is
critical for early embryonic development (Korinek et al. 1998; Merrill et al. 2004;
Pereira et al. 2006). To determine how the Wnt pathway is connected to the
gene expression program of ES cells, we have determined the genome-wide
binding profile of Tcf3 and examined how perturbations of the pathway affect the
gene expression program. Remarkably, the genome-wide data reveal that Tcf3
co-occupies the ES cell genome with the pluripotency transcription factors Oct4
and Nanog. These and other results reveal that the Wnt pathway brings
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developmental signals directly to the core regulatory circuitry of ES cells, which
consists of the pluripotency transcription factors and Tcf3, together with their
mutual target genes.
Results
Identification of Tcf3 Bindinq Sites Genome-wide
To determine how the Wnt pathway regulates the gene expression program of
murine embryonic stem cells, we first identified genes occupied by Tcf3. Murine
embryonic stem cells were grown under standard conditions (Supplemental Fig.
S1) and DNA sequences occupied by Tcf3 were identified using chromatin
immunoprecipitation (ChIP) combined with DNA microarrays (ChIP-Chip). For
this purpose, DNA microarrays were designed with 60-mer oligonucleotide
probes tiling the entire non-repeat portion of the mouse genome. The results
revealed that Tcf3 occupies over 1000 murine promoters (Supplemental Table
S1), including those of the known Wnt targets Axin2 and Myc (Fig. 1A)(He et al.
1998; Yan et al. 2001; Jho et al. 2002).
Tcf3 Co-occupies the Genome with ES Cell Master Requlators
Inspection of the genes occupied by Tcf3 revealed a large set that were
previously shown to be bound by the homeodomain transcription factor Oct4
(Boyer et al. 2005; Loh et al. 2006), which is an essential regulator of early
development and ES cell identity (Nichols et al. 1998; Hay et al. 2004). To
examine the overlap of gene targets more precisely, we carried out ChIP-Chip
experiments with antibodies directed against Oct4 in mES cells and used the
same genome-wide microarray platform employed in the Tcf3 experiment.
Remarkably, the binding profiles of Tcf3 and Oct4 revealed that they bind the
same genomic regions and display identical spatial distribution patterns with
regards to transcription start sites (Fig. 1 B; Supplemental Fig. S2). These results
identified a set of 1224 genes that are co-occupied by Tcf3 and Oct4 at high
confidence (Supplemental Table SI) and suggested that the Wnt pathway
connects directly to genes regulated by Oct4 through Tcf3.
Previous studies in human embryonic stem cells have shown that Oct4
shares target genes with the transcription factors Nanog and Sox2 (Boyer et al.
2005), suggesting that Tcf3-occupied genes in murine ES cells should also be
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occupied by Nanog and Sox2. Additional genome-wide ChIP-Chip experiments
with antibodies directed against Nanog revealed that it does indeed bind the
same sites occupied by Oct4 and Tcf3 (Fig. 1B,C and 2, Supplemental Fig. S2).
The fact that Oct4 and Sox2 form heterodimers in ES cells (Dailey and Bascilico
2001; Okumura-Nakanishi et al. 2005) and frequently co-occupy promoters in
human ES cells (Boyer et al. 2005) makes it likely that Tcf3 co-occupies much of
the genome with Oct4, Nanog and Sox2.
The observation that Tcf3 co-occupies much of the genome with the ES
cell pluripotency transcription factors has a number of implications for the
regulatory circuitry of these cells. Tcf3 binds its own promoter as well as the
promoters of genes encoding Oct4, Sox2 and Nanog (Fig. 2). Thus Tcf3 is an
integral component of an interconnected autoregulatory loop, where all four
transcription factors together occupy each of their own promoters (Fig. 3A). This
feature of ES cell regulatory circuitry was previously described for Oct4, Sox2
and Nanog alone (Boyer et al. 2005) and has been postulated to be a common
regulatory motif for master regulators of cell state (Chambers et al. 2003;
Okumura-Nakanishi et al. 2005; Rodda et al. 2005; Odom et al. 2004; Odom et
al. 2006). Autoregulation is thought to provide several advantages to the control
of cell state, including reduced response time to environmental stimuli and
increased stability of gene expression (McAdams et al. 1997; Rosenfeld et al.
2002; Shenn-Orr et al. 2002; Thieffry et al. 1998). It is also notable that Tcf3
and the pluripotency transcription factors together occupy genes encoding many
Wnt pathway components (Supplemental Fig. S3), suggesting that this
transcription factor regulates much of its own signaling pathway apparatus
together with the pluripotency factors.
Figure 1
A.
-16 Tcf3 -16 Tcf
12 12
LU w
L0.2 o108733300 108744600 61806200 61823000
Chromosomal Position Chromosomal Position
1 Axin2 Ayc
20 Tcf3 2 Tcf3
5 Oct4 Oct4Nanog 15 l o ll
10
S5
81986000 8196300 95139000 9119300
Chromiosomnal Position Chromosomal Position
20 r3
Figure 1. Tcf3, Oct4 and Nanog co-occupy the genome in mouse ES cells.
(A) Tcf3 binds to known target genes. Examples of previously known Tcf3 bound
regions are displayed as unprocessed ChIP-enrichment ratios for all probes
within the chromosomal region indicated beneath the plot. The gene is depicted
below the plot, and the TSS and direction are denoted by an arrow.
(B) Tcf3, Oct4 and Nanog display nearly identical binding profiles. Analysis of
ChIP-chip data from genes bound by Tcf3, Oct4, or Nanog reveals that the three
factors bind to similar genomic regions at all promoters. Regions from -8kb to
+2kb around each TSS were divided into bins of 250bp. The raw enrichment
ratio for the probe closest to the center of the bin was used. If there was no
probe within 250bp of the bin center then no value was assigned. For genes with
multiple promoters, each promoter was used for analysis. The analysis was
performed on 3764 genes, which represents 4086 promoters. Promoters are
organized according to the distance between the maximum Tcf3 binding ratio
and the TSS.
(C) Tcf3, Oct4 and Nanog bind in close proximity at target genes. Plots display
unprocessed ChIP-enrichment ratios for all probes within the chromosomal
region indicated beneath the plot. The gene is depicted below the plot, and the
TSS and direction are denoted by an arrow.
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Tcf3, Oct4 and Nanog bind the promoters of Tcf3, Oct4, Sox2 and Nanog.
Plots display unprocessed ChIP-enrichment ratios for all probes within the
chromosomal region indicated beneath the plot. The gene is depicted below the
plot, and the TSS and direction are denoted by an arrow.
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Figure 3. Tcf3 is an integral component of the core regulatory circuitry of
ES cells.
(A) Tcf3 forms an interconnected autoregulatory loop with Oct4, Sox2 and
Nanog. Proteins are represented by ovals and genes by rectangles.
(B) Model showing a key portion of the regulatory circuitry of murine embryonic
stem cells where Oct4, Sox2, Nanog and Tcf3 occupy both active and silent
genes. The evidence that Oct4, Nanog and Tcf3 occupy these genes is
described here; Sox2 occupancy is inferred from previous studies in human ES
cells (Boyer et al. 2005). Evidence that the transcriptionally silent genes are
occupied by Polycomb Repressive Complexes is from Boyer et al. (2006) and
unpublished data and that these genes have stalled RNA polymerases is from
Guenther et al. (2007) and Stock et al. (2007). Proteins are represented by ovals
and genes by rectangles.
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A model for the core regulatory circuitry of ES cells has been proposed in
which the genes bound by the master regulators Oct4, Sox2 and Nanog fall into
two classes: transcriptionally active genes encoding transcription factors,
signaling components and other products that support the stem cell state, and
transcriptionally inactive genes, consisting mostly of developmental regulators,
where Polycomb is bound and RNA polymerase II is recruited, but transcription is
stalled (Boyer et al. 2005; Boyer et al. 2006; Lee et al. 2006; Guenther et al.
2007; Stock et al. 2007; Zeitlinger et al. 2007). Our results reveal that Tcf3,
together with the pluripotency regulators, is associated with both classes of
genes, and thus provide a modified model of the core regulatory circuitry of ES
cells (Fig. 3B). The association of Tcf3 with the set of genes encoding key
transcription factors, signaling pathway components, and developmental
regulators suggests that the Wnt signaling pathway contributes to the regulation
of these genes, thereby impacting embryonic stem cell pluripotency and self-
renewal.
Expression Analysis of Tcf3 Knockdown in mES Cells
Genes bound by Tcf/Lef proteins are thought to be repressed in the absence of
Wnt/p-catenin signaling and to be activated upon Wnt pathway stimulation
(Behrens et al. 1996; Brantjes et al. 2001; Miyabayashi et al. 2007; Daniels et al.
2005; Cavallo et al. 1998). Murine ES cells have low endogenous Wnt activity in
standard culture conditions and the Wnt pathway can be further stimulated in
culture (Dravid et al. 2005; Yamaguchi et al. 2005; Lindsley et al. 2006; Ogawa K
et al. 2006; Anton et al. 2007; Takao et al. 2007) (Supplemental Fig. S4). Thus it
is unclear whether Tcf3-occupied genes are being repressed or activated at the
low level of Wnt activity characteristic of standard ES cell culture conditions. To
investigate whether the effect of Tcf3 occupancy is to repress or to activate
genes, RNAi constructs were used to deplete Tcf3 mRNA in mES cells in two
independent experiments (Supplemental Fig. S5) and changes in global mRNA
levels were assayed with DNA microarrays (Fig. 4A). The -3.5% of mouse
genes whose mRNA levels changed by at least two-fold were significantly
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enriched for Tcf3 targets relative to genes whose expression was unaltered by
the Tcf3 knockdown (p value < 2 x 1010; Supplemental Fig. S6; Supplemental
Table S2). The genes whose expression increased upon loss of Tcf3 included
those encoding the master regulators Oct4, Sox2 and Nanog, other genes
involved in pluripotency such as Lefty2 and Nodal, and the Wnt pathway
component Dkk1 (Fig. 4A). The fact that upregulated genes are strongly
enriched for Tcf3 binding suggests that Tcf3 mainly acts to repress genes. Upon
loss of Tcf3, target genes are no longer repressed and can now be activated by
other factors (such as Oct4, Sox2 and Nanog) present at their promoters.
While expression of Tcf3 target genes was often up-regulated upon loss of
Tcf3, the expression of a substantial number of Tcf3-bound genes remained
unchanged, and a relatively small number of Tcf3-bound genes showed reduced
expression (Fig. 4A). Nearly half of the genes occupied by Tcf3, Oct4 and
Nanog are co-occupied by Polycomb Repressive Complexes (Boyer et al. 2006;
Lee et al. 2006; Wilkinson et al. 2006; Rajaskhar and Begemann 2007), and their
transcriptional state would not be expected to change as Polycomb would
prevent elongation of transcripts at these genes (Stock et al. 2007). Indeed, we
find that expression of genes occupied by Tcf3 and Polycomb do not show a
significant expression change upon loss of Tcf3 (p value > 0.4). There were
some Tcf3 target genes whose expression was down-regulated upon loss of
Tcf3; because mES cells have a low level of Wnt pathway activation, it is
possible that sufficient p-catenin enters the nucleus in order to associate with and
activate this subset of genes. Indeed, we find that some amount of p-catenin
does associate with Tcf3 and Oct4 as p-catenin can be detected in crosslinked
chromatin extracts immunoprecipitated for either Tcf3 or Oct4 (Supplemental Fig.
S7). It is also possible that the loss of expression of this set of Tcf3 target genes
is a secondary consequence of the knockdown. The repressive activity of Tcf3
appears to be its dominant function for most genes under these conditions, as
the set of Tcf3 bound genes were found to have a significantly higher increase in
expression upon knockdown compared to all genes (Fig. 4A; p value < 7 x 105).
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Expression Analysis of Wnt Pathway Activation in mES Cells
We next studied the effect of increased stimulation of the Wnt pathway on Tcf3
target genes in murine ES cells. Cells were treated with Wnt3a conditioned
media in two independent experiments, and changes in global mRNA levels were
assayed with DNA microarrays (Fig. 4B). The <1% of mouse genes whose
mRNA levels changed by at least two-fold in the Wnt treated cells were
significantly enriched for Tcf3 targets relative to genes whose expression was
unaltered by the addition of Wnt (p value < 1.5 x 10-5; Supplemental Fig. S8;
Supplemental Table S3). The genes whose expression most increased encode
the pluripotency factors Oct4 and Nanog, Wnt pathway components such as
Wnt8a and Dkkl, and known Wnt targets such as Brachury (Fig. 4B). These
results are consistent with a model where Tcf3 acts to partially repress many of
its target genes under standard mES cell culture conditions, yet contributes to
increased expression of its target genes under conditions of increased Wnt
stimulation. We would therefore expect a correlation between genes up-
regulated upon loss of Tcf3 and genes up-regulated upon Wnt stimulation.
Indeed, we do find these gene sets to be significantly correlated (p value < 1 x
108; Supplemental Fig. S9). Although a significant portion of Tcf3 target genes
undergo expression changes upon Wnt stimulation, it is possible that a second
class of Tcf3 target genes are regulated independently of Wnt signaling and
therefore are uninfluenced by changes in pathway activation (Yi and Merrill
2007). In fact, several studies have shown a p-catenin independent role for Tcf3
(Kim et al. 2000; Merrill et al. 2001; Roel et al. 2002). It should also be noted that
ES cells express other mammalian Tcf/Lef proteins and that these factors may
also mediate the functional consequences of Wnt signaling (Pereira et al., 2006).
Influence of Tcf3 and Wnt on Pluripotency Requlators and ES Cell State
Evidence that Tcf3 is an integral component of the core transcriptional circuitry of
ES cells that functions to partially repress transcription of pluripotency genes led
us to examine whether Tcf3 knockdown enhances features of ES cells
associated with pluripotency and self-renewal. Quantitative real-time PCR
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analysis demonstrated that Tcf3 knockdown in mES cells results in higher
transcript levels for the pluripotency genes Oct4, Sox2 and Nanog (Fig. 4C).
Upregulation of Nanog upon Tcf3 depletion confirms a previous report that Tcf3
acts to repress this gene under normal ES cell growth conditions (Pereira et al.
2006). Thus the results of the Tcf3 knockdown experiment indicate that under
normal conditions Tcf3 functions to reduce expression of the three pluripotency
regulators.
We next measured the levels of Oct4 and Nanog proteins in ES cells
subjected to Tcf3 knockdown. The results of immunofluorescence experiments
show that there are substantial increases in the levels of Oct4 and Nanog
transcription factors in the nucleus of such cells (Fig. 4D). There is a significant
increase of Oct4 in Tcf3 knockdown cells compared to control cells based on
quantitative measurements of staining intensity using Cellomics software (Fig.
4E). Remarkably, Tcf3 knockdown mES cells display enhanced proliferation and
Oct4 staining in the absence of feeders and LIF compared to control cells,
supporting previous results (Fig. 4F; Supplemental Fig. S10)(Pereira et al. 2006).
Previous studies have demonstrated that activation of the Wnt/p-catenin pathway
can have similar effects on ES cell pluripotency (Sato et al. 2003; Singla et al.
2006; Hao et al. 2006) and we also find that cells treated with Wnt conditioned
media show increased staining of Oct4 (Supplemental Fig. S11). The
observation that Tcf3 knockdown and Wnt stimulation have similar functional
consequences is consistent with the expression data described above for ES
cells subjected to Tcf3 knockdown and ES cells treated with Wnt3a CM. These
studies demonstrate the functional importance of Tcf3 occupancy and Wnt
pathway activation for a subset of target genes that includes the pluripotency
regulators.
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Knockdown of Tcf3 and activation of the Wnt pathway in mES cells reveals
a role for Tcf3 in repression of target genes and a role in regulating
pluripotency.
(A) Tcf3 knockdown results in up-regulation of target genes. The effect of Tcf3
knockdown on gene expression was measured by hybridization of labeled RNA
prepared from Tcf3 knockdown cells against RNA prepared from cells infected
with non-silencing control lentivirus at 48 hours post infection. A heat map of
biological replicate datasets of expression changes was generated where genes
are ordered according to average expression change. Tcf3 target genes have a
higher average expression change than the average for all genes upon
knockdown of Tcf3.
(B) Wnt conditioned media (CM) results in up-regulation of Tcf3 target genes.
The effect of Wnt activation on gene expression was measured by hybridization
of labeled RNA prepared from mES cells grown in Wnt CM against RNA
prepared from cells grown in mock CM. A heat map of biological replicate
datasets of expression change upon addition of Wnt conditioned media where
genes are ordered according to average expression change of replicates. Tcf3
target genes have a higher average expression change than the average for all
genes upon addition of Wnt CM.
(C) Tcf3 knockdown results in increased expression of Oct4, Sox2 and Nanog.
Real-time PCR demonstrates that Oct4, Sox2 and Nanog have increased
expression upon knockdown of Tcf3. Values are normalized to Gapdh transcript
levels, and fold change is relative to cells transfected with a non-silencing hairpin.
(D) Tcf3 knockdown results in increased staining for Oct4 and Nanog.
Immunofluorecence was performed on mES cells grown one passage off of
feeders that were either infected with Tcf3 knockdown lentivirus or infected with
non-silencing control lentivirus. Cells were fixed with 4% paraformaldehyde 96
hours post-infection. Cells were stained with Oct4, Nanog and DAPI. Images for
Oct4 and Nanog staining were taken at 40x magnification and an exposure time
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of 300 msec. Tcf3 KD 1 and 2 represent different knockdown hairpin constructs.
Tcf3 KD 2 is the virus also used in panels 4A,C,E,F.
(E) Tcf3 knockdown results in a significant increase of Oct4 staining.
Quantification of Oct4 staining was performed in cells infected with Tcf3 or Gfp
knockdown virus.
(F) Tcf3 knockdown cells proliferate over more passages in the absence of LIF.
Relative cell numbers of ES cells transfected with Tcf3 or control virus through
multiple passages off of feeders in the presence or absence of LIF. Identical cell
numbers were initially plated and cells were split 1:12 every 2-3 days. Cells were
counted at each passage and values for cells grown in the absence of LIF were
normalized to cells grown in the presence of LIF.
Discussion
It is fundamentally important to determine how signaling pathways control ES cell
pluripotency and differentiation and how these pathways connect to discrete sets
of target genes to affect such states. We have found that a terminal component
of the Wnt signaling pathway, the transcription factor Tcf3, is physically
associated with the same genomic sites as the pluripotency regulators Oct4 and
Nanog in murine embryonic stem cells. This result reveals that the Wnt pathway
is physically connected to the core regulatory circuitry of these cells. This core
circuitry consists of two key features: an interconnected autoregulatory loop and
the set of target genes that are mutually bound by the pluripotency transcription
factors and Tcf3.
The genome-wide datasets we report here enhance our knowledge of the
targets of Oct4, Nanog and Tcf3. These new datasets were generated using the
same protocols and genome-wide tiling microarrays in ES cells grown under
identical conditions, allowing more reliable conclusions about the overlap of
these factors throughout the genome; previous datasets for these factors came
from different murine ES cells grown in different settings, using different
chromatin IP analysis platforms, and these data were not always genome-wide
(Boyer et al. 2005; Boyer et al. 2006; Loh et al. 2006). The new data reveal, for
example, the remarkable extent to which Oct4 and Nanog binding overlap
throughout the ES cell genome and the striking association of Tcf3 with those
sites (Fig. 1 B). The new data also provide a revised model for the core
regulatory circuitry of murine ES cells, which incorporates Tcf3 and high
confidence target genes of key ES cell regulators (Fig. 3).
The revised model of core regulatory circuitry extends our knowledge of
how extracellular signals from the Wnt pathway contribute to stem cell state.
Pereira et al. (2006) demonstrated that Tcf3 binds the Nanog promoter and
represses its mRNA expression in mES cells. Our data confirm Tcf3 binding and
function at Nanog and extend our knowledge of Tcf3 targets to the other well-
characterized pluripotency regulators Oct4 and Sox2, as well as most of their
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target genes. Pereira et al. (2006) proposed a model wherein Tcf3-mediated
control of Nanog levels allows stem cells to balance the creation of lineage-
committed and undifferentiated cells. Our results also support this model, but
argue that Tcf3 contributes to the balance through its functions in the core
regulatory circuitry described here.
Our results suggest that the Wnt pathway, through Tcf3, influences the
balance between pluripotency and differentiation in ES cells, as modeled in
Figure 5. Under standard culture conditions, where there is a low-level of Wnt
activation, ES cells are poised between the pluripotent state and any of a number
of differentiated states. It is well established that Oct4, Sox2 and Nanog act to
promote the pluripotent state, as depicted in the model where the influence of
these factors is shown by an arrow. Under standard culture conditions, Tcf3 may
exist in an activating or repressive complex, but is predominantly in a repressive
complex promoting differentiation. The loss of Tcf3 in Tcf3 knockdown cells,
would, in this model, favor pluripotency. Wnt stimulation converts the repressive
complex to an activating complex and thus promotes pluripotency. Our results
suggest that the Wnt pathway, through Tcf3, influences the balance between
pluripotency and differentiation by bringing developmental signals directly to the
core regulatory circuitry of ES cells. The observation that the Wnt pathway can
be manipulated to affect the balance between pluripotency and differentiation
suggests that perturbation of this pathway may impact the efficiency of
reprogramming somatic cells into pluripotent stem cells.
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Figure 5. Model depicting the influence of Wnt pathway components on
pluripotency and differentiation in ES cells.
ES cells are poised between the pluripotent state and any of a number of
differentiated states. Oct4, Sox2 and Nanog act to promote the pluripotent state
(depicted by an arrow). Tcf3 can exist in an activating complex with p-catenin or
a repressive complex with Groucho (Reya and Clevers, 2005). Under standard
growth conditions, the Wnt pathway is only active at low levels (Dravid et al.
2005; Yamaguchi et al. 2005; Lindsley et al. 2006; Ogawa K et al. 2006; Anton et
al. 2007; Takao et al. 2007)(Supplemental Fig. S4). Therefore Tcf3 is mainly in a
repressive complex promoting differentiation (depicted by a thick arrow),
although some Tcf3 associates with p-catenin to activate target genes and
promote pluripotency (depicted by a thin arrow). In Tcf3 knockdown cells, there
is no influence from Tcf3 on cell state. Thus the balance is tipped towards
maintaining pluripotency. Upon Wnt stimulation, the balance again tips towards
maintaining pluripotency as more Tcf3 associates with p-catenin in an activating
complex (depicted by a thick arrow). This model is not meant to imply that Wnt
or Tcf3 are themselves pluripotency factors, but rather that they can influence
cell state in the presence of other pluripotency factors, such as Oct4, Sox2 and
Nanog.
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Materials and methods
Mouse embryonic stern cell culture conditions
V6.5 murine ES cells were grown on irradiated murine embryonic fibroblasts
(MEFs) unless otherwise stated. Cells were grown under mES cell conditions as
previously described in Boyer et al. (2005). Briefly, cells were grown on 0.2%
gelatinized tissue culture plates in DMEM-KO (Invitrogen 10829-018)
supplemented with 15 % fetal bovine serum (Hyclone, Characterized
SH3007103), 1000 Units/mL leukemia inhibitory factor (LIF) (ESGRO ESGI 106),
100pM nonessential amino acids (Invitrogen 11140-050 ), 2mM L-glutamine
(Invitrogen 25030-081 ),100 Units/mL pennicillin and 100 pg/mL streptomycin
(Invitrogen 15140-122), and 8 nL/ml 2-mercaptoethanol (Sigma M7522).
Genome-wide location analysis
Chromatin immunoprecipitation protocol
Protocols describing ChIP methods were downloaded from
http://iura.wi.mit.edu/younq public/hESregulation/ChIP.html with slight
modifications. Briefly, 108 mES cells were grown for one passage off of feeders
and then crosslinked using formaldehyde. Cells were resuspended, lysed in lysis
buffer and sonicated to solubilize and sheer crosslinked DNA. Triton X-100 and
SDS were added to the lysate after sonication to final concentrations of 1% and
0.1% respectively. The resulting whole cell extract was incubated at 40C
overnight with 100 uL of Dynal Protein G magnetic beads that had been
preincubated with 10 ug of the appropriate antibody overnight. After 16-18
hours, beads were washed with the following 4 buffers for 4 minutes per buffer:
low salt buffer (20mM Tris pH 8.1, 150mM NaCI, 2mM EDTA, 1% Triton X-
100, 0.1% SDS), high salt buffer (20mM Tris pH 8.1, 500mM NaCI, 2mM EDTA,
1% Triton X-100, 0.1% SDS), LiCI buffer (10mM Tris pH 8.1, 250mM LiCI, 1mM
EDTA, 1% deoxycholate, 1% NP-40), and TE+ 50mM NaCl. Bound complexes
were eluted from the beads in elution buffer by heating at 65*C with occasional
vortexing, and crosslinks were reversed by overnight incubation at 650C.
ChIP Antibodies
Cell extracts were immunoprecipitated using antibodies against Tcf3 (Santa Cruz
sc-8635), Oct4 (Santa Cruz sc-8628) or Nanog (Bethyl Labs bl1662).
Array Design
The murine 244k whole genome array was purchased from Agilent Technology
(www.agilent.com). The array consists of 25 slides each containing -244,000
60mer oligos (slide ID 15310-3, 15317, 15319-21, 15323, 15325, 15327-30,
15332-7, 15339-41, 15343-44) covering the entire non-repeat portion of the
mouse genome at a density of about 1 oligo per 250bp.
Data Normalization and Analysis
Data normalization and analyses were performed as previously described in
Boyer et al. (2005).
Tcf3 Knockdown
Lentiviral Production
Lentivirus was produced according to Open Biosystems Trans-lentiviralTM shRNA
Packaging System (TLP4614). The shRNA constructs targeting murine Tcf3
were designed using an siRNA rules based algorithm consisting of sequence,
specificity and position scoring for optimal hairpins that consist of a 21 base stem
and a 6 base loop (RMM4534-NM-009332). Five hairpin constructs were used to
produce virus targeting Tcf3. A negative control virus was made from the
pLKO.1 empty vector (RHS4080).
Lentiviral Infection of mES Cells
Murine V6.5 ES cells were plated at approximately 30% confluence on the day of
infection. Cells were seeded in 2x mES media with 6 ug/ml of polybrene (Sigma
H9268-10G) and Tcf3 knockdown or control (pLKO.1) virus was immediately
added. After 24 hours, infection media was removed and replaced with mES
media with 2 ug/ml of Puromycin (Sigma P8833). RNA was harvested at 48
hours after infection.
Knockdown Efficiency
Knockdown efficiency was measured using real-time PCR to measure levels of
Tcf3 mRNA (Supplemental Fig. S5).
RNA Isolation, Real-time PCR and Analysis of Transcript Levels
To determine transcript levels by RT-PCR, RNA was isolated from approximately
106 - 107 mES cells using TRIzol reagent following the protocol for cells grown in
monolayer (Invitrogen 15596-026). Samples were treated with Dnase I
(Invitrogen 18068-015) and cDNA was prepared using SuperScript III reverse
transcriptase kit (Invitrogen 180808-051) using oligo dT primed first strand
synthesis. Real-time PCR was carried out on the 7000 ABI Detection System
using Taqman probes for the housekeeping gene Gapdh (Applied Biosystems
Mm99999915_g1) as a control and genes of interest (Applied Biosystems; Tcf3
Mm00493456_ml, Oct4 Mm00658129_gH, Sox2 Mm00488369_s1, Nanog
Mm02384862_g1).
Expression Arrays
Genomic expression analysis was measured using Agilent Whole Mouse
Genome Microarrays (Agilent G4122F). 2 ug of RNA was labeled for each
sample using the Two-color Low RNA Input Linear Amplification Kit PLUS
(Agilent 5188-5340). RNA from the treated sample (either Tcf3 KD cells or cells
treated with Wnt3a conditioned media) were labeled with Cy5 and RNA from
control cells (infected with empty-vector virus or a mock conditioned media
control, respectively) were labeled with Cy3. Labeled cRNA was hybridized
overnight at 650C. Slides were washed according to the Agilent protocol and
scanned on an Agilent DNA microarray scanner BA. Data was analyzed using
Agilent Feature Extraction Version 9.5.3 with default settings recommended by
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Agilent. Flagged and low-intensity spots were then removed and spots
representing a single gene were averaged.
Wnt Pathway Activation
Wnt pathway activity in mES cells was stimulated using Wnt3a conditioned
media (ATCC CRL-2647) and mock conditioned media (ATCC CRL-2648) was
used as a control. Preparation of conditioned medias was performed as per
protocol provided with the cells. Conditioned media was diluted with mES media
at a ratio of 1:1.
Immunohistochemical Analysis
Mouse ES cells were crosslinked for 10 minutes at room temperature with 4%
paraformaldehyde. Cells were permeabilized with 0.2% Triton X-100 for 10
minutes and stained for Oct4 (Santa Cruz, sc-5279; 1:200 dilution), Nanog
(Abcam, abl 603; 1:250 dilution), and DAPI Nucleic Acid Stain (Invitrogen D1 306;
1:10000 dilution) overnight at 40C. After several washes cells were incubated for
2 hours at room temperature with goat-anti mouse conjugated Alexa Fluor 488
(Invitrogen 1:200 dilution) or goat-anti rabbit conjugated Alexa Fluor 568
(Invitrogen 1:200 dilution).
Quantitative Imaqe Acquisition and Data Analysis
Image acquisition and data analysis was performed essentially as described in
Moffat et al. (2006). Five days post infection cells were fixed and stained with
Oct4 and Hoechst 33342 (1:1000 dilution). Stained cells were imaged on an
Arrayscan HCS Reader (Cellomics) using the standard acquisition camera mode
(10x objective, 9 fields). Hoechst was used as the focus channel and intra-well
focusing was done every 3 fields. The Apotome feature was applied to acquire
all images. Objects selected for analysis were identified based on the Hoechst
staining intensity using the Target Activation Protocol and the Isodata Threshold
method. Parameters were established requiring that individual objects pass an
intensity and size threshold. The Object Segmentation Assay Parameter was
adjusted for maximal resolution. Following object selection the average Oct4
intensity was determined and then a mean value for each well was calculated.
All wells used for subsequent analysis contained at least 5000 selected objects.
Supplemental Data
Supplemental Data includes nine figures, three tables and Supplemental text and
can be found with this article at
http://www.qenesdev.orq/cqi/content/full/22/6/746/DC1.
Accession Numbers
All microarray data from this study are available at ArrayExpress at the EBI
(http://www.ebi.ac.uk.arrayexpress) under the accession designation E-TABM-
409.
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Abstract
Transforming growth factor beta (TGF-p1) signaling, which is involved in diverse
developmental processes, is effected through the transcription factors Smad2
and Smad3, which require interaction with other transcription factors to stably
bind DNA. Cell-type specific variation in the transcription factor milieu has been
proposed to play a role in determining the cell-specific effects of TGF-p signaling,
but the mechanism by which these Smad proteins exert their broad range of
effects remains unclear. We report here that Smad3 co-occupies genomic sites
with the master transcription factors that determine cellular identity and thereby
transmits signals to the genes associated with these sites. Smad3 co-occupies
sites with the master regulators Oct4, Sox2 and Nanog in ES cells, with Myod1 in
myotubes, and with PU.1 in pro-B cells. In each cell type, genes bound by these
master regulators of cell state are regulated by TGF-p signaling. We conclude
that TGF-p signals are directed to unique genomic sites in different cell types
through association of Smad proteins with the key transcription factors that
determine cellular identity.
Introduction
TGF-p signaling directs essential cellular responses including differentiation,
proliferation, cell cycle arrest and migration, and through these responses plays a
central role in stem cell biology, development, autoimmunity, tumorigenesis and
metastasis (Li and Flavell, 2008; Massague et al., 2005; Padua and Massague,
2009). Activation of the TGF-p receptor leads to phosphorylation of the
transcription factors Smad2 and Smad3 (Smad2/3), allowing these proteins to
accumulate in the nucleus in association with Smad4, where they regulate
transcription of specific genes (Ross and Hill, 2008). Smad3 and the less
common isoform of Smad2 can both bind DNA directly through interaction with
the Smad binding element (SBE) (Dennler et al., 1998; Shi et al., 1998; Zawel et
al., 1998). However, this short binding element is not sufficient for Smad proteins
to bind to DNA alone, so Smad proteins must interact with additional transcription
factors in order to stably bind DNA (Ross and Hill, 2008; Shi et al., 1998). Much
progress has been made in the last decade in understanding how the Smad
proteins can interact with a transcription factor to regulate expression of a
specific gene in a specific cell type (Choy and Derynck, 2003; Gomis et al., 2006;
Hanai et al., 1999; Ross and Hill, 2008; Seoane, 2004). Nonetheless, the
mechanisms responsible for the pleiotropic effects of TGF-p signaling in various
cell types is poorly understood, in part because only a fraction of Smad target
genes have been identified in a limited number of cell types.
While cells express many different transcription factors, cellular identity
can be determined by a small number of key transcription factors (Feng et al.,
2008; Lassar et al., 1986; Seale et al., 2008; Takahashi and Yamanaka, 2006;
Zhou et al., 2008). The concept that a few master transcription factors can
control and even reprogram cell identity, and evidence that transcription factors
can function to make DNA more accessible to other DNA-binding factors (Barrera
and Ren, 2006; Cairns, 2009; Narlikar et al., 2002; Panne, 2008; Roeder, 2005;
Segal and Widom, 2009), led us to investigate the hypothesis that Smad3 might
preferentially interact with sites occupied by master regulators in various cell
types.
Results and Discussion
TGF-p signaling via Smad2 and Smad3 is required to maintain human embryonic
stem (ES) cell identity (Beattie et al., 2005; James et al., 2005; Vallier et al.,
2005; Vallier et al., 2009; Xu et al., 2008). If Smad2 and Smad3 preferentially
interact with sites occupied by key regulators of cell state, then we would expect
that either protein could be found at sites occupied by Oct4, which is a master
regulator of ES cells (Chambers, 2004; Hay et al., 2004; Matin et al., 2004;
Nichols et al., 1998; Zaehres et al., 2005). To identify the sites occupied by
Smad3 and Oct4 in human ES cells, we performed chromatin
immunoprecipitation combined with massively parallel DNA sequencing (ChIP-
seq) using antibodies against both of these proteins (Fig. 1). The results showed
a striking association of Smad3 and Oct4 at well-studied Oct4 target genes (Fig.
1A) and throughout the genome (Fig. 1B, table SI). Over 80% of the 1000
highest confidence Smad3-bound regions were also occupied by Oct4. De-novo
DNA sequence motif analysis (Bailey and Elkan, 1994) revealed that the sites
occupied by Smad3 were highly enriched in the Oct4 binding sequence (Fig. 1C),
and inspection of each bound region revealed that the Smad binding element
(SBE) (Ross and Hill, 2008) was also enriched at these sites (Fig. 1D). These
results suggest that in human ES cells, Smad3 does not co-occupy DNA with a
large variety of transcription factors, but instead predominantly binds DNA sites
co-occupied by Oct4 that contain adjacent SBEs.
Human and mouse ES cells are both capable of responding to TGF-
p signaling through activation of Smad2 and Smad3 (James et al., 2005;
Rossant, 2008). To take advantage of the considerable knowledge of
transcriptional circuitry in murine ES cells, where genome-wide binding data is
available for many transcription factors (Chen et al., 2008; Kim et al., 2008; Loh
et al., 2006; Marson et al., 2008), we performed ChIP-seq to determine if Smad3
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Figure 1. Smad3 and Oct4 co-occupy DNA sites in human ES cells.
(A) Gene tracks represent binding of Oct4 (blue) and Smad3 (red) at Pou5fl, the
gene encoding Oct4 (top) and Leftyl (bottom) in human ES cells (BGO3) (online).
The x-axis represents the linear sequence of genomic DNA and the y-axis in all
tracks represents the total number of binding events. The black horizontal bar
above the tracks indicate the genomic scale in kilobases (kb), and the gene map
is located beneath the tracks. Black boxes represent exons and the arrow
indicates the location and direction of transcription initiation.
(B) Smad3 and Oct4 co-occupy the genome. Region plots show the distribution
of Oct4- (left) and Smad3- (Amsen et al.) bound regions relative to Oct4-bound
regions. For each Oct4-bound region (y-axis) the presence of Oct4-bound
regions (left) and Smad3-bound regions (Amsen et al.) are displayed within a 5
kb window centered on the Oct4-bound region. Intensity at the midpoint
indicates that bound regions overlap. 7532 regions are occupied by Oct4 and
5282 are occupied by Smad3.
(C) Smad3 binding sites are enriched for the Oct4 motif. Motif discovery was
performed using Oct4- and Smad3-bound regions identified by ChIP-seq. The
motif enriched at Oct4-bound regions (top) and Smad3-bound regions (center)
were identified using MEME (Bailey and Elkan, 1994).
(D) The Smad motif (Smad binding element, SBE) is enriched at both Oct4 and
Smad3 binding sites. The histogram shows the frequency of the canonical SBE
or the reverse complement (y-axis) relative to the distance from the peak (x-axis)
of Oct4 for all Oct4-bound regions (left) and Smad3 for all Smad3-bound regions
(Amsen et al.).
co-occupies DNA binding sites with Oct4, Sox2 and Nanog. These three
transcription factors make up the core regulatory circuitry of transcription factors
in ES cells and are required to maintain ES cell state (Boyer et al., 2005; Chen et
al., 2008; Kim et al., 2008; Loh et al., 2006; Marson et al., 2008). We found that
Smad2/3 (fig. S1) and Smad3 tend to bind at DNA sites occupied by these
master transcription factors in murine ES cells, and this co-occupancy occurs at
sites enriched for the SBE (Fig. 2A, B, table S1). Recent evidence of a
biochemical interaction between Smad2/3 and Nanog (Vallier et al., 2009)
suggests that Nanog may contribute to recruitment of Smad2/3 to these sites. To
exclude the possibility that Smad3 was enriched at sites of all highly expressed
transcription factors, we asked if Smad3 co-occupied DNA sites with Zfx, which
does not co-occupy many sites bound by Oct4 (Chen et al., 2008). While Smad3
was enriched at DNA sites bound by Oct4, Sox2 and Nanog, Smad3 was not
enriched at sites bound by Zfx (Fig. 2B). Furthermore, there were fewer SBEs at
sites bound by Zfx (Fig. 2B, bottom).
If Smad3 co-occupies DNA with Oct4, Sox2 and Nanog, we would predict
that genes bound by these master transcription factors are modulated by TGF-p
signaling, while genes that are bound by Zfx are not affected. To test this we
performed genome-wide expression analysis under normal culture conditions
and in the presence of a TGF-p inhibitor and found that genes bound by Smad3,
Oct4, Sox2 and Nanog were significantly affected by inhibition of TGF-p signaling
while genes bound by Zfx were not (Fig. 2C, table S2,S3). These results suggest
that TGF- signaling, through activation of Smad2 and Smad3, is directed to the
set of genes regulated by the master transcription factors, which are responsible
for maintaining ES cell identity.
Figure 2
Smad3 and the core regulatory circuitry
co-occupy DNA sites
10kb
18 OCM4
231o Sox2
211 1 Nanog
"I..L ."'"""
Po~ft -enaO
10 kb
21=Nanog
LeftylC.
Smad3 and the core regulatory circuitry co-occupy the genome
Smad3
C inhibitbig the TGF-p pathway afects genes
bound by the core regulatory circuitry
0-10
dS
-2.5 0 +2.5 -2.5 0 +2.5 45 0 +2.54 0 +2.5 -2.5 a +2.5 45 0 +2.5
Distance from bound region (kb)
Figure 2. Smad3 and the core regulatory circuitry of transcription factors
co-occupy DNA binding sites in mouse ES cells.
(A) Gene tracks represent binding of Oct4, Sox2, Nanog (Marson et al., 2008)
and Smad3 at Pou5fl, the gene encoding Oct4 (left) and at Leftyl (Amsen et al.).
Similar results were found using an antibody against Smad2/3 (fig. SI).
(B) Smad3 and the core regulatory circuitry co-occupy the genome. Region plots
show the distribution of Smad3-bound regions relative to regions bound by Oct4,
Sox2, Nanog (Marson et al., 2008), Smad3, Zfx (Chen et al., 2008) and matched
background control. The distribution of Smad3-bound regions (red) is shown
relative to all bound regions for the indicated transcription factors (y-axis) in a 5
kb window centered on the bound region for each transcription factor.
Background represents 10000 DNA regions with the same average distribution
relative to the transcription start site (TSS) as the other transcription factors
shown. Enrichment of the SBE (Smad motif) relative to the binding site of each
transcription factor is indicated below each plot.
(C) Inhibiting the TGF-p pathway affects genes bound by the core regulatory
circuitry of transcription factors. Mouse ES cells were cultured under normal
conditions or in the presence of the TGF-p inhibitor, SB431542 (James et al.,
2005) for 24 hours. The significance of the overlap between genes affected by
SB431542 and genes bound by each transcription factor (x-axis) was calculated
using the hypergeometric distribution and is plotted on the y-axis. O/S/N
represents genes bound by Oct4, Sox2 and Nanog.
We next asked if Smad3 DNA-binding sites are conserved between
different cell types or if Smad3 binding sites are cell-type specific. We performed
ChIP-seq profiling to identify the genome-wide binding sites of Smad3 in mouse
myotubes and pro-B cells and found that Smad3 occupies very different DNA
binding sites in each cell type (Fig. 3A, table S1). Only 0.7% of Smad3-bound
regions were conserved between ES cells and pro-B cells, 1.1% were conserved
between ES cells and myotubes and 3.0% were conserved between myotubes
and pro-B cells. These results indicate that there are remarkably few universal
Smad3 binding sites and, instead, demonstrate that Smad3 binding is highly cell-
type specific.
Motif discovery identified the Oct4 motif in Smad3-bound regions in
human ES cells (Fig. 1C), and we used this method to identify transcription
factors that might co-occupy Smad3 binding sites in mouse ES cells, myotubes
and pro-B cells (Fig. 3B, S2). The Smad3-bound regions in mouse ES cells were
most enriched for the Oct4 motif, while in myotubes the Smad3-bound regions
were most enriched for an E-box motif (Tapscott, 2005) and in pro-B cells the
Smad3-bound regions were most enriched for an Ets motif (Fig. 3B)
(Kodandapani et al., 1996).
Myotube formation in C2C12 cells is directed by Myod1, an E-box protein
that functions as a key determinant of muscle cell differentiation (Davis et al.,
1987; Tapscott, 2005). TGF-p signaling in muscle cells causes atrophy
(Zimmers et al., 2002) and has been suggested to function by inhibiting
expression of muscle-specific genes (Liu et al., 2001). We used ChIP-seq
profiling to identify genome-wide DNA binding targets of Myod1 in C2C12
myotubes to determine if Smad3 and Myod1 occupy the same DNA binding sites.
The results demonstrate that Smad3 co-occupies sites bound by Myod1 in
myotubes (Fig. 3C,E, table SI). Over 75% of the 1000 highest confidence
Smad3-bound regions in myotubes are occupied by Myod1 (Fig. 3F), including
the Myodi enhancer (Fig. 3C) (Tapscott, 2005). Smad3 and Myod1 have been
shown to interact biochemically (Liu et al., 2001), suggesting how Smad3 may be
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Figure 3. Smad3 co-occupies DNA with different master transcription
factors in different cell types.
(A) Smad3 binds unique sites in different cell types. The Venn diagram shows
overlap of Smad3-bound regions between three cell types. ChIP-seq was
performed to identify genome-wide binding sites for Smad3 in mouse ES cells,
C2C12 cells induced to form myotubes and the pro-B cell line, 38B9 (table S1).
The numbers represent the total Smad3-bound regions in each shaded area.
C2C12 myotubes and 38B9 cells were stimulated with TGF-p prior to analysis.
All ChIP-seq binding data shown for myotubes and pro-B cells contain merged
biological replicates.
(B) Smad3 binding sites are enriched for motifs of cell-specific master
transcription factors. The top identifiable motifs enriched at the Smad3-bound
regions in mouse ES cells (top), myotubes (center) and pro-B cells (bottom) are
shown.
(C) Smad3 and Myod1 co-occupy DNA sites in myotubes. Gene tracks
represent Myod1 (purple) and Smad3 (red) binding at Myod1 (top) and Adoral
(bottom).
(D) Smad3 and PU.1 co-occupy DNA sites in pro-B cells. Gene tracks represent
PU.1 (green) and Smad3 (red) binding at Vpreb3 (top) and Spfil (bottom).
(E) Smad3 co-occupies binding sites with cell-specific master transcription
factors. Region plots show the distribution of Smad3-bound regions in mouse ES
cell (ESC, left), myotubes (center) and pro-B cells (Amsen et al.) relative to
regions bound by Oct4 in ES cells (top), Myod1 in myotubes (middle) and PU.1
(bottom).
(F) Over 70% of Smad3 sites are also bound by the master transcription factors
in each cell type. The percentage of Smad3-bound regions (y-axis) that are co-
occupied by Oct4, Myod1 and PU.1 are indicated for ESCs, myotubes, and pro-B
Cells. Percentages were calculated using the 1000 highest-confidence Smad3-
bound regions for each cell-type.
recruited to these sites. These results suggest that the primary effect of TGF-p
signaling in myotubes may be directed at genes bound by Myod1.
Pro-B cell development requires the Ets family member, PU.1, for
specification and proliferation of early B cell fates (DeKoter and Singh, 2000; Nutt
and Kee, 2007), and TGF-p signaling inhibits proliferation in early B cell
development (Lee et al., 1989). We performed ChIP-seq profiling to identify DNA
sites bound by PU.1 in the pro-B cell line 38B9 and found that Smad3 co-
occupies sites bound by PU.1 (Fig. 3D-E, table SI). Over 70% of the 1000
highest confidence Smad3 binding sites in pro-B cells were also bound by PU.1
(Fig. 3F), including Sfpil, the gene encoding PU.1 (Fig. 3D). Thus, Smad3 binds
to different sites in three different cell types, and in each case these sites are co-
occupied by the master transcription factors specific for that cell type (Fig. 3E).
These results suggest that the primary effect of TGF-p signaling may be directed
at genes bound by master transcription factors.
Our results indicate that TGF-p signaling regulates genes bound by the
master transcription factors in ES cells (Fig. 2C), so we sought to determine
whether TGF-p signaling regulates genes bound by the master transcription
factors in other cell types. We performed genome-wide expression analysis
before and after stimulation with TGF-p in both myotubes and pro-B cells. We
found that TGF-p signaling tended to affect a unique set of genes in each cell
type (Fig. 4A). If the TGF- P pathway targets genes bound by master
transcription factors, we would expect that the genes affected in each cell type
would tend to be bound by the cell-specific master transcription factors. Indeed,
we found that TGF-p signaling preferentially affected genes bound by Oct4 in ES
cells (Fig. 4B, table S2,S3), Myod1 in myotubes (Fig. 4C) and PU.1 in pro-B cells
(Fig. 4D). These results demonstrate that Smad3 co-occupies DNA binding sites
with transcription factors that control cell state in multiple cell types and directs
TGF-p signaling to regulate expression of the genes bound by these master
transcription factors.
Why might Smad3 preferentially co-occupy and function at sites with
master regulators of cell state? Transcriptional regulators of cell state tend to be
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expressed at high levels relative to other transcription factors. These
transcription factors can nucleate cooperative binding as well as recruit ATP-
dependent chromatin remodeling factors and histone acetyl transferases, which
together mobilize and modify nucleosomes, thus providing more access to
sequences for other DNA-binding factors (Cairns, 2009; Narlikar et al., 2002;
Panne, 2008; Roeder, 2005; Segal and Widom, 2009). Smad binding elements
present near the binding sites of master transcription factors may become more
available through these mechanisms, providing Smad proteins with both the
specific DNA sequences and the transcription factor partners, which are
necessary for stable Smad binding.
TGF-p signaling, through activation of Smad2 and Smad3, plays an
essential role in normal development and tissue homeostasis as well as in
human diseases from cancer to autoimmunity (Li and Flavell, 2008; Massague et
al., 2005; Padua and Massague, 2009). It is therefore critical to understand how
activation of Smad2 and Smad3 can lead to such diverse cellular responses.
Our findings reveal that the cell-type specific effects of TGF-p signaling are
determined in large part by the interaction of Smad proteins with one or a small
number of master transcription factors that maintain cellular identity. It is by this
mechanism that TGF-p signaling is tailored to modulate genes that are most
relevant to cell state, which may explain why aberrations in this pathway can
have such profound effects in a range of human disease.
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Figure 4. TGF-p signaling regulates genes bound by Smad3 and master
transcription factors.
(A) TGF-p signaling regulates different genes in different cell types. Genome-
wide expression analysis was performed to compare changes in gene expression
24 hours after inhibition with TGF-p inhibitor (SB431542) in ES cells and 12
hours after activation of TGF- P signaling in myotubes and pro-B cells. All genes
affected by TGF-p signaling are plotted on the y-axis. The change in expression
for each affected gene is indicated by the intensity of blue color and is shown for
ES cells (left), myotubes (center) and pro-B cells (Amsen et al.).
(B) TGF-p signaling regulates genes bound by Oct4 and Smad3 in ES cells. The
significance of the overlap of genes affected by TGF- P signaling in ES cells and
bound by each transcription factor (x-axis) was calculated using the
hypergeometric distribution and is plotted on the y-axis. Genes affected by TGF-
p signaling in ES cells tend to be bound by Oct4 and Smad3 in ES cells while
genes bound by Smad3 or master transcription factors in other cell types are not
affected.
(C) Genes affected by TGF- P signaling in myotubes tend to be bound by Myod1
and Smad3 in myotubes.
(D) Genes affected by TGF- P signaling in pro-B cells tend to be bound by PU.1
and Smad3 in pro-B cells.
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Experimental Procedures
Located in the supplemental materials, Appendix A
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My contribution on this project
The work to study the role of Mediator and Cohesin in embryonic stem cells was
a project worked on in close collaboration with three postdocs in the lab Michael
Kagey, Steve Bilodeau and David Orlando. I worked with Michael Kagey to
screen a short hairpin library in mouse embryonic stem cells and initiated the
follow-up of Mediator as a result of the hits in that screen. My involvement in this
project included ChIP-seq of various factors, knockdown experiments to validate
and explore the affects of loss of both Mediator and Cohesin, and analysis of the
data. I contributed intellectually to the communication of the concept that
Mediator and Cohesin work together to regulate gene expression and to
additional experiments presented in this paper.
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Abstract
DNA loop formation has been implicated in gene activation and repression, but
the processes that regulate DNA loop formation throughout the genome are
poorly understood. We report here evidence that Mediator and Cohesin
physically and functionally connect the enhancers and core promoters of a key
subset of active genes in embryonic stem (ES) cells. Mediator and Cohesin were
found to be essential for normal expression of the genes they occupy and for
maintenance of ES cell state. The Mediator complex was found to interact with
Cohesin and its loading factor Nipbl, which is found predominantly at promoters
occupied by Mediator and Cohesin. DNA looping between the enhancers and
promoters occupied by Mediator and Cohesin was confirmed using Chromosome
Conformation Capture. We propose the interaction between Mediator and
Cohesin creates a stable, looped chromatin structure at active promoters
throughout the genome, thus generating cell-type specific chromatin architecture.
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Introduction
Eukaryotic genomes are packaged into chromatin such that long DNA fibers can
be compacted within the nucleus yet allow for replication, transcription and other
processes. Much is known about DNA packaging at the level of the nucleosome,
the fundamental unit of chromatin, which is composed of an octamer of four core
histone proteins around which 147 base pairs of DNA are wrapped (Davey et al.,
2002; Luger et al., 1997). Further chromatin compaction occurs, which involves
looping of nucleosomal DNA (Finch and Klug, 1976; Olins and Olins, 1974; Ris
and Kubai, 1970). Recent studies have identified a variety of looping interactions
in the genomes of eukaryotes (Dostie et al., 2006; Fullwood and Ruan, 2009;
Hadjur et al., 2009; Kurukuti et al., 2006; Levasseur et al., 2008; Lieberman-
Aiden et al., 2009; Nativio et al., 2009; Spilianakis and Flavell, 2004; Tolhuis et
al., 2002; Vakoc et al., 2005), but the mechanisms involved in formation of loops
remain poorly understood.
Transcriptional regulatory proteins have been proposed to provide a
mechanism by which specific loops can be formed in DNA (Adhya, 1989; Bulger
and Groudine, 1999; Matthews, 1992; Ptashne, 1986; Saiz and Vilar, 2006;
Schleif, 1992; Treisman and Maniatis, 1985). For example, bacteriophage
lambda repressor proteins bind cis elements located 3kb apart and can
multimerize, forming a DNA loop that has been visualized using electron
microscopy (Revet et al., 1999). Bacterial DNA-binding regulators and some
RNA polymerase molecules can bind elements located approximately 100 base
pairs apart and cause looping of the intervening DNA when the two proteins bind
to one another (Borowiec et al., 1987; Dunn et al., 1984; Hahn et al., 1986;
Hochschild and Ptashne, 1988; Huo et al., 1988; Popham et al., 1989; Xu and
Hoover, 2001). In addition, some bacterial DNA loops are facilitated or stabilized
by proteins such as Integration Host Factor (IHF), which can bend DNA as much
as 1600, and can thereby enhance gene expression (Xu and Hoover, 2001).
These and other studies with bacteria and bacteriophage have thus established
the concept that transcriptional regulation often involves DNA loop formation
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between specific sites and that some regulatory proteins such as IHF contribute
to this process by facilitating or stabilizing loops.
In eukaryotes, transcription factors bind to enhancer elements that can be
located some distance (e.g., 1 kb to 1 Mb) from the core promoter elements where
the transcription initiation apparatus is bound (Atchison, 1988; Banerji et al.,
1981; Benoist and Chambon, 1981; Levine and Tjian, 2003; Maniatis et al., 1987;
Visel et al., 2009; Wasylyk et al., 1983). The enhancer-bound transcription
factors bind coactivators such as Mediator and p300, which in turn bind the
transcription initiation apparatus (Conaway et al., 2005; Malik and Roeder, 2005,
2008; Roeder, 1998; Taatjes et al., 2004; Visel et al., 2009). This set of
interactions, well established in vitro, implies that activation of gene expression is
accompanied by DNA loop formation. Indeed, Chromosome Conformation
Capture (3C) experiments have confirmed that some enhancers are brought into
proximity of the promoter during active transcription (Amano et al., 2009; Carter
et al., 2002; Drissen et al., 2004; Hatzis and Talianidis, 2002; Park et al., 2005;
Tolhuis et al., 2002; Vernimmen et al., 2007; Wang et al., 2005). If DNA looping
does occur between the enhancers and core promoters of active genes, it would
be valuable to identify the proteins that play key roles in the formation and
stability of such loops.
While screening for genes essential for maintenance of cell state in
embryonic stem (ES) cells, we identified components of the Mediator and
Cohesin complexes. Both Mediator and Cohesin were found to occupy the
enhancers and core promoters of a key subset of actively transcribed genes and
to be necessary for normal transcriptional activity in ES cells. The Cohesin
loading factor Nipbl was found at the sites co-occupied by Mediator and Cohesin,
providing a mechanism for Cohesin loading at these sites. Mediator and Cohesin
physically interact, further explaining how the recruitment of Mediator by a
transcription factor could lead to association with Cohesin. Chromosome
Conformation Capture experiments revealed that the enhancer and core
promoter sites occupied by Mediator and Cohesin are brought into close physical
proximity, confirming DNA loop formation. Mediator and Cohesin co-occupancy
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of the genome was found to be cell-type specific due to cell-type specific gene
activity. These and other results lead us to propose that Mediator and Cohesin
contribute to a looped and reinforced chromatin structure at active promoters
genome-wide, thus generating a cell-type specific chromatin architecture
associated with the transcriptional program of each cell. Furthermore, our results
provide new insights into Cornelia de Lange syndrome, which affects 1/10,000
children and where most cases are due to mutations in Nipbl (Krantz et al., 2004;
Liu and Krantz, 2009; Liu et al., 2009).
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Results
Reduced levels of Mediator and Cohesin Cause Loss of ES Cell State
We used a small hairpin RNA (shRNA) library to screen for regulators of
transcription and chromatin necessary for the maintenance of embryonic stem
(ES) cell state (Figure 1A; Figure S1). The screen was designed to detect
changes in the level of the ES cell transcription factor Oct4, which is a master
regulator of the pluripotent state, in cells that remain viable during the course of
the experiment. Most known regulators of ES cell state were identified in this
screen, including Oct4, Sox2, Nanog, Esrrb, Sa114, and Stat3 (Figure IA; Table
S1 and S2), suggesting that other components identified in this screen may also
be important for maintenance of ES cell state. It was particularly striking that
many of the subunits of the Mediator complex (Med6, Med7, Med1O, Med12,
Med14, Med15, Med17, Med21, Med24, Med27, Med28 and Med30), the
Cohesin complex (Smcla, Smc3 and Stag2) and the Cohesin loading factor
(Nipbl) emerged from the screen. Mediator and Cohesin are thought to play
essential roles in gene expression and chromosome segregation in many
different cell types, so their identification in this screen suggests that ES cell state
may be highly sensitive to a reduction in the levels of these protein complexes.
The loss of ES cell state is characterized by reduced levels of Oct4
protein, a loss of ES cell colony morphology, reduced levels of mRNAs specifying
transcription factors associated with ES cell pluripotency (e.g., Oct4, Sox2 and
Nanog) and increased expression of mRNAs encoding developmentally
important transcription factors (Bernstein et al., 2006; Boyer et al., 2006; Lee et
al., 2006a; Niwa et al., 2000). We confirmed that shRNAs targeting Mediator and
Cohesin subunits produced all these effects (Figure 1B and 1C; Figure S1; Table
S3). Thus, reduced levels of Mediator and Cohesin have the same effect on
these key characteristics of ES cell state as loss of Oct4 itself.
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Figure 1. Loss of Mediator and Cohesin Affects ES Cell State.
(A) Components of the Mediator and Cohesin complexes were highly
represented in an shRNA screen designed to identify transcriptional and
chromatin regulators of ES cell state. The shRNAs were designed against -2000
transcriptional and chromatin regulators, with -5 shRNAs/regulator. Murine ES
cells were seeded in 384-well plates and infected with individual lentiviral shRNA
constructs, fixed five days post infection and quantified for Oct4 staining intensity.
To normalize for plate effects, Z-scores for every shRNA were calculated based
on average Oct4 staining intensity and rank ordered. Details of the screening
protocol are described in Extended Experimental Procedures.
(B) Knockdown of Mediator (top panel) and Cohesin (bottom panel) caused
reduced Oct4 protein levels and changes in ES cell colony morphology. Murine
ES cells were infected with GFP, Med12 or Smcla shRNAs, and stained for Oct4
and with Hoechst.
(C) Global gene expression analysis indicates that Mediator and Cohesin
knockdowns both cause a decrease in expression of key ES cell regulators and
an increase in expression of developmental regulator genes. ES cells were
infected with GFP control, Smcla and Med12 shRNAs. Five days post-infection,
gene expression levels relative to the control GFP infection from two biological
replicates were determined with Agilent whole genome expression arrays. Log2
fold expression changes were rank ordered from lowest to highest and are
shown for every gene. A relative signal scale is shown at the bottom of both
panels.
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Mediator is Detected at Enhancers and Core Promoters of Active Genes
Transcription factors bound to enhancers are thought to bind coactivators such
as the Mediator complex, which in turn can bind RNA polymerase 11 at the core
promoter (Conaway et al., 2005; Malik and Roeder, 2005, 2008; Roeder, 1998;
Taatjes et al., 2004; Visel et al., 2009). This concept suggests that Mediator
should be detected at both enhancer and core promoter sites at active genes in
vivo. We used chromatin immunoprecipitation coupled with massively parallel
DNA sequencing (ChIP- Seq) to identify sites occupied by Mediator subunits
Med1 and Med12 in the ES cell genome (Figure 2; Table S4). Med1 and Med12
were studied because they occupy different functional domains within the
Mediator complex (Malik and Roeder, 2005; Taatjes and Tjian, 2004). Analysis
of the results revealed that Mediator frequently occupied the promoter regions of
actively transcribed genes (Figure 2A). We estimate that approximately 79% of
genes occupied by Pol2 were co-occupied by Mediator (Table S5; Med12 data).
Many of the Pol2 bound genes that had little or no Mediator occupancy play
general and essential housekeeping roles in cells (Figure S3).
More detailed examination of the ChIP-Seq data for Mediator with that of
key transcription factors (Oct4, Nanog and Sox2) and components of the
transcription initiation apparatus (Pol2 and TBP) revealed that Mediator is found
at both the enhancers and core promoters of actively transcribed genes (Figure
2B). For example, Mediator was detected at the well-characterized enhancers of
the Oct4 (Pou5fl) and Nanog genes, which are bound by the ES cell master
transcription factors Oct4, Sox2 and Nanog (Boyer et al., 2005; Marson et al.,
2008; Okumura-Nakanishi et al., 2005; Seila et al., 2008; Wu et al., 2006; Yeom
et al., 1996). Mediator was also detected at the Oct4 (Pou5fl) and Nanog core
promoters together with RNA polymerase I and TATA-binding protein (TBP).
These observations provide in vivo support for the model that Mediator bridges
interactions between transcription factors at enhancers and the transcription
initiation apparatus at core promoters.
Cohesin and Mediator Co-occupy Sites Independent of CTCF
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Cohesin has been shown to occupy sites bound by CTCF and to contribute to
DNA loop formation associated with gene repression or activation (Hadjur et al.,
2009; Parelho et al., 2008; Rubio et al., 2008; Stedman et al., 2008; Wendt et al.,
2008). To gain insights into why Cohesin and Mediator knockdowns cause very
similar phenotypes in ES cells, we used ChIP-Seq to determine the genome-wide
occupancy of the two Cohesin core complex proteins, Smcl and Smc3 (Table
S4). The results show that Cohesin occupies sites bound by CTCF, as expected,
but also occupies the enhancer and core promoter sites bound by Mediator
(Figure 2B and 2C). Approximately 57% of Cohesin sites were coincident with
CTCF sites and 31% were associated with Mediator sites (Figure 2C). The
regions co-occupied by Cohesin and Mediator were associated with RNA
polymerase 11 whereas those co-occupied by Cohesin and CTCF were not
(Figure 2D). These results demonstrate that a portion of Cohesin is associated
with the enhancer and core promoter sites occupied by Mediator in active
promoters.
The Cohesin loading factor Nipbl, which was also identified in the shRNA
screen, has been implicated in transcriptional regulation and is mutated in the
majority of individuals afflicted with Cornelia de Lange Syndrome, a
developmental disorder (Figure 1A; Figure S1D and S1F) (Krantz et al., 2004;
Tonkin et al., 2004). ChIP-Seq data revealed that Nipbl generally occupies the
enhancer and core promoter regions bound by Mediator and Cohesin, but is only
rarely found at sites occupied by CTCF and Cohesin but not Mediator (Figure 2B,
2C and 2D; Figure S4A). The association between Nipbl and Mediator/Cohesin
sites was highly significant (P-val <10-300) whereas the association of Nipbl with
CTCF/Cohesin sites was no greater than expected by chance (P-val =1). Thus,
the Cohesin loading factor Nipbl is associated with Cohesin/Mediator sites but
not with Cohesin/CTCF sites in ES cells.
Gene Requlation Depends on Both Mediator and Cohesin
The presence of Mediator and Cohesin in the promoter regions of Oct4 (Pou5fl)
and other active ES cell genes (Figure 2A, 2B and 2D) suggests that these
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complexes may both contribute to control of transcription. If Mediator and
Cohesin function together to regulate the genes they occupy, then we would
expect that knockdown of key components of these complexes would have
similar effects on expression of these genes. Analysis of changes in mRNA
levels in knockdown cells revealed that this is the case (Figure 2E). Of the
approximately 4092 genes that are co-occupied by Mediator, Cohesin and Pol2
at high confidence, approximately 1792 showed significant expression changes
(P-val <0.01) in both the Mediator and Cohesin knockdown datasets (Figure 2E;
Table S3). The two knockdowns had strikingly similar effects at this set of genes
(Pearson Correlation of 0.73), which may explain why Mediator and Cohesin
knockdowns cause very similar ES cell phenotypes. Similar results were
observed at an earlier time point (3 days post knockdown) (Figure S4B), and
there was a significant enrichment (P-val <1 0-87) for Mediator/Cohesin co-
occupancy at genes with expression changes, indicating that most expression
changes were likely a direct result of Mediator and Cohesin knockdown. These
results indicate that actively transcribed genes occupied by Mediator and
Cohesin typically depend on both complexes for normal expression.
Maintenance of ES cell state is dependent on several key transcription
factors, including Oct4 (Nichols et al., 1998; Niwa et al., 2000; Scholer et al.,
1990). If the presence of Mediator and Cohesin is dependent on Oct4, then loss
of Oct4 should lead to loss of Mediator and Cohesin at sites co-occupied by
Oct4, while Cohesin alone should continue to occupy CTCF sites. To test this
notion, we utilized a doxycycline-inducible Oct4 shutdown mES cell line (Niwa et
al., 2000) and monitored Mediator and Cohesin levels genome-wide by ChIP-Seq
(Figure 3A; Table S4; Table S6). At Oct4, Mediator and Cohesin co-occupied
sites, Mediator and Cohesin levels were reduced (Figure 3B and 3C). Cohesin
continued to occupy most CTCF sites throughout the genome (Figure 3D).
These results indicate that the presence of Mediator and Cohesin with Oct4 is
dependent on Oct4, that Cohesin's association with CTCF is independent of Oct4
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Figure 2. Mediator and Cohesin Genome-wide Occupancy in ES cells.
(A) Density map of ChIP-Seq results for Mediator (Med1 and Med12), RNA
polymerase II (Pol2) and di-methylated histone H3 lysine 79 (K79me2)
demonstrates Mediator occupancy at genes that are actively transcribed in ES
cells. Normalized read counts are shown for 10kb surrounding 18,968 Refseq
promoters (from -5kb to +5kb) sorted by maximum level of Pol2 enrichment. A
relative signal scale (reads/million) and the position of the transcription start site
are shown at the bottom of the panel. Reads from two biological replicates for
the Med1 and Med12 ChIP-Seq datasets were combined. The specificity of the
Mediator antibodies was validated as shown in Figure S2.
(B) Binding profiles for ES cell transcription factors (Oct4, Nanog and Sox2),
Mediator (Med1 and Med12), Cohesin (Smcl, Smc3 and Nipbl), CTCF and
components of the transcription apparatus (Po12 and TBP) at the Oct4 (Pou5fl)
and Nanog loci. ChIP-Seq data is shown in reads/million with the base of the y-
axis set to 0.5 reads/million. Oct4/Sox2, CTCF and TBP (TATA Box) binding
motifs are shown as blue, black and green boxes respectively. The transcription
start site and direction of transcription are noted by an arrow. Reads from two
biological replicates for the Smcl, Smc3, Med1, Med12, Nipbl, Pol2 and TBP
ChIP-Seq datasets were combined. The specificity of the Mediator, Cohesin and
Nipbl antibodies was validated as shown in Figure S2.
(C) Venn diagram showing the overlap of high confidence (P-val <10-9) Cohesin
occupied sites with CTCF and Mediator (Med12). Approximately 57% of the
genomic sites occupied by the Cohesin protein Smcl were co-occupied by
CTCF, -31% were co-occupied by Mediator.
(D) Region map demonstrating that Smcl, Nipbl and Med12 co-occupied sites
generally occur in the absence of CTCF occupancy and within close proximity to
RNA polymerase II (Pol2). For each Smcl occupied region, the presence of
Med12, Nipbl, Pol2 and CTCF occupancy is indicated within a 10kb window
centered on the Smcl occupied site.
(E) Heat map indicating that regions co-occupied by Smcl and Med12 are
associated with active genes that exhibit similar expression changes with either
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Smcla or Med12 knockdown (5 days post knockdown). Log2 expression data
from biological replicates is shown for all Smcl and Med12 co-occupied regions
that could be mapped to a gene. Mapped genes have evidence of a co-occupied
Smc1/Med12 region within the gene body or within 10kb upstream of the
transcriptional start site, evidence of Pol2 occupancy within the gene body and
significant (P-val <0.01) expression changes in both an Smcla and Med12
knockdown in independent experiments. The log2 expression data was ordered
based on the Smcla knockdown and the corresponding expression change for
each gene following a Med12 knockdown is shown. A relative signal scale for the
expression data is shown at the bottom of both panels.
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Figure 3. Mediator and Cohesin Occupancy of Oct4 Regulated Promoters
(A) Schematic of inducible Oct4 shutdown experiment. ES cells were treated
with doxycycline to induce shutdown of the Oct4 (Pou5fl) gene, cells were
crosslinked 24 hours later and ChIP-Seq experiments were performed. A
western blot shows a significant drop in Oct4 protein levels 24 hours after
doxycycline treatment.
(B) ChIP-Seq data demonstrating that Mediator and Cohesin occupancy are not
detectable at the Oct4 (Pou5fl) promoter following Oct4 shutdown by
doxycycline treatment. ChIP-Seq data for Mediator (Med12) and Cohesin
(Smc3) at the Oct4 (Pou5fl) locus is shown for wildtype ES cell (-Dox) and ES
cells treated with doxycycline (+Dox). The data is displayed in reads/million with
the base of the y-axis set to 0.5 reads/million. Oct4/Sox2, CTCF and TBP (TATA
Box) binding motifs are shown as blue, black and green boxes respectively. The
transcription start site and direction of transcription are noted by an arrow.
(C) Heat maps showing that Mediator and Cohesin occupancy is reduced at sites
co-occupied with Oct4 following loss of Oct4 protein. Change in occupancy for
Mediator and Cohesin was calculated as the log2 ratio of the normalized total
read densities in each co-occupied region between untreated ES cells and ES
cells 24 hours post doxycycline treatment. A relative signal scale for occupancy
change is shown.
(D) Cohesin occupancy at Cohesin/CTCF co-occupied regions is not reduced
following doxycycline treatment to deplete Oct4 protein. Heat maps were
generated as described for (C), except that the regions examined were those co-
occupied by Cohesin/CTCF in untreated ES cells.
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and that Cohesin-CTCF co-occupancy continues to occur throughout the
genome even when cells have lost all the key features of ES cell state.
Evidence for Interaction Between Mediator and Cohesin
The ChIP-Seq results show that Mediator and Cohesin co-occupy thousands of
sites in the ES cell genome and thus suggest that these complexes may
physically interact. To investigate this possibility, we crosslinked ES cells using
the ChIP protocol, immunoprecipitated complexes using antibodies against
Mediator (Med1 and Med12) and Cohesin (Smcl, Smc3) and determined
whether the Mediator subunit Med23 could be detected in the immunoprecipitate.
(Figure 4A). The results showed that Mediator and Cohesin components can
coprecipitate with one another. Oct4 is present at many Mediator/Cohesin co-
occupied sites in ES cells, so it might be expected to coprecipitate with Mediator
and Cohesin. Indeed, Oct4 was detected in both Mediator and Cohesin
immunoprecipitates (Figure 4A). Similar results were obtained when extracts
were prepared from cells that had not been subjected to crosslinking (Figure 4B)
or were subject to DNase I treatment (Figure S5A). Furthermore, an antibody
against the Cohesin loading factor Nipbl co-precipitated both Cohesin and
Mediator subunits (Figure 4C). These results suggest that Mediator and Cohesin
interact.
We obtained additional evidence for a Mediator and Cohesin interaction
by using the purification protocol outlined in Figure 4D. Mediator was affinity
purified from ES cell nuclei using the activation domain of SREBP-1a, which is
known to bind Mediator (Toth et al., 2004; Yang et al., 2006). Following elution
from the SREBP-1a affinity resin, the Mediator-containing eluate was subjected
to a second, orthogonal immunoprecipitation step, with an anti-CDK8 antibody
resin (Figure 4D). CDK8 is a Mediator specific subunit, which ensured that
Mediator and Mediator-associated factors would be specifically retained on the
antibody column. After binding, the CDK8 antibody resin was subjected to a
series of high-salt washes, bound proteins were then eluted and examined by
silver stain and western blot. The results show that Cohesin and Nipbl co-
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purified with Mediator following the second orthogonal purification step (Figure
4D). Similar results were obtained with an anti-Med1 antibody (Figure S5B and
S5C). These results indicate that Mediator and Cohesin physically interact and
suggest that this interaction accounts for their co-occupancy at active promoters
in vivo.
Mediator and Cohesin are expressed in all cell types, so we purified the
Mediator complex from HeLa cells using a different protocol and subjected the
complex to analysis using Multidimensional Protein Identification Technology
(MudPIT, Figure 4E), which combines multidimensional liquid chromatography
with electrospray ionization tandem mass spectrometry to give an unbiased
analysis of proteins within the sample (Wolters et al., 2001). In addition to the
consensus Mediator subunits (Sato et al., 2004), all of which were identified in
this preparation, the Cohesin subunits Smcla, Smc3 and Nipbl were each well
represented in the sample (Figure 4E). Collectively, the results in Figure 4 and
Figure S5 confirm that Mediator can be purified in association with Cohesin and
Nipbl and show that such complexes occur in multiple vertebrate cell types.
Mediator and Cohesin Binding Profiles Predict DNA Looping Events
Mediator bridges interactions between transcription factors and the transcription
apparatus (Conaway et al., 2005; Malik and Roeder, 2005, 2008; Roeder, 1998;
Taatjes et al., 2004; Visel et al., 2009). Cohesin has been shown to contribute to
transcriptional regulation at specific loci by altering chromosomal architecture
(Hadjur et al., 2009; Parelho et al., 2008; Rubio et al., 2008; Stedman et al.,
2008; Wendt et al., 2008). Our evidence shows that Mediator and Cohesin
occupy the enhancer and core promoter regions of a set of active genes,
suggesting that they contribute to DNA looping between the enhancer and core
promoter of these genes. We selected four different loci, Phc1, Nanog, Oct4
(Pou5fl) and Leftyl, to test enhancer-promoter interaction frequencies in ES
cells and in Murine Embryonic Fibroblasts (MEFs). These genes were selected
because Mediator and Cohesin occupy their enhancer and core promoter regions
in ES cells, where they play a positive role in their transcription, whereas
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Figure 4. Mediator and Cohesin Interact.
(A) Mediator (Med23) and Oct4 are detected by western blot analysis when
crosslinked, sheared chromatin is subjected to immunoprecipitation with
antibodies directed against Mediator (Med1 or Med12) or Cohesin (Smcl or
Smc3).
(B) Mediator (Med23) and Oct4 are detected by western blot analysis following
immunoprecipitation of uncrosslinked ES cell nuclear extracts (NE) with Smcl or
Med12 antibodies.
(C) Cohesin (Smcl, Smc3) and Mediator (Med23) are detected by western blot
analysis following immunoprecipitation of uncrosslinked ES cell nuclear extracts
with a Nipbl antibody.
(D) Cohesin and Nipbl co-purifies with a Mediator complex. The Mediator
complex was initially affinity purified from an ES nuclear extract utilizing a
SREBP-1a activation domain. The eluted (Input) material was further purified
over an anti-CDK8 antibody resin. The IP Elution was subjected to silver staining
and western blot analysis.
(E) Multidimensional Protein Identification Technology (MudPIT) identifies co-
purifying Cohesin subunits (Smcl and Smc3) and Nipbl with the Mediator
complex. The Mediator complex was affinity purified from a HeLa cell nuclear
extract, separated by glycerol gradient and subjected to MudPIT analysis. Each
consensus Mediator subunit was identified in this analysis, as were Smcla,
Smc3 and Nipbl. Spectral counts for Smc1A, Smc3 and Nipbl are shown, after
applying 1 % false discovery rate threshold are shown.
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Mediator and Cohesin are not present at these genes in MEFs, where these
genes are transcriptionally silent (see below).
We utilized Chromosome Conformation Capture (3C) technology (Dekker,
2006; Dekker et al., 2002) to determine whether a looping event could be
detected between the enhancer and promoter of Phc1, Nanog, Oct4 (Pou5fl)
and Leftyl loci in both ES cells and MEFs (Figure 5 and Figure S6). Crosslinked
cells were restriction digested and religated, under conditions that favor
intramolecular ligation events, to capture distal DNA fragments that interact
within close proximity. We then used semi-quantitative PCR to detect the
interaction frequency of distal fragments with a specific anchoring point
(upstream enhancer for Phc, Oct4 and Lefty, and core promoter for Nanog).
The interaction frequency was normalized to a BAC template and control regions
(Dekker, 2006). For all loci tested we observed an increased interaction
frequency between the core promoter and the enhancer in ES cells, indicating
the presence of a DNA loop (Figure 5 and Figure S6). Importantly, this
interaction was not observed in MEFs where Phc, Nanog, Oct4 (Pou5fl) and
Leftyl are silent. Knockdown of either Cohesin subunit Smcla or Mediator
subunit Med12 caused a reduction in the interaction frequency at Nanog (Figure
S6E). These 3C results are consistent with a model where the
Mediator/Cohesin/Nipbl complex promotes cell-type specific gene activation
through enhancer/promoter DNA looping.
Mediator and Cohesin in Embryonic Fibroblasts
Mediator and Cohesin are expressed in a broad range of cell types, so we sought
to determine whether the key themes that emerged from their study in ES cells
were maintained in other cell types. We first investigated whether Mediator
occupies the promoters of actively transcribed genes in MEFs (Figure 6A and
6B). High confidence ChIP-Seq data showed that Mediator occupies at least
14% of genes bound by Pol2 (Table S5; Med1 data). We then compared sites
occupied by Mediator, Cohesin and CTCF, and found Cohesin co-occupies most
Mediator sites and most CTCF sites (Figure 6B and 6C). As in ES cells, the
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Mediator/Cohesin co-occupied sites generally showed evidence of RNA
polymerase II occupancy, whereas the CTCF/Cohesin sites typically lacked
evidence for RNA polymerase II (Figure 6D).
We then investigated whether knockdowns of Mediator and Cohesin have
similar effects on the expression of genes that they co-occupy in MEFs. Indeed,
knockdown of Med12 and Smcla had very similar effects on this group of active
genes (Pearson Correlation of 0.65)(Figure 6E). Of the 443 genes that are co-
occupied by Mediator, Cohesin and Pol2 at high confidence, approximately 300
showed significant expression changes (P-val <0.01) in both the Mediator and
Cohesin knockdown datasets (Figure 6E). These results indicate that Mediator
and Cohesin have similar effects on the expression of genes they occupy in
MEFs, as was observed in ES cells.
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Figure 5. Mediator and Cohesin Binding Profiles Predict Enhancer-
Promoter Looping Events.
(A) A looping event between the upstream enhancer and the core promoter of
Phc1 was detected by Chromosome Conformation Capture (3C) in ES cells, but
not in MEFs. ES cell and MEF crosslinked chromatin was digested by Mspl and
religated under conditions that favor intramolecular ligation events. The
interaction frequency between the anchoring point and distal fragments was
determined by PCR and normalized to BAC templates and control regions. The
error bars represent the standard error of the average of 3 independent PCR
reactions. The restriction enzyme sites are indicated above the 3C graph. The
ChIP-Seq binding profiles for Med12 and Smcl are shown in reads/million with
the base of the y-axis set to 0.5 reads/million. Reads from two biological
replicates for the Med12 and Smcl (ES cells) ChIP-Seq datasets were
combined. Biological replicates of the 3C experiments and the full 3C profile are
presented in Figure S6.
(B) A looping event between an upstream Mediator/Cohesin co-occupied region
and the core promoter was detected at the Nanog locus in ES cells but not in
MEFs using 3C as described in (A).
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Figure 6. Mediator and Cohesin Occupancy in Embryonic Fibroblasts.
(A) Density map of ChIP-Seq results for Mediator (Med1 and Med12), RNA
polymerase II (Pol2) and di-methylated histone H3 lysine 79 (K79me2)
demonstrates Mediator occupancy at genes that are actively transcribed in
MEFs. Normalized read counts are shown for 10kb surrounding 18,968 Refseq
promoters (from -5kb to +5kb) sorted by maximum level of Pol2 enrichment. A
relative signal scale (reads/million) and the position of the transcription start site
is shown at the bottom of the panel. Reads from two biological replicates for the
Pol2 and H3K79me2 ChIP-Seq datasets were combined.
(B) Binding profiles for Mediator (Med1 and Med12), Cohesin (Smcl), CTCF and
RNA polymerase II (Pol2) at Ctgf. ChIP-Seq data is shown in reads/million with
the base of the y-axis set to 0.5 reads/million. CTCF and TBP (TATA Box)
binding motifs are shown as black and green boxes respectively. The
transcription start site and direction of transcription are noted by an arrow. Reads
from two biological replicates for the Pol2, H3K79me2, Smcl and CTCF ChIP-
Seq datasets were combined.
(C) Venn diagram showing the overlap of high confidence (P-val <10-9) Cohesin
occupied sites with CTCF and Mediator. Approximately 41 % of the genomic sites
occupied by the Cohesin protein Smcl were co-occupied by CTCF, 5% were co-
occupied by Mediator.
(D) Region map demonstrating that Smcl and Med1 co-occupied sites in MEFs
generally occur in the absence of CTCF occupancy and within close proximity to
RNA polymerase II (Pol2). For each Smcl occupied site, the presence of Med1,
Pol2 and CTCF occupancy is indicated within a 10kb window centered on the
Smcl occupied region.
(E) Heat map indicating that regions co-occupied by Smcl and Med1 are
associated with active genes that exhibit similar expression changes with either
Smcla or Med12 knockdown. Log2 expression data from biological replicates is
shown for all Smcl and Med1 co-occupied regions that could be mapped to a
gene. Mapped genes have evidence of a co-occupied Smcl/Medl region within
the gene body or within 10kb upstream of the transcriptional start site, evidence
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of Pol2 occupancy within the gene body and significant (P-val <0.01) expression
changes for both an Smcla and Med12 knockdown in independent experiments.
The log2 expression data was ordered based on the Smcla knockdown and the
corresponding expression change for each gene following a Med12 knockdown
is also shown. A relative signal scale for the expression data is shown at the
bottom of both panels.
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Cell-type Specific Behavior of Mediator and Cohesin
The observation that Mediator and Cohesin occupied the promoters of ES cell
specific genes such as those encoding the pluripotency regulators Oct4 and
Nanog, but had less occupancy at many housekeeping genes, led us to ask
whether Mediator and Cohesin tend to occupy cell-type specific genes. Indeed,
Mediator and Cohesin were found to occupy very different sets of promoters in
ES cells and MEFs (Figure 7A). In contrast, Cohesin and CTCF occupied many
of the same sites in the two cell types (Figure 7B). The levels of Mediator were
found to be considerably higher in ES cells than in MEFs (Figure 7C; Figure
S2C), accounting for the differences in the number of genes bound by Mediator
and Cohesin in the two cell types. These observations suggest that Mediator
and Cohesin play especially important roles in cell-type specific gene expression
and thus, in cell-type specific chromosome structure.
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Figure 7. Cell Type Specific Occupancy of Mediator and Cohesin.
(A) Region map of Mediator and Cohesin co-occupied regions for ES cells (Smcl
and Med12) and MEFs (Smcl and Med1) indicates that co-occupied regions are
largely different between the cell types. Mediator and Cohesin co-occupied
regions are indicated for both cell types within a 10kb window. Reads from two
biological replicates for the Smcl and Med12 ChIP-Seq datasets were combined.
(B) Region map of Cohesin (Smcl) and CTCF co-occupied regions indicates that
a large fraction of these regions are co-occupied in ES cells and in MEFs.
Cohesin and CTCF co-occupied regions are indicated for both cell types within a
10kb window. Reads from two biological replicates for the Smcl and CTCF
(MEF) ChIP-Seq datasets were combined.
(C) Western blot analysis of ES and MEF cell extracts indicates that Cohesin
protein levels are similar for both cell types, whereas Mediator protein levels are
substantially lower in MEFs.
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Discussion
DNA loop formation has been implicated in gene control in prokaryotes and
eukaryotes, but the processes that connect DNA loop formation and gene
regulation throughout the genome are not well understood. Our results reveal
that Mediator and Cohesin contribute to the control of a subset of active genes,
where they mediate the interaction between transcription factors at enhancers
and the transcription apparatus at core promoters, and thus facilitate DNA loop
formation. The subset of genes occupied by Mediator and Cohesin is cell-type
specific, thus indicating that cell-type specific loops exist in the chromosomes of
vertebrate cells as a consequence of active gene regulation.
Mediator Functions at a Key Subset of Active Promoters
At eukaryotic protein coding genes, transcription factors bind enhancers and
other regulatory elements and recruit the transcription apparatus to core
promoter sites where transcription begins (Fuda et al., 2009; Orphanides and
Reinberg, 2002; Roeder, 1998). Enhancers are typically occupied by multiple
transcription factors, which can have positive or negative influences on
expression of their target genes (Maston et al., 2006; Panne, 2008; Panne et al.,
2007; Visel et al., 2009). Coactivators such as Mediator provide an interface that
transduces regulatory information from the transcription factors at regulatory
elements to the transcription apparatus, thus producing finely calibrated output
levels of gene activity (Conaway et al., 2005; Ding et al., 2008; Kornberg, 2005;
Malik and Roeder, 2005; Taatjes et al., 2004).
In yeast, Mediator has been shown to be essential for expression of most,
but not all, genes (Fan et al., 2006; Holstege et al., 1998; Thompson and Young,
1995). In vertebrates, Mediator is known to be essential, as null mutations
produce embryonic lethality (Tudor et al., 1999), but the set of genes that require
its function are not known in any cell type. We found that Mediator is associated
with approximately 79% of promoters that are occupied by Pol2 in ES cells and
approximately 14% of promoters that are occupied by Pol2 in embryonic
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fibroblasts. Interestingly, Mediator tends to be associated with genes that are
cell-type specific. Evidence that the ES cell specific transcription factors Oct4
and Nanog contribute to Mediator's recruitment may account, at least in part, for
this observation (Figure 3)(Tutter et al., 2009).
Cohesin Occupies at Least Two Sites Associated with Gene Control
The Cohesin complex mediates cohesion of sister chromatids, which is essential
for proper chromosome segregation and post-replicative DNA repair (Hirano,
2006; Nasmyth and Haering, 2005). Recent studies have shown that
mammalian Cohesin complexes are also involved in the control of gene
expression (Dorsett, 2007; Hagstrom and Meyer, 2003). Evidence that Cohesin
associates with the insulator CCCTC-binding factor CTCF throughout the
mammalian genome has led to the proposal that CTCF recruits Cohesin to these
sites, where it can mediate chromosomal interactions between CTCF-bound sites
(Hadjur et al., 2009; Parelho et al., 2008; Rubio et al., 2008; Stedman et al.,
2008; Wendt et al., 2008). The CTCF/Cohesin interaction has been implicated in
repressing gene expression through enhancer blocking (Parelho et al., 2008;
Wendt et al., 2008), but there is also evidence that Cohesin and CTCF are
involved in organizing distal looping events that are associated with gene activity
(Hadjur et al., 2009). Our results show that Cohesin occupies a large fraction of
CTCF sites throughout the genomes of ES cells and MEFs, reveal that many
CTCF/Cohesin co-occupied sites are conserved between these two cell types,
and demonstrate that CTCF/Cohesin sites typically lack evidence of gene activity
in these cells.
We find that Cohesin also occupies the set of enhancers and core
promoters of active genes that are occupied by Mediator in ES cells and in
MEFs. Multiple lines of evidence indicate that Mediator and Cohesin physically
and functionally interact to control gene expression at these genes. ChIP-Seq
data shows that the two protein complexes co-occupy nearly 14,000 sites in ES
cells and 2000 sites in MEFs. Mediator and Cohesin co-precipitate in
immunoprecipitation experiments and Cohesin is found associated with Mediator
142
complexes following a rigorous, multi-step affinity purification from ES cells.
Knockdowns of Mediator and Cohesin components have strikingly similar effects
on ES cell state and on gene expression at co-occupied genes. Thus, Cohesin
appears to function together with CTCF at loci that are not generally transcribed
and with Mediator at promoters that are generally transcriptionally active.
A Model for Gene Requlation and DNA Loopinq via Mediator and Cohesin
Our results and those of others suggest a model for the mechanistic contributions
of Mediator and Cohesin to gene regulation and DNA looping in vertebrate cells.
In this model, DNA loop formation between enhancers and core promoters
occurs as a consequence of the interaction between enhancer-bound
transcription activators, Mediator and promoter-bound RNA polymerase 11. When
the transcription activators bind Mediator, the Mediator complex undergoes a
conformational change, and we show that this form of Mediator binds Cohesin
(Taatjes et al., 2002). The Cohesin loading factor Nipbl is located at the sites co-
occupied by Mediator and Cohesin, providing a mechanism for Cohesin loading
at these sites.
Studies in bacteria first established the concept that transcriptional
regulation can involve DNA loop formation due to interactions between regulators
and the transcription apparatus when the two occupy distal DNA sites, and
introduced the notion that certain proteins such as IHF are devoted to DNA loop
stabilization (Borowiec et al., 1987; Dunn et al., 1984; Hahn et al., 1986;
Hochschild and Ptashne, 1988; Huo et al., 1988; Popham et al., 1989; Xu and
Hoover, 2001). Our results suggest that Mediator and Cohesin may contribute to
these two types of regulatory processes in mammalian cells. While Mediator
connects transcription factors and the transcription apparatus and thus
contributes to DNA loop formation, Cohesin's contribution may be to stabilize the
loop. Importantly, because different cells express different sets of genes, the
DNA loops mediated by Mediator and Cohesin are cell-type specific.
Control of Cell State
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ES cells provide an exceptional model system to study the regulatory
components that contribute to control of cell state and early development (Chen
et al., 2008; Cole and Young, 2008; Deato and Tjian, 2008; Enver et al., 2009;
Jaenisch and Young, 2008; Kagalwala et al., 2008; MacArthur et al., 2008; Orkin
et al., 2008; Yu and Thomson, 2008). The genetic screen described here, and
those described previously (Fazzio et al., 2008; Hu et al., 2009; Ivanova et al.,
2006; van den Berg et al., 2008), identified ES cell-specific regulators such as
the transcription factors Oct4, Sox2, Nanog, Esrrb, Sall4, and Stat3 as key to
maintenance of the ES cell state. These screens have also identified important
regulators of global gene expression that are found more generally in cells,
including a variety of chromatin regulators (e.g., Polycomb, Tip60-p400 and other
histone modifying enzymes) and Mediator and Cohesin. This suggests that
maintenance of the embryonic state is especially sensitive to the functional levels
of certain general regulatory components, particularly those that contribute to
chromatin structure.
Through their roles in DNA loop formation at a subset of active promoters,
Mediator and Cohesin link gene expression with cell-type specific chromatin
structure. In this context, it is interesting that mutations in the genes encoding
Mediator and Cohesin components can cause an array of human developmental
syndromes and diseases. Mediator mutations have been associated with Opitz-
Kaveggia (FG) syndrome, Lujan syndrome, schizophrenia and some forms of
congenital heart failure (Ding et al., 2008; Philibert and Madan, 2007; Risheg et
al., 2007; Schwartz et al., 2007). Mutations in Nipbl are responsible for most
cases of Cornelia de Lange syndrome (CdLS), which is characterized by
developmental defects and mental retardation and appears to be the result of
mis-regulation of gene expression rather than chromosome cohesion or mitotic
abnormalities (Borck et al., 2004; Musio et al., 2006; Strachan, 2005; Zhang et
al., 2007). It is possible that these disorders and diseases are due to
deficiencies in the chromatin structure generated by Mediator and Cohesin,
which we have shown is essential for normal transcriptional programs in
mammalian cells.
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Experimental Procedures
Additional information on materials and methods can be found in Supplementary
Information.
Cell Culture Conditions
V6.5 murine embryonic stem (mES) and ZHBTc4 (Niwa et al., 2000) Oct4
shutdown cells were grown under standard mES cell conditions as described
previously (Boyer et al., 2005). Murine embryonic Fibroblasts (MEFs) were
cultured in DMEM supplemented with 10% FBS, 100 mM nonessential amino
acids 2 mM L-glutamine,100 U/mL penicillin, 100 mg/mL streptomycin, and 8
nL/mL of 2-mercaptoethanol.
High Throughput shRNA Screening
Small hairpins targeting approximately 2000 chromatin regulators and
transcription factors were designed and cloned into pLKO.1 lentiviral vectors
(Moffat et al., 2006). Lentiviral supernatants were generated and arrayed in 384-
well plates along with negative control supernatants targeting GFP, RFP,
Luciferase and LacZ (Moffat et al., 2006). mES cells were seeded off of a MEF
feeder layer into 384-well plates, infected the following day and placed under
puromycin selection 24 hours post infection. Five days post infection cells were
fixed and stained with Hoechst and for Oct4 (Santa Cruz sc-5279). Image
acquisition and data analysis were performed essentially as described (Moffat et
al., 2006). The average Oct4 pixel staining intensity was determined for all
identified cells in a well and a mean value for each well was calculated. Z-scores
were determined for each well based on average Oct4 staining and the values of
the negative controls. Z-scores for replicate infections were averaged. A
detailed description of the screening protocol and analysis is described in
Extended Experimental Procedures.
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Micorarray Hybridization and Analysis
RNA for expression analysis was extracted with TRizol (Invitrogen) and purified
with a RNAeasy column (Qiagen) before labeling. Samples were Cy3 (GFP
shRNA control infected cells) or Cy5 (Med12 and Smcla shRNA infected cells)
labeled and hybridized to Agilent mouse 4x44K expression arrays. The details of
hybridization, wash conditions and analysis are described in Extended
Experimental Procedures.
ChIP-Seq
Chromatin immunoprecipitations (ChlPs) were performed as previously
described (Lee et al., 2006b). For this paper, ChlPs were performed for
Med1/TRAP220 (Bethyl A300-793A), Med12 (Bethyl A300-774A), Smcl (Bethyl
A300-055A), Smc3 (Abcam ab9263), Nipbl (Bethyl A301-778A), TBP (Abcam
ab818), RNA Polymerase II (Covance 8WG16), CTCF (Upstate 07-729), and
H3K79me2 (Abcam ab3594). RNA Polymerase 11, CTCF, and H3K79me2 ChIP-
Seq experiments for mES cells were performed previously (Chen et al., 2008;
Marson et al., 2008; Seila et al., 2008). All protocols for Illumina/Solexa
sequence preparation, sequencing and quality control are provided by Illumina
(http://www.illumina.com/paqes.ilmn?ID=203). A brief summary of the technique,
minor protocol modifications and data analysis are described in Extended
Experimental Procedures. A summary of the ChIP-Seq data generated for this
paper can be found in Table S7.
ChIP-Western and Co-Immunoprecipitation
For the ChIP-Western experiments, the same conditions as for ChIP-Seq were
used. Following immunoprecipitation and washes, proteins were separated by
SDS-PAGE and analyzed by western blot. For the co-immunoprecipitation
experiment, mES cells were harvested in PBS and proteins were extracted for 30
min at 40C in TNEN250 buffer with protease inhibitors. After centrifugation,
supernatant was increased to two volumes with TNENG buffer. Protein
complexes were immunoprecipitated overnight at 4*C using antibodies against
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Med12 (Bethyl A300-774A), Smcl (Bethyl A300-055A), Nibpl (Bethyl A301-
778A) and isotype-matched non-immune IgG (Upstate). Immunoprecipitates
were washed three times with TNEN125 buffer, and proteins were separated by
SDS-PAGE and analyzed by western blot. For both experiments, blots were
probed with antibodies against Med23 (Bethyl A300-425A), Smcl (Bethyl, A300-
055A), Smc3 (Abcam, Ab9236), Nipbl (Bethyl A301-778A) and Oct4 (Santa Cruz
sc-5279).
Mediator Complex Purification
The Mediator complex was purified from mES cell nuclear extracts using
immobilized GST-SREBP-1a (residues 1-50). Bound material washed 4x with 20
column volumes of 0.5M KCI HEGN (20mM Hepes, 0.1mM EDTA, 10% Glycerol,
0.1% NP-40 & 0.5M KCI) buffer, 2x with 0.15M KCI HEGN buffer, and eluted.
The eluted sample was further purified with a CDK8 antibody. After binding, this
resin was washed 4x with 50 column volumes of 0.5M KCI HEGN buffer, 2x with
0.1M KCI HEGN buffer and eluted with 0.1M Glycine, pH 2.75.
Multidimensional Protein Identification Technoloqy (MudPIT) assays
GST-SREBP-1a (residues 1-50) was immobilized to GSH-Sepharose beads (GE
Lifesciences) and used as bait for overnight pull downs (40C) from HeLa nuclear
extract. Beads were washed with 5 x 20 column volumes 0.5M KCI HEGN
(20mM Hepes, 0.1mM EDTA, 10% Glycerol, 0.1% NP-40 & 0.5M KCI) and 1 x 20
column volumes 0.15M KCI HEGN. Bound material was eluted with 30mM GSH
in elution buffer (80mM Tris, 0.1mM EDTA, 10% Glycerol, 0.02% NP-40, 100mM
KCI). GSH elutions were applied to the top of 15% to 40% linear glycerol
gradients and centrifuged for 6h at 50,000rpm. Mediator-containing fractions
were combined and TCA precipitated. The protein pellet was suspended with
4%(w/v) SDS, 0.1M Tris pH 8.5, 10mM TCEP then added to 8M Urea, 0.1M Tris
pH 8.5 for iodoacetamide alkylation and trypsin digestion (37C, 1h) using a
modified FASP protocol (Wisniewski et al., 2009). Digested peptides were
separated using high pH (pHl10 ammonium formate) /low pH (0.1%(v/v) formic
147
acid) reversed-phase two-dimensional liquid chromatography. An Agilent
HP1 100 nanoLC/MSD XCT ion trap mass spectrometer (Agilent Technologies)
was used for all analyses. Peptide identifications (from a Mascot search of the
human IPI_v3.65 database) were filtered at a 1% false discovery rate as
determined by a search of the reversed database. Quantitation of proteins used
the method of spectral counting, which is the total number of ms/ms assignments
to peptides within a protein, described by Old et al. (Old et al., 2005).
Chromosome Conformation Capture (3C)
3C analysis was performed as previously described (Miele and Dekker, 2009).
mES cells or MEFs were crosslinked, lysed and chromatin was digested with
1000 units HaellI (NEB) for the Nanog and Oct4 (Pou5fl) loci or 2000 units Mspl
(NEB) for the Phc1 and Leftyl loci. Crosslinked fragments were subsequently
ligated with 50 units T4 DNA ligase (Invitrogen) for 4 hours at 16*C. Control
templates were generated using BAC clones covering the Nanog, Oct4 (Pou5fl),
Leftyl or Phc1 loci. 3C primers were designed for fragments upstream and
surrounding the transcriptional start site. 3C analysis was done in triplicate and
averaged for each primer pair. A complete list of primers, are available in Table
S8. Details of the analysis are described in Extended Experimental Procedures.
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Chapter 5
Concluding Remarks
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The work described in the previous chapters presents new contributions to the
study of transcriptional regulatory mechanisms in embryonic stem cells. The
connections of both Wnt and TGF- P signaling to the core regulatory circuitry of
ES cells are novel findings that reveal how signaling pathways and transcription
factors coordinately control gene expression. Discovery of the role that Mediator
and Cohesin play in cell-type specific gene expression has highlighted a
previously underappreciated mechanism of gene control in mammals. Together
these studies add to our knowledge of the multiple layers of gene control
required for mammalian cellular differentiation and development.
Signaling pathways are essential in the regulation of nearly all biological
processes. Specific combinations and concentrations of signaling molecules
stimulate the pathways, forcing the terminal factors into the nucleus where they
often interact with transcription factors to influence gene epxression. The work
presented here on Wnt and TGF-p signaling adds to the overall understanding of
how various regulatory mechanisms work together to control transcription and
embryonic stem cell state. Studies examining the consequences on cell state of
a variety of signaling pathways, including LIF, Wnt, BMP4 and TGF-p signaling
provided the functional data and a reason to further research the role of each of
these pathways in ES cells. The data presented in chapters 2 and 3 identifies
the specific genes controlled by Tcf3 and the Wnt signaling pathway and Smad3
and the TGF-p signaling pathway, respectively. The identification of interactions
between terminal signaling components and transcription factors through these
genome-wide ChIP-Seq studies has deepened our understanding of how groups
of proteins might be acting together to regulate gene expression and cell state in
ES cells. The finding that Tcf3 co-occupied the genome with Oct4, Sox2 and
Nanog provided the first evidence that a signaling pathway was linked directly to
the core regulatory circuitry and was in fact part of the interconnected
autoregulatory loop of transcription factors that make up the foundation of this
network. The study of TGF-p signaling not only provided additional evidence that
signaling pathways act with key ES cell regulators to control cell state, but the
data from myotubes and pro-b cells provided novel information on the
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relationship between TGF-p signaling and cell-type specific transcription factors.
Together, the studies presented here add novel genome-wide binding data and
functional studies involving perturbations of signaling pathways to enhance our
understanding of signaling pathways and their role in maintaining ES cell state.
The data collected from the high-throughput genetic screen in murine
embryonic stem cells presented here in Chapter 4 adds to a growing list of novel
factors that control ES cell state. The in-depth study of Mediator and Cohesin in
ES cells led to the identification of a novel protein complex that is essential for
maintaining a cell-type specific gene expression profile. This study provided the
first genome-wide binding data for the Mediator complex, supporting its role as a
coactivator. The genome-wide binding data for Cohesin subunits Smcl and
Smc3, supported previous studies that Cohesin predominantly associates with
CTCF but also exists at a subset of regions across the genome in the absence of
CTCF. This study provided novel data for the role of those Cohesin-independent
occupied sites across the genome. The Cohesin-independent sites were
identified at the promoters and enhancers of active genes along with Mediator
and ES cell transcription factors Oct4, Sox2 and Nanog. In addition to
determining occupancy across the genome, Mediator and Cohesin were
indentified to be part of a protein complex regulating cell-type specific gene
expression programs by participating in long-range looping events. The concept
of DNA looping has been demonstrated previously in bacteria and has more
recently been shown at specific loci in vertebrate cells. The co-occupancy of
promoter and enhancer regions by Mediator and Cohesin allows for the accurate
prediction of cell-type specific looping events that are responsible for maintaining
gene expression profiles and cell state, something that had not yet been
demonstrated in vertebrate cells.
Together, the work presented in this thesis contributes to a growing area
of biomedical research working to better understand embryonic stem cell biology
and the control of a pluripotent cell state. I have provided novel evidence for the
relationship of signaling pathways with master transcription factors in embryonic
stem cells as well as more differentiated cell-types supporting a cell-type specific
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role for terminal components of signaling pathways. In addition, I have identified
a novel protein complex that also acts in cell-type specific manner to regulate a
gene expression program to maintain cell state. As similar studies move forward,
the knowledge of how embryonic stem cell state is maintained and changed will
continue to grow, greatly impacting the use of ES cells in biomedical research.
Recent progress in cellular reprogramming and the potential use for
reprogrammed cells in regenerative medicine highlight the importance of
understanding the mechanisms through which cell state is altered during cellular
differentiation. We are now in a position to examine in increased detail the
changes that occur at multiple cellular levels, from extracellular signaling to the
modifications of histones that regulate the binding of transcription factors and the
transcription apparatus. Here I describe future studies that will (1) define the
biochemical and molecular mechanisms of gene control downstream of signaling
pathways, (2) elucidate the biochemical regulation of DNA looping and the
functional roles that complex DNA architecture plays in the control of gene
regulation, and (3) exploit improved genetic techniques to identify novel layers of
transcriptional regulation. These studies of the multiple mechanisms of gene
control that are crucial for normal human development have significant potential
to increase our understanding of human disease and lead to novel therapeutics.
Mechanisms of gene control downstream of signaling pathways
The effect that different signaling pathways have on embryonic stem cell state is
studied easily through the visualization of changes in cell morphology. The
molecular events associated with pluripotency and differentiation and the ways
that signaling pathways control these events are only now beginning to be
understood. ChIP-Seq is a robust new technology that allows for the identification
of genes occupied by components of signaling pathways. The combination of
this data, along with genome-wide expression changes following perturbations of
a given signaling pathway help to reveal the function of that signaling pathway.
What still remains unknown is the precise mechanism through which signaling
pathways affect gene expression. The studies presented here in Chapter 2 and
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3 suggest that transcription factors are likely responsible for recruiting Tcf3 and
Smad3 to defined genomic loci to regulate gene expression. In order to fully
understand how signaling pathways influence gene expression and cell state,
further studies must better define biochemical and molecular changes that occur
in the nucleus when signaling pathways are activated. Some of the key studies
that remain involve the identification of other factors being recruited along with
transcription factors and signaling pathways both in embryonic stem cells and in
more differentiated cells. In addition, an understanding of the dynamic changes
that take place at the level of chromatin structure- changes required both to allow
protein binding and to promote active transcription- will be necessary for a full
understanding of how all levels of regulatory circuitry cooperate to control a cell-
specific gene expression program.
A combination of techniques will be required for detailed mechanistic
examinations of gene control, including small scale studies of genome structure
and biochemical purifications to determine the complete list of proteins acting at
a given loci. One of the current limitations of ChIP-Seq is the large number of
cells required for a single experiment and the heterogeneous population that
likely exists in a population of 10-100 million cells. As a result of this limitation,
current studies of the dynamic changes in chromatin modifications that
accompany differentiation are limited by uncertainty if all of the cells examined
are at the same stage of differentiation. Smaller scale ChIP-Seq experiments
may allow for better controlling cell population, although the challenges would not
be eliminated. More likely, reporter assays will have to be designed to monitor
changes in chromatin at specific loci. For example, knowing the profound impact
that over-expression of MyoD has on cell state, the over-expression of MyoD and
a reporter assay designed to monitor regulatory mechanisms at genes turned on
early in muscle cell differentiation, like myogenin, could begin to answer some of
these questions. By using ChIP-Seq to monitor changes in chromatin marks at
specific loci we could begin to see what's happening at the level of chromatin
structure during changes in gene expression. With the addition of a reporter
assay these changes could be monitored as a particular gene is being
163
expressed. Similar experiments could be designed using iPS cells where
reactivation of the endogenous Oct4 locus could be tracked and changes in
chromatin structure surrounding this locus could be monitored.
Requlation of DNA loopinq
The study presented in Chapter 4 describing the role of Mediator and Cohesin in
regulating cell-type specific gene expression demonstrates a link between the
core transcriptional regulatory circuitry of embryonic stem cells and higher-order
chromatin structure. A more complete understanding of how DNA architecture
contributes to gene regulation will depend on further investigations of the factors
that control DNA looping events. There appear to be looping events associated
with both activation and repression of gene expression, but the factors that
facilitate each of these looping events remains unknown. Future studies must
not only identify what other proteins are involved in regulating these looping
events, but should focus on the changes that accompany the formation of DNA
loops; specifically the changes in chromatin structure and nucleosome
positioning that facilitate long-range looping events.
Detailed, genome-wide studies of DNA architecture and related changes
in chromatin are now possible due to several newly developed techniques that
are derivatives of chromosome conformation capture including 4C, 5C, Hi-C and
ChIA-PET (Dostie and Dekker, 2007; Dostie et al., 2006; Dostie et al., 2007;
Fullwood and Ruan, 2009; Li et al.; Lieberman-Aiden et al., 2009; Vassetzky et
al., 2009; Zhao et al., 2006). These techniques are geared towards identifying
looping events across more of the genome. ChIA-PET and 4C specifically focus
on identifying DNA loops, genome-wide, that are associated with a specific
protein. Hi-C and 5C use next-generation sequencing technologies to identify
looping events across entire genomes. Although providing useful information,
the amount of sequencing required to adequately cover the genome is currently
cost prohibitive. Microscopy will likely provide complentary data on DNA looping.
High-resolution microscopy would be able to detect distinct fluorophores
corresponding to the proteins of interest in the absence of a loop and would
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detect an overlap of fluorophores during a looping event. Unlike the millions of
cell required for 3C and ChIP-seq experiments, microscopy experiments require
very few cells. Additionally, microscopy allows for the investigation of individual
cells, rather than a large population of cells that inevitably contain some
heterogeneous mix of cell states and cell cycle phases.
A genetic approach to identifying novel layers of transcription regulation
Genetic screens in mammalian cells are increasingly feasible and have
demonstrated success in the identification of novel factors with essential roles in
gene expression and maintenance of cell state. As screening technology
improves in quality, the depth of libraries increases and new assays to measure
the effects of perturbations on cell state are developed, more factors contributing
to different branches of transcriptional regulatory circuitry are sure to be
identified. Additionally, perturbations that direct ES cells down particular lineages
will likely be identified by these screening approaches. Small molecules to
activate or inhibit particular genes are likely to be identified that will improve
methods of directed differentiation or even cellular reprogramming.
A recent short hairpin screen I conducted in human embryonic stem cells
has already identified additional factors with a role in regulating cell state. This
screen followed the same model used for the screens in mouse ES cells
presented in Chapter 4. Human ES cells were plated in 384 well plates, infected
with individual shRNA-containing lentiviral constructs and stained for Oct4 five
days after infection. Some of the factors identified by the screen that reduce
Oct4 levels include the histone methylase SetD8 (Fang J et al. 2002; Couture JF
2005) and members of the family of histone deacetylases. The follow-up of novel
chromatin modifiers, by more closely examining the affects following knockdown
and their role in regulating specific genes both in ES cells and during changes in
ES cell state, will continue to add information to how chromatin remodeling
affects gene expression and cell state. HDACs have already been demonstrated
to have a role in certain forms of cancer. The information gathered from ES cells
could aid in the study of HDACs, their role in cancer and the impact that HDAC
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inhibitors have on altering cell state. In addition, proteins involved in DNA
architecture, including Condensin and high mobility group box (HMGB) proteins
appear to be necessary for the maintenance of cell state. Condensin has been
shown to have a role in regulating gene expression, specifically a role in
controlling sex determination in both C. elegans and Drosophila, but the
regulatory role of this complex in mammals has not yet been demonstrated
(Csankovszki et al., 2009; Ercan and Lieb, 2009; Grimaud and Becker, 2009;
Meyer, 2005). HMG box proteins are involved in facilitating bends in the DNA to
aid in the interactions of various proteins involved in transcription. It will be
interesting to better understand where these shorter-range DNA bends occur in
the genome and how they are involved in regulating gene expression and cell
state. The follow-up study of the hits from this shRNA screen in human ES cells
will add critical insight to novel elements of the circuitry and their roles in the
maintenance of the ES cell gene expression profile.
Regulation of gene expression and human disease
The studies of transcriptional regulation in ES cells described here provide new
information on the molecular underpinnings of pluripotency. More broadly, these
studies also serve as a model for understanding the multiple levels of
transcriptional control required for mammalian cellular differentiation. As we
learn more about the transcriptional regulation required for normal human
development, we will inevitably learn about regulatory dysfunctions that
contribute to human disease and arrive at new approaches for the treatment of
disease. Already the identification of transcription factors that are essential for
ES cell state have led to the generation of patient-specific induced pluripotent
stem (iPS) cells as a realistic therapeutic possibility. Combining iPS cells with
studies of development will lead to significant insights into developmental
disorders. For example, the work presented in Chapter 4 suggests a mechanism
for how a mutation in the Cohesin loading factor, Nipbl, could lead to Cornelia de
Lange syndrome. The generation of PS cells with CdLs and the subsequent
differentiation of those cells could illuminate where during the developmental
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process this mutation causes a detrimental effect. ES cells share some
characteristics with malignant cancers including the capability to self-renew, a
property commonly acquired by mutations in critical regulatory mechanisms. The
study of self-renewal in ES cells and perturbations including those that target
specific genes, signaling pathways or transcription factors and limit the self-
renewing capabilities of ES cells could lead to new therapeutic strategies for the
treatment of various forms of cancer. This idea is being investigated in our own
group, where the same protocol used to screen an shRNA library in human ES
cells now is being used to screen a library of FDA approved drug compounds.
The information collected from this screen will provide insights into how drugs
target self-renewal and pluripotency and how these drugs may be useful in the
clinic. The discoveries that result from continued study will only serve to increase
our understanding and ability to treat a number of developmental diseases,
cancer, and degenerative diseases.
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Appendix A
Supplementary Material for Chapter 3
Cell-Type Specific TGF-p Signaling is Targeted to Genes that
Control Cell Identity
170
Table of Contents
Supplemental Fiqures
Figure S1. Antibodies against Smad3 and Smad2/3 show similar co-occupancy with
Oct4 in mES cells.
Figure S2. DNA motif discovery was performed using bound regions for Smad3 and the
associated master transcription factors for human ES cells, mouse ES cells, myotubes,
and pro-B cells.
Supplemental Table (Available from Younq lab)
Table S1. DNA regions bound by each factor in human ES, mouse ES, C2C12 and
38B9 cells.
Table S2. Genes bound each factor in human ES, mouse ES, C2C12 and 38B9 cells.
Table S3. Gene expression with changes in TGF-p signaling in mouse ES, C2C12 and
38B9 cells.
Materials and Methods
Supplemental References
171
Figure S1
A smeM and SrnadW o -occupy DNA
sites with the core regulatory circultry
1I Oct4t 1m Oct4
200 Sox2 270 Sox2
21s _ Nanog 2o Nanog
501o Smad3 11s Smad3
aoi-L Smad2/3 170 Smad2/3
|k |I
B sm3 nd smfadm co-occupy
me genome with Oc4
Smad2/3 Smad3
-
-2.5 0 +2.5 -2.5 0 +2.5
... nefom Oc4-
bound region (kb)
C Smad2rabinding sites a enriched fr the ot molr
- - - - -
Antibodies against Smad3 and Smad2/3 show similar co-occupancy with
Oct4 in mES cells.
(A) Smad3 and Smad 2/3 co-occupy DNA sites with the core regulatory circuitry.
Gene tracks represent binding of Oct4, Sox2, Nanog (Marson et al., 2008),
Smad3, and Smad2/3 at Pou5fl, the gene encoding Oct4 (left) and at Leftyl
(Amsen et al.).
(B) Smad3 and Smad2/3 co-occupy the genome with Oct4. Region plots show
the distribution of Smad2/3- (left) and Smad3- (Amsen et al.) bound regions
relative to regions bound by Oct4. A 5 kb window centered on each regions
bound by Oct4 is displayed on the y-axis. Red intensity at 0 indicates that
Smad2/3- (left) or Smad3- (Amsen et al.) bound regions overlap with Oct4-bound
regions.
(C) The Oct4 motif was the top identifiable motif enriched in sites bound by
Smad2/3.
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DNA motif discovery was performed using bound regions for Smad3 (top)
and the associated master transcription factors (bottom) for human ES
cells (Oct4), mouse ES cells (Oct4), myotubes (Myodi), and pro-B cells
(PU.1). The top four motifs identified for each set of bound regions are
displayed.
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Materials and Methods
Growth Conditions for Cells
Mouse Embryonic Stem Cells
V6.5 murine embryonic stem (mES) cells were maintained on irradiated murine
embryonic fibroblasts (MEFs) and expanded for two passages on gelatinized-tissue
culture plates without MEFs prior to all experiments. Cells were grown under standard
mES cell conditions as described previously (Marson et al., 2008). Briefly, cells were
grown on 0.2% gelatinized (Sigma, G1890) tissue culture plates in ES cell media
composed of DMEM-KO (Invitrogen, 10829-018) supplemented with 15% fetal bovine
serum (Hyclone, characterized SH3007103), 1000 U/mL LIF (ESGRO, ESG1106), 100
[M nonessential amino acids (Invitrogen, 11140-050), 2 mM L-glutamine (Invitrogen,
25030-081), 100 U/mL penicillin, 100 [g/mL streptomycin (Invitrogen, 15140-122), and
8 nL/mL of 2-mercaptoethanol (Sigma, M7522). Cells were grown to 80-90%
confluence before crosslinking. For expression analysis, cells were cultured in normal
conditions and in the presence of 10 uM SB431542 (Tocris, 1614) solubulized in
DMSO. Mouse ES cells were treated with 10 ng/ml Activin (R&D, 338-AC) to activate
the TGF-p pathway for one hour prior to crosslinking cells used for the Smad2/3 ChIP-
seq and for the second replicate of Smad3. This treatment was necessary to increase
the Smad2/3 signal with a weaker antibody. The presence of Activin expanded the
number of Smad3-bound regions compared to normal culture conditions (table S1).
Human Embryonic Stem Cells
The human ES cell line (BGO3) was maintained in feeder free conditions using defined
media (Ludwig et al., 2006). Cells were grown in a monolayer on tissue culture plates
coated with matrigel at the dilution recommended by the manufacturer (BD, 354277).
Cells were maintained in mTESR1 media and supplement (Stemcell Technologies,
05850) with 100 U/mL penicillin, 100 [g/mL streptomycin and passaged as described in
the Stemcell Techologies protocol. Briefly, cells were washed two times with
DMEM/F12 (Invitrogen, 11320) before treatment with dispase (Stemcell Technologies,
07913) for 7 minutes at 37*C. Cells were then washed three times with DMEM/F12
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before being resuspend in mTESR1 with a cell lifter (Corning, 3008). Cells for these
experiments were between passage 40-60 and had been maintained off feeders for four
passages. Cells were grown to 80% confluence before crosslinking.
C2C12 Myoblasts
C2C12 myoblasts (ATCC, CRL-1772) were expanded in C2C12 growth media and
differentiated into myotubes as previously described (Caretti et al., 2004; Yaffe and
Saxel, 1977). Briefly, cells were cultured in DMEM (Invitrogen, 11965) supplemented
with 20% fetal bovine serum, 2 mM L-glutamine, 100 U/mL penicillin, 100 [tg/mL
streptomycin. To induce differentiation, C2C12 cells were grown to confluence and
shifted to differentiation media containing DMEM, 2% horse serum (GIBCO, 26050-
070), 1x transferrin/selenium/insulin (GIBCO, 51300-044), 2 mM L-glutamine, 100 U/mL
penicillin, 100 Rg/mL streptomycin. Multinucleated myotubes were visible after 48 hours
of culture in differentiation media. Myotubes were treated with 2.5 ng/ml TGF-p (R&D
Systems, 240-B) for 2 hours prior to crosslinking for ChIP-seq analysis or addition of
TRIzol reagent (Invitrogen, 15596-026) for genome-wide expression analysis.
38B9 Pro-B Cells
38B9 cells (Ramakrishnan and Rosenberg, 1988) were grown in suspension in RPMI-
1640 (Invitrogen, 22400), 10% fetal calf serum, 2 mM L-glutamine 100 U/mL penicillin,
100 [tg/mL streptomycin, and 8 nL/mL of 2-mercaptoethanol. Cells were treated with 5
ng/ml of TGF- p for 1 hour prior to prior to crosslinking for ChIP-seq analysis or addition
of TRIzol reagent for genome-wide expression analysis. Cells were crosslinked at a
concentration of approximately 1x106 per ml.
Chromatin Immunoprecipitation
A summary of the bound regions determined for all ChIP-seq data is contained within
table S1.
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For ChIP-seq experiments the following antibodies were used: Oct4 (Santa Cruz,
sc8628), Smad3 (Abcam, ab28379), Smad2/3 (Gift from D. Wotton), Myod1 (Santa
Cruz, sc760), PU.1 (Santa Cruz, sc352).
The protocol for Chromatin Immunoprecipitation (ChIP) was performed as
previously described (Lee et al., 2006). Cells were chemically crosslinked by the
addition of one-tenth volume of fresh 11% formaldehyde. BGO3, V6.5 and C2C12 are
adherent and were crosslinked for 10 minutes at room temperature. Cells were rinsed
twice with 1X PBS and harvested using a silicon scraper and flash frozen in liquid
nitrogen. 38B9 cells were grown in suspension and were crosslinked for 20 minutes at
room temperature. Crosslinking was quenched with one-twentieth volume 2.5 M
glycine. Cells were washed twice with 1X PBS and flash frozen in liquid nitrogen. Cells
were stored at -80*C prior to use. Cells were resuspended, lysed and sonicated to
shear and solubilize crosslinked DNA. Appropriate sonication conditions vary depending
on cells, culture conditions, crosslinking and equipment.
Sonication was performed on approximately 1x10 8 cells in sonication buffer
(10mM Tris-HCI pH8, 100mM NaCI, 1mM EDTA, 0.5 mM EGTA, 0.1% Na-Deoxycholate
and 0.5% N-lauroylsarcosine) using a Misonix Sonicator 3000. BGO3 cells, C2C12
cells and 38B9 cells were sonicated at 21 watts for 8 x 20 second pulses (60 second
pause between pulses). V6.5 murine ES cells were sonicated under the same
conditions for 9 x 20 second pulses. After Sonication, samples were divided in half.
10% Triton-X was added for samples to be precipitated with Oct4, Myod1 and PU.1. No
Triton-X was added for Smad3 or Smad2/3 antibodies. Sonicated samples were
centrifuged at 20,000g for 10 minutes and the soluble whole cell extracts were
incubated overnight with 50 I1 of Dynal Protein G magnetic beads that had been pre-
incubated with 5 [tg of the appropriate antibody. Beads were washed 1X with 20mM
Tris-HCI pH8, 150 mM NaCI, 2mM EDTA, 0.1% SDS, 1%Triton X-100, 1X with 20mM
Tris-HCI pH8, 500mM NaCl, 2mM EDTA, 0.1% SDS, 1%Triton X-100, 1X, 1X with
10mM Tris-HCI pH8, 250nM LiCI, 2mM EDTA, 1% NP40 and 1X with TE containing 50
mM NaCI. A second wash of TE containing 50mM NaCI was performed for Smad3 and
Smad2/3.
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Bound complexes were eluted from the beads (50 mM Tris-Hcl, pH 8.0, 10 mM
EDTA and 1-0.5% SDS) by heating at 650C for 45 min and vortexing every 5 minutes.
Crosslinking was reversed by incubating samples at 650C for 6 hrs. Whole cell extract
DNA reserved from the sonication step was treated in the same way to reverse
crosslinking.
ChIP-seq Sample Preparation and Analysis
All protocols for Illumina/Solexa sequence preparation, sequencing and quality control
are provided by Illumina (http://www.illumina.com/pages.ilmn?lD=203). A brief summary
of the technique and minor protocol modifications are described below.
Sample Preparation
DNA was prepared for sequencing according to a modified version of the
Illumina/Solexa Genomic DNA protocol. Fragmented DNA was prepared for ligation of
Solexa linkers by repairing the ends and adding a single adenine nucleotide overhang
to allow for directional ligation. A 1:100 dilution of the Adaptor Oligo Mix (Illumina) was
used in the ligation step. A subsequent PCR step with limited (18 cycle) amplification
cycles added additional linker sequence to the fragments to prepare them for annealing
to the Genome Analyzer flow-cell. After amplification, a narrow range of fragment sizes
was selected by separation on a 2% agarose gel and excision of a band between 150-
350 bp (representing shear fragments between 50 and 250 nucleotides in length and
-100bp of primer sequence). The DNA was purified from the agarose and diluted to 10
nM for loading on the flow cell. Human and mouse ES cell samples were prepared
using the Illumina/Solexa Genomic DNA Kit. C2C12 and 38B9 samples were prepared
in a similar manner using individually purchased reagents with the following differences.
End repair of fragmented DNA was performed using the End-It-DNA Repair Kit
(Epicentre #ER0720). DNA was purified with the Qiaquick PCR Purification Kit
(#21806). Purified DNA was treated with Klenow fragment (NEB#M0212) and 1mM
dATP for 37*C for 30 minutes to add an A tail. DNA was purified by Qiaquick MiniElute
Purification Kit (#28006). Adapters from the Illumina/Solexa Kit were ligated onto the
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fragmented DNA with DNA ligase (Promega #M8221) during a 15 minute incubation at
room temperature. DNA was purified by MiniElute Purification Kit. PCR was performed
using Phusion NZ (NEB#F531) and primers from the Illumina/Solexa Kit.
Polony Generation and Sequencing
The DNA library (2-4 pM) was applied to the flow-cell (8 samples per flow-cell) using the
Cluster Station device from Illumina. The concentration of library applied to the flow-cell
was calibrated such that polonies generated in the bridge amplification step originate
from single strands of DNA. Multiple rounds of amplification reagents were flowed
across the cell in the bridge amplification step to generate polonies of approximately
1,000 strands in 1 pm diameter spots. Double stranded polonies were visually checked
for density and morphology by staining with a 1:5000 dilution of SYBR Green I
(Invitrogen) and visualizing with a microscope under fluorescent illumination. Validated
flow-cells were stored at 40C until sequencing.
Flow-cells were removed from storage and subjected to linearization and
annealing of sequencing primer on the Cluster Station. Primed flow-cells were loaded
into the Illumina Genome Analyzer 1G. After the first base was incorporated in the
Sequencing-by-Synthesis reaction the process was paused for a key quality control
checkpoint. A small section of each lane was imaged and the average intensity value for
all four bases was compared to minimum thresholds. Flow-cells with low first base
intensities were re-primed and if signal was not recovered the flow-cell was aborted.
Flow-cells with signal intensities meeting the minimum thresholds were resumed and
sequenced for 26, 32, or 36 cycles.
ChIP-seq Data Analysis
Images acquired from the Illumina/Solexa sequencer were processed through the
bundled Solexa image extraction pipeline, which identified polony positions, performed
base-calling and generated QC statistics. Bowtie (version 0.12.2) (Langmead et al.,
2009) was used to align sequences to NCBI Build 36 (UCSC mm8) of the mouse
genome and NCBI Build 36 (UCSC hg18) of the human genome. Alignments were
performed using the following criteria: -n2, -e 70, -m2, -k2, --best. Only sequences that
178
aligned to a unique location were used to determine enriched regions as described
below. ChIP-seq quality score (FASTQ) files profiling the genomic occupancy of Oct4,
Sox2, Nanog (Marson et al., 2008), and Zfx (Chen et al., 2008) in mES cells were
aligned using Bowtie as described above.
Analysis methods were derived from previously published methods (Marson et
al., 2008). Each read (reads from biological replicates were combined) was extended
200bp, towards the interior of the sequenced fragment, based on the strand of the
alignment. Across the genome, in 25 bp bins, the number of ChIP-seq reads within a
1kb window surrounding each bin (+/- 500bp) was tabulated. The 25bp genomic bins
that contained statistically significant ChIP-seq enrichment were identified by
comparison to a Poissonian background model. Assuming background reads are
spread randomly throughout the genome, the probability of observing a given number of
reads in a 1kb window can be modeled as a Poisson process in which the expectation
can be estimated as the number of mapped reads multiplied by the number of bins (40)
into which each read maps, divided by the total number of bins available. Enriched bins
within 200bp of one another were combined into regions.
The Poissonian background model assumes a random distribution of background
reads. However, significant deviations from this expectation have been observed.
Some of these non-random events can be detected as sites of apparent enrichment in
negative control DNA samples creating false positives. To remove these false positive
regions, negative control DNA from whole cell extract (WCE) or IgG ChlPs were
sequenced for each cell type. Enriched bins and enriched regions were defined as
having greater than five-fold density in the experimental sample compared with the
control sample when normalized to the total number of reads in each dataset. This
served to filter out genomic regions that are biased to having a greater than expected
background density of ChIP-seq reads. For mouse, the complete set of RefSeq genes
was downloaded from the UCSC website
(http://hgdownload.cse.ucsc.edu/goldenPath/mm8/database/refGene.txt.gz) on March
5, 2010. For human, the complete set of RefSeq genes was downloaded from the
UCSC table browser (http://qenome.ucsc.edu/cqi-bin/hqTables?command=start) on
179
March 1, 2009. Genes with enriched regions within 10kb upstream of the transcription
start site or within the body of the gene were called bound.
A summary of the bound regions (table S1) and bound genes (table S2) for each
antibody is provided, and the totals are provided below. These data represent merged
biological replicates for C2C12 and 38B9 cells. Data for Smad3 in murine ES cells
contains separate analysis for biological replicates. These samples were not combined
because the second sample was analyzed after treatment with Activin for 1 hour as
described above. Data for BGO3 human ES cells and Smad2/3 in mES cells represent
single experiments.
Total enriched regions transcription factor:
Human
Factor Cell Type # Enriched Regions #Bound Genes
Oct4 ESC 7532 4387
Smad3 ESC 5282 4658
Mouse
Oct4 ESC 15003 8024
Sox2 ESC 15699 7637
Nanog ESC 16006 6949
Zfx ESC 14561 12070
Smad3 ESC 2018 1311
Smad2/3 ESC 888 568
Smad3 - Activin ESC 2269 1426
Myod Myotube 14678 4387
Smad3 Myotube 1746 1429
PU.1 Pro-B 26349 12277
Smad3 Pro-B 3602 2709
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Motif discovery
DNA motif discovery was performed as previously described (Marson et al., 2008).
Briefly, a modified version of the ChIP-seq read mapping algorithm was used. The
genomic bin size was reduced to 10 bp and the read extension placed greater weight
towards the middle of the 200 pb extension. Greater weight was placed toward the
middle of the extension to increase the precision of the peak for each region and
worked by placing 1/3 count in the 8 bins from 0-40 and 160- 200 bp, 2/3 counts in the 8
bins from 40-80 and 120-160 bp and 1 count in the 4 bins from 80-120 bp. 250 bp of
genomic sequence, centered at the 500 largest peaks of ChIP-seq density, were
submitted to the motif discovery tool MEME (Bailey and Elkan, 1994) to search for over-
represented DNA motifs. The top 4 motifs identified for each antibody is shown in fig.
S2.
Background region generation
The distribution of distances from the center of each enriched region in the datasets
shown in Fig. 2B (excluding background) to the closest transcription start site was
calculated. A set of background regions (Fig. 2B, far right) was generated by selecting
10,000 random genomic locations such that the distribution of distances to the closest
transcription start site within the random dataset was highly similar to the observed
distribution.
Canonical motif scanning
The genomic sequence +/- 2.5kb from the center of each enriched region in the dataset
indicated was downloaded from the UCSC website with repeats masked with "N". A
window of 250 bp was shifted across each sequence at 50 bp intervals, and the number
of occurrences of the complete Smad2/3 canonical motif "AGAC" or its reverse-
complement "GTCT" within the window was counted. The plots in Fig. 1 D and 2B show
the number of occurrences within each window averaged across all sequences.
Expression arrays
Genomic expression analysis was measured using Agilent Whole-Mouse Genome
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Microarrays (Agilent, G4122F). Total RNA was isolated from cells using TRIzol reagent
following the protocol for cells grown in monolayer and suspension as appropriate
(Invitrogen, 15596-026). RNA was further purified with RNeasy columns (Qiagen,
74104) after DNase treatment (Invitrogen, 18068-015) following the manufacturers'
protocols. RNA samples from two biological replicates were used for duplicate
microarray expression analysis. Two micrograms of RNA were labeled for each sample
using the two-color low RNA Input Linear Amplification Kit PLUS (Agilent, 5188-5340).
Briefly, double-stranded cDNA was generated using MMLV-RT enzyme and an oligo-dT
based primer. In vitro transcription was performed using T7 RNA polymerase and either
Cy3-CTP or Cy5-CTP, directly incorporating dye into the cRNA. Labeled cRNA was
hybridized overnight at 650C. which differs slightly from the standard protocol provided
by Agilent. The hybridization cocktail consisted of 825 ng cy-dye labeled cRNA for each
sample, Agilent hybridization blocking components, and fragmentation buffer. The
hybridization cocktails were fragmented at 600C for 30 minutes, and then Agilent 2X
hybridization buffer was added to the cocktail prior to application to the array. The
arrays were hybridized for 16 hours at 600C in an Agilent rotor oven set to maximum
speed. The arrays were treated with Wash Buffer #1 (6X SSPE / 0.005% n-
laurylsarcosine) on a shaking platform at room temperature for 2 minutes, and then
Wash Buffer #2 (0.06X SSPE) for 2 minutes at room temperature. The arrays were then
dipped briefly in acetonitrile before a final 30 second wash in Agilent Wash 3
Stabilization and Drying Solution, using a stir plate and stir bar at room temperature.
Arrays were scanned using an Agilent DNA microarray scanner. Array images
were quantified and statistical significance of differential expression was calculated for
each hybridization using Agilent's Feature Extraction Image Analysis software with the
default two-color gene expression protocol.
Determination of change in gene expression
Biological replicates of each expression array were generated. To calculate an average
dataset from the biological replicates the log10 ratio values for each feature was
averaged and the log ratio p-values were multiplied. For each gene in the RefSeq
dataset (see above), we used the feature with the median log10 ratio among all the
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features annotated to that gene. If there were an even number of features associated to
a gene, the middle two features were averaged. The feature(s) used for each gene in
each experiment can be found in table S3. Genes without annotated features are
reported as NA and were excluded from any expression analysis. A gene was classified
as affected by TGF-p if its expression changed by over 50% (absolute loglO ratio of
greater than 0.176) and had a p-value for that log ratio less than or equal to 0.05.
Genes that changed in expression by more than 50%, but had a p-value greater than
0.05, were classified as unaffected and excluded from the analysis. Fig. 4A is an
expression heatmap of the 3067 genes (one per row) affected by TGF-p signaling in at
least one of the three cell-types. Genes affected in mESC cells were placed at the top,
genes affected in myotubes in the middle and genes affected in pro-B cells at the
bottom. Each gene is represented only once even if it was affected in multiple cell types.
Region plots
The visualization in Fig. 1B shows the location of Oct4 and Smad3 binding (x-axis) in
relation to regions bound by Oct4 (y-axis). Fig. 2B and Fig.3E show the location of
Smad3 binding (x-axis) in relation to regions bound by the identified transcription factor
(y-axis). For each bound region in the base dataset (y-axis) the genomic interval +/- 2.5
kb from the center of that enriched region is shown, and any bound region in the query
dataset (x-axis) within that 5 kb window is displayed.
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Figure S1. Screening Protocol and Validation of Mediator and Cohesin
shRNAs, Related to Figure 1.
(A) Outline of the screening protocol. Murine embryonic stem cells were seeded
without a MEF feeder layer into 384-well plates. The following day cells were
infected with individual lentiviral shRNAs targeting chromatin regulators and
transcription factors. Infections were done in quadruplicate (chromatin regulator
set) or duplicate (transcription factor set) on separate plates (Table S1). Five
days post-infection cells were fixed and stained with Hoechst and for Oct4. Cells
were identified based on the Hoechst staining and the average Oct4 staining
intensity was quantified using Cellomics software.
(B) Representative images from control wells on a 384-well plate infected with
shRNAs targeting positive regulators of pluripotency (Oct4 and Stat3) and a
negative regulator of pluripotency (Tcf3) (Borowiec et al., 1987; Cole et al., 2008;
Hay et al., 2004; Nichols et al., 1998; Niwa et al., 2000; Pereira et al., 2006). OSI
indicates the average Oct4 staining intensity of the cells in the well.
(C and D) Multiple shRNAs targeting Mediator (C) and Cohesin (D) components
reduce Oct4 protein levels and result in changes in colony morphology. Murine
ES cells were infected with the indicated shRNA and stained with Hoechst and
for Oct4.
(E and F) Effect of multiple Mediator (E) and Cohesin (F) shRNAs on transcript
levels for Med12, Med15, Smcla, Smc3, Nipbl and Oct4. Murine ES cells were
infected with the indicated shRNA and transcript levels were evaluated by real-
time qPCR.
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Figure S2. Validation of Mediator, Cohesin and Nipbl Antibodies Used for
ChIP-Seq, Related to Figure 2, 3, 6 and 7.
(A) Antibodies against Med12, Med1, Smcl, Smc3 and Nipbl are specific and
shRNAs targeting Med12, Med1, Smcl, Smc3 and Nipbl result in reduced levels
of the target protein. Murine ES cells were infected with the indicated shRNA and
protein levels were determined by western blot analysis.
(B) Gene specific ChlPs demonstrating that a reduction in Smcl, Smc3, Nipbl,
Med1 and Med12 protein levels by shRNA result in a decreased ChIP signal at
the indicated gene. Murine ES cells were infected with the indicated shRNA,
gene specific ChIP experiments were performed and analyzed by real-time
qPCR.
(C) Antibodies against Med12, Med1, Smcl and Smc3 are specific. Proteins
were detected by western blot analysis from either ES or MEF cell lysates.
(D) Gene specific ChlPs verifying that Mediator, Cohesin and Nipbl occupy the
promoter regions of Oct4 and Nanog in ES cells.
(E) Gene specific ChlPs demonstrating that Mediator does not occupy Oct4 and
Nanog in MEFs.
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Figure S3. Mediator and Pol2 Occupancy of Ribosomal Protein Genes,
Related to Figure 2.
(A) Gene tracks are displayed for a housekeeping (Ybxl) and a ribosomal protein
gene (RpI4) in ES cells, where there is a high level of Pol2 and TBP occupancy
and a low level of Mediator occupancy. ChIP-Seq data is shown in reads/million
with the base of the y-axis set 0.5 reads/million. The transcription start site and
direction of transcription are noted by an arrow.
(B) Many actively transcribed housekeeping and ribosomal protein genes have
low levels of Mediator (Med12) occupancy as opposed to pluripotency genes.
The ratio of Pol2 occupancy to Mediator occupancy is significantly higher for the
housekeeping and ribosomal genes, when compared to pluripotency genes.
Maximum reads/million of Pol2 and Med12 observed within 5kb of the TSS for
selected pluripotency, housekeeping and ribosomal protein genes are shown.
(C) Gene specific ChlPs demonstrate that Mediator (Med1 and Med12) does not
strongly occupy the promoters of the house keeping genes (Ybxl and No/5).
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Figure S4. Mediator, Cohesin and Nipbl co-occupy at Mediator and Cohesin
Regulated Genes, Related to Figure 2.
(A) Venn diagram demonstrating the overlap of high confidence Nipbl occupied
sites with Mediator/Cohesin co-occupied sites. The overlap of high confidence
(P-val 10-9) Cohesin sites with Nipbl, Mediator and CTCF is shown. The overlap
of Nipbl, Mediator and Cohesin sites is highly significant (P-val < 10-300). Reads
from two biological replicate for the Smcl, Med12 and Nipbl ChIP-Seq data sets
were combined.
(B) Heat map indicating that regions co-occupied by Smcl and Med12 are
associated with active genes that exhibit similar expression changes with either
Smcla or Med12 knockdown (3 days post knockdown). Log 2 expression data is
shown for all Smcl and Med12 co-occupied regions that could be mapped to a
gene. Mapped genes have evidence of a co-occupied Smcl and Med12 region
within the gene body or within 10kb upstream of the transcriptional start site,
evidence of Pol2 occupancy within the gene body and significant (Pval <0.01)
expression changes in both an Smcla and Med12 knockdown in independent
experiments. The two knockdowns had a strikingly similar effect at this set of
genes (Pearson Correlation of 0.68). There is also significant enrichment (P-val
= 5.3x10-26) for Mediator/Cohesin co-occupancy at the genes that change
expression for both knockdowns in contrast to CTCF only occupied regions that
are not enriched (P-val = 1). The log2 expression data was ordered based on the
Smcla knockdown and the corresponding expression change for each gene
following a Med 12 knockdown is shown. A relative signal scale for the expression
data is shown at the bottom of both panels.
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Figure S5. Mediator and Cohesin co-purify, Related to Figure 4.
(A) DNase I treatment does not effect Mediator and Cohesin interaction by co-
immunoprecipitation. Cell lysates were Mock or DNase I treated prior to
immunoprecipitation. DNase I treatment resulted in a reduction in the amount
DNA detected in a whole cell extract (bottom panel).
(B) Cohesin (Smc3) interacts with the Mediator complex purified by Med1. The
Mediator complex was initially affinity purified from a HeLa cell nuclear extract
utilizing a SREBP-1a activation domain GST fusion. The eluted (Input) material
was further purified by immunoprecipitation with a Med1 antibody. The IP Elution
was subjected to western blot analysis for Smc3 and Med 15.
(C) Silver stained gels from the purification scheme outlined in (B).
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Figure S6. Mediator and Cohesin Binding Profiles Predict Enhancer-
Promoter Looping Events, Related to Figure 5.
(A-D) A looping event between the upstream enhancer and the core promoter of
Phc (A), Nanog (B), Leftyl (C) and Oct4 (Pou5fl) (D) and was detected by
Chromosome Conformation Capture (3C) in ES cells, but not in MEFs. Biological
replicates are shown for each locus. ES cell and MEF crosslinked chromatin was
digested by the indicated restriction enzyme and religated under conditions that
favor intramolecular ligation events. The interaction frequency between the
anchoring point and distal fragments was determined by PCR and normalized to
BAC templates and control regions. The restriction enzyme sites are indicated
above the 3C graph. The error bars represent the standard error of the average
of 3 independent PCR reactions. The ChIP-Seq binding profiles for Med12 and
Smcl are shown in reads/million for both ES cells and MEF cells. Reads from
two biological replicates for Smcl (ES cells and MEFs) and Med12 (ES cells)
ChIP-Seq datasets were combined.
(E) 3C data demonstrating that the interaction frequency between the promoter
and enhancer of Nanog decrease for a Cohesin (Smcla) or a Mediator (Med12)
knockdown. The Interaction Frequency Ratio (red dash) was calculated for each
graph using the interaction frequency between primer 4 (within the enhancer)
and primer 20 (anchoring primer). A Fold Decrease in Nanog Expression (ES
cells to MEFs or shRNA GFP to Knockdown cells) was determined by qPCR and
is shown for each graph (See Nanog mRNA). For all graphs the interaction
frequency between primer 4 (within the enhancer) and primer 20 (anchoring
primer) was normalized to 1 for the ES and shRNA GFP cells. All other
interaction frequencies were scaled accordingly.
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Extended Experimental Procedures
Cell Culture Conditions
Embryonic Stem Cells
V6.5 murine embryonic stem (mES) cells were grown on irradiated murine
embryonic fibroblasts (MEFs) unless otherwise stated. Cells were grown under
standard mES cell conditions as described previously (Boyer et al., 2005).
Briefly, cells were grown on 0.2% gelatinized (Sigma, G1890) tissue culture
plates in ESC media; DMEM-KO (Invitrogen, 10829-018) supplemented with
15% fetal bovine serum (Hyclone, characterized SH3007103), 1000 U/mL LIF
(ESGRO, ESG1106), 100 [M nonessential amino acids (Invitrogen, 11140-050),
2 mM L-glutamine (Invitrogen, 25030-081), 100 U/mL penicillin, 100 Rg/mL
streptomycin (Invitrogen, 15140-122), and 8 nL/mL of 2-mercaptoethanol
(Sigma, M7522).
Mouse Embryonic Fibroblasts (MEFs)
Low passage MEFs were grown on tissue culture plates DMEM -(Invitrogen,
11965) supplemented with 10% fetal bovine serum (Hyclone, characterized
SH3007103), 100 [M nonessential amino acids (Invitrogen, 11140-050), 2 mM L-
glutamine (Invitrogen, 25030-081), 100 U/mL penicillin, 100 jg/mL streptomycin
(Invitrogen, 15140-122), and 8 nL/mL of 2-mercaptoethanol (Sigma, M7522).
ZHBTc4 mES Cells
ZHBTc4 Oct4 shutdown cells (Niwa et al., 2000) were grown under standard
mES cell conditions, expanded off of MEF feeders for two passages and treated
with 2 [tg/ml doxycycline for 24 hours prior to formaldehyde crosslinking or
protein extraction.
Hiqh-Throuqhput shRNA Screeninq
Library Design and Lentiviral Production
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Small hairpins targeting 197 chromatin regulators and 2021 transcription factors
were designed and cloned into pLKO.1 lentiviral vectors as previously described
(Moffat et al., 2006). On average 5 different shRNAs targeting each chromatin
regulator or transcription factor were used. Lentiviral supernatants were arrayed
in 384-well plates with negative control lentivirus (shRNAs targeting GFP, RFP,
Luciferase and LacZ) (Moffat et al., 2006).
Lentiviral Infections
Murine ES cells were split off MEFs and placed in a tissue culture dish for 45
minutes to selectively remove the MEFs. Murine ES cells were counted with a
Coulter Counter (Beckman, #1499) and seeded using a [tFill (Bioteck) at a
density of 1500 cells/well in 384-well plates (Costar 3712) treated with 0.2%
gelatin (Sigma, G1890). An initial cell plating density of 1500 cells/well was
established so that an adequate amount of cells would survive puromycin
selection for analysis. However, the initial cell plating density was kept low
enough to avoid wells reaching confluency during the timeframe of the assay.
One day following cell plating the media was removed, replaced with ESC media
containing 8 Rg/ml of polybrene (Sigma, H9268-10G) and cells were infected with
2 pl of shRNA lentiviral supernatant. Infections were performed in duplicate
(transcription factor set) or quadruplicate (chromatin regulator set) on separate
plates. Table S1 denotes which screening set the shRNAs were in. Control
wells on each plate were mock infected and designated as "Empty". Positive
control wells on each plate were infected with 3 pl of validated control shRNA
lentiviral supernatant targeting Oct4 (TRCN0000009613), Tcf3
(TRCN0000095454) and Stat3 (TRCN0000071454) that was generated
independently of the screening sets (Lentiviral Production and Infection).
Sequence and shRNAs are available from Open Bioystems. Plates were spun
for 30 minutes at 2150 rpm following infection. Twenty-four hours post infection
cells were treated with 3.5 [tg/ml of puromycin (Sigma, P8833) in ESC media to
select for stable integration of the shRNA construct. ESC media with puromycin
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was changed daily. Five days post infection cells were crosslinked for 15
minutes with 4% paraformaldehyde (EMS Diasum, 15710).
Immunofluorescence
Following crosslinking, the cells were washed once with PBS, twice with blocking
buffer (PBS with 0.25% BSA, Sigma, A3059-10G) and then permeabilized for 15
minutes with 0.2% Triton X-100 (Sigma, T8797-100ml). After two washes with
blocking buffer cells were stained overnight at 40C for Oct4 (Santa Cruz
Biotechnology, sc-5279; 1:100 dilution) and washed twice with blocking buffer.
Cells were incubated for 4 hours at room temperature with goat anti-mouse-
conjugated Alexa Fluor 488 (Invitrogen; 1:200 dilution) and Hoechst 33342
(Invitrogen; 1:1000 dilution). Finally, cells were washed twice with blocking buffer
and twice with PBS before imaging.
Image Acquisition and Analysis
Image acquisition and data analysis were performed essentially as previously
described (Moffat et al., 2006). Stained cells were imaged on an Arrayscan HCS
Reader (Cellomics) using the standard acquisition camera mode (10X objective,
9 fields). Hoechst was used as the focus channel. Objects selected for analysis
were identified based on the Hoechst staining intensity using the Target
Activation Protocol and the Fixed Threshold Method. Parameters were
established requiring that individual objects pass an intensity and size threshold.
The Object Segmentation Assay Parameter was adjusted for maximal resolution
between individual cells. Following object selection, the average Oct4 pixel
staining intensity was determined per object and then a mean value for each well
was calculated. Image acquisition for a well continued until at least 2500 objects
were identified, the entire well (9 fields) was imaged or less than 20 objects were
identified for three fields imaged in a row. To account for viability defects or low
titer lentivirus for the chromatin regulator screening set an shRNA was excluded
from subsequent analysis if less than 250 objects were identified for any one of
the 4 replicates. The 250 identified objects threshold was determined based on
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the average number of identified objects for the "Empty" (no virus) wells (mean:
53.4, standard deviation: 49.3). To account for viability defects or low titer
lentivirus for the transcription factor screening set a shRNA was excluded from
subsequent analysis if less than 300 objects were identified for any one of the 2
replicates. The 300 identified objects threshold was determined based on the
average number of identified objects for the "Empty" (no virus) wells (mean: 39.2,
standard deviation: 147.5).
To normalize for plate effects, a Z-score based on the Oct4 staining
intensity was calculated for each well using the following negative control
infections, 24 different shRNAs targeting GFP, 16 different shRNAs targeting
RFP, 25 different shRNAs targeting Luciferase and 20 different shRNAs targeting
LacZ. There were a total of between 16 and 22 wells infected with various
negative control shRNAs on each 384-well plate, with the exception of one plate
within the transcription factor set that contained 99 wells with control infections.
The average Oct4 staining intensity for the negative control infected wells was
calculated along with a standard deviation to give an estimation of the amount of
the signal variability. The average Oct4 staining intensity for all the negative
control infected wells on a plate and the standard deviation were utilized to
calculated a Z-score for every well on the plate. The Z-scores for the four
quadruplicate infections (chromatin regulator set) or two duplicate infections
(transcription factor set) were averaged for a final Z-score for every shRNA. The
Z-score data for both sets were combined (Table S1). Representative control
384-well plate images (shRNAs targeting Oct4, Stat3, Tcf3 and GFP) were
exported (Cellomics Software), converted from DIBs to TIFs (CellProfiler,
http://www.cellprofiler.org), and manipulated with Photoshop CS3 Extended
(Figure S1B).
Combining Screening Data (Table SI)
We recently published the results of an ES screen where 197 chromatin
regulators were selectively targeted for knockdown (Bilodeau et al., 2009). For
the present study we screened an additional 2021 genes encoding transcription
204
factors and chromatin regulators. In order to generate a more complete picture
of factors required for maintaining ES cells state we included the set of chromatin
regulator results from the previous study. The shRNAs from each set are
denoted in Table S1.
The same methodology was followed for screening with both the
chromatin regulator and transcription factor sets with the following exception,
infections for the chromatin regulator set were done in quadruplicate and
infections for the transcription factor set were carried out in duplicate, due to the
large size of the transcription factor screening set (30 x 384-well plates, 2021
genes). Because the average Z-scores of the added controls (Oct4 and Stat3)
were within close proximity for both screening sets (Chromatin Regulator Set: -
3.3 and -2.4 for Oct4 and Stat3 respectively; Transcription Factor Set: -3.0 and -
2.1 for Oct4 and Stat3 respectively) we reasoned that Z-scores between the two
screening sets were comparable.
Criteria for Identifying Screening Hits (Table S2)
We used multiple Z-score level thresholds to select chromatin regulators and
transcription factors that had significantly reduced Oct4 levels for inclusion in
Table S2. First, a chromatin regulator or transcription factor had to have at least
two shRNA with a Z-score less than -1.5 and it was possible to classify the gene
based on the literature. Second, a chromatin regulator or transcription factor with
a single shRNA hit and a Z-score of less than -1.5 was also included if it could
be classified with one of the multiple shRNA hits. Third, the following chromatin
regulators (Cbx7, Cbx8/Pc3 and Ezh2) were included even though each was only
a single shRNA hit, because all had strong negative Z-scores, all are polycomb
proteins, and polycomb has been previously demonstrated to be important for
regulating ES cell (Boyer et al., 2006). The -1.5 cut-off was chosen because it
was within close proximity to the Z-score of the Stat3 controls (-2.4 and -2.1 for
the chromatin regulator and the transcription factor sets respectively).
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Validation of shRNAs
Lentiviral Production and Infection
Lentivirus was produced according to Open Biosystems Trans-lentiviral shRNA
Packaging System (TLP4614). The shRNA constructs targeting Med12, Med15,
Smcla, Smc3, Nipbl, Oct4, Stat3 and Tcf3 are listed below. All are available,
including sequences from Open Biosystems. The shRNA targeting GFP
(TRCN0000072201, Hairpin Sequence: gtcgagctggacggcgacgta) was one of the
negative controls included on all plates for the screen.
Smcla #1 TRCN0000109033
Smcla #2 TRCN0000109034
Smc3 #1 TRCN0000109009
Smc3 #2 TRCN0000109007
Nipbl #1 TRCN0000124037
Nipbl #2 TRCN0000124036
Med12 #1 TRCN0000096467
Med12 #2 TRCN0000096466
Med15 #1 TRCN0000175270
Med15 #2 TRCN0000175823
Oct4 TRCN0000009613
Stat3 TRCN0000071454
Tcf3 TRCN0000095454
For validation of the Mediator and Cohesin shRNAs, mES cells were split off
MEFs, placed in a tissue culture dish for 45 minutes to selectively remove the
MEFs and then plated in 6-well plates (200,000 cells/well). The following day
cells were infected in ESC media containing 8 pg/ml polybrene (Sigma, H9268-
10G). After 24 hours the media was removed and replaced with ESC media
containing 3.5 pg/mL puromycin (Sigma, P8833). ESC media with puromycin
was changed daily. Five days post infection RNA or proteins were extracted or
the cells were crosslinked for immunofluorescence.
206
Immunofluorescence
Cells were crosslinked, permeabilized and stained as described for high-
throughput screening. Images were acquired on a Nikon Inverted TE300 with a
Hamamatsu Orca camera. Openlab
(http://www.improvision.com/products/openlab/) was used for image acquisition.
Openlab and Photoshop CS3 Extended were used for image manipulation.
RNA Extraction, cDNA, and TaqMan Expression Analysis
RNA utilized for real-time qPCR was extracted with TRIzol according to the
manufacturer protocol (Invitrogen, 15596-026). Purified RNA was reverse
transcribed using Superscript III (Invitrogen) with oligo dT primed first-strand
synthesis following the manufacturer protocol.
Real-time qPCR were carried out on the 7000 ABI Detection System using
the following Taqman probes according to the manufacturer protocol (Applied
Biosystems).
Gapdh Mm99999915_g1
Med12 Mm00804032_ml
Med15 Mm01171155_ml
Smcla Mm01253647_ml
Smc3 Mm00484012_ml
Nipbl Mm01297461_ml
Oct4 Mm00658129_gH
Nanog Mm02384862_g1
Expression levels were normalized to Gapdh levels. All knockdowns are relative
to control shRNA GFP infections.
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Protein Extraction and Western Blot Analysis
Cells were lysed with CelLytic Reagent (Sigma, C2978-50ml) containing
protease inhibitors (Roche), proteins were separated by SDS-PAGE and
Western blots were revealed with antibodies against Med1 (Bethyl, A300-793A),
Med12 (Bethyl, A300-774A), Smcl (Bethyl, A300-055A), Smc3 (Abcam,
ab9263), Nipbl (Bethyl, A301-778A) or Gapdh (Abcam, ab9484).
Chromatin Immunoprecipitation
A summary of the ChIP-Seq data is contained within Table S7.
For Med1 (CRSP1/TRAP220) occupied genomic regions, we performed ChIP-
Seq experiments using Bethyl Laboratories (A300-793A) antibody. The affinity
purified antibody was raised in rabbit against an epitope corresponding to amino
acids 1523-1281 mapping at the C-terminus of human Med1.
For Med12 occupied genomic regions, we performed ChIP-Seq experiments
using Bethyl Laboratories (A300-774A) antibody. The affinity purified antibody
was raised in rabbit against an epitope corresponding to amino acids 2150-2212
mapping at the C-terminus of human Med12.
For Smcl occupied genomic regions, we performed ChIP-Seq experiments using
Bethyl Laboratories (A300-055A) affinity purified rabbit polyclonal antibody. The
epitope recognized by A300-055A maps to a region between residue 1175 and
the C-terminus of human Smcl.
For Smc3 occupied genomic regions, we performed ChIP-Seq experiments using
Abcam (ab9263) antibody. The affinity purified antibody was raised in rabbit
against an epitope corresponding to the last 100 amino acids of the human Smc3
protein.
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For TBP occupied genomic regions, we performed ChIP-Seq experiments using
Abcam (ab818) antibody. The antibody was raised with a synthetic peptide which
represents amino acid residues 1-20 of human TBP.
For Pol2 occupied genomic regions, we performed ChIP-Seq experiments using
Covance 8WG16 antibody. This mouse monoclonal antibody was raised against
the C-terminal heptapeptide repeat region on the largest subunit of Pol2, purified
from wheat germ extract.
For H3K79me2 occupied genomic regions, we performed ChIP-Seq experiments
using Abcam ab3594 rabbit polyclonal antibody. The antibody was raised with a
synthetic peptide that is within residues 50 to the C-terminus of Human Histone
H3, di methylated at K79.
For CTCF occupied genomic regions, we performed ChIP-Seq experiments
using an Upstate 07-729 rabbit polyclonal antibody.
For Nipbl occupied genomic regions, we performed ChIP-Seq experiments using
a Bethyl A301-778A rabbit polyclonal antibody. The affinity purified antibody was
raised in rabbit to a region between amino acid residues 550 and 600 of human
Nipbl.
Protocols describing chromatin immunoprecipitation materials and methods have
been previously described (Boyer et al., 2006). Embryonic stem cells were grown
to a final count of 5-10 x 107 cells for each ChIP experiment. Cells were
chemically crosslinked by the addition of one-tenth volume of fresh 11%
formaldehyde solution for 15 minutes at room temperature. Cells were rinsed
twice with 1X PBS and harvested using a silicon scraper and flash frozen in liquid
nitrogen. Cells were stored at -800C prior to use. Cells were resuspended, lysed
in lysis buffers and sonicated to solubilize and shear crosslinked DNA. Sonication
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conditions vary depending on cells, culture conditions, crosslinking and
equipment.
For Nipbl, Smcl, Smc3, Pol2, H3K79me2 and Med1 the sonication buffer
was 20mM Tris-HCI pH8, 150mM NaCI, 2mM EDTA, 0.1% SDS, 1% Triton X-
100. We used a Misonix Sonicator 3000 and sonicated at approximately 24 watts
for 10 x 30 second pulses (60 second pause between pulses). Samples were
kept on ice at all times. The resulting whole cell extract was incubated overnight
at 40C with 100 Id of Dynal Protein G magnetic beads that had been pre-
incubated with approximately 10 [tg of the appropriate antibody. Beads were
washed 1X with the sonication buffer, 1X with 20mM Tris-HCI pH8, 500mM NaCl,
2mM EDTA, 0.1% SDS, 1%Triton X-100, 1X with 10mM Tris-HCI pH8, 250nM
LiCI, 2mM EDTA, 1% NP40 and 1X with TE containing 50 mM NaCl.
For Med12 and CTCF, the sonication buffer was 10mM Tris-HCI pH8,
100mM NaCI, 1mM EDTA, 0.5mM EGTA, 0.1% Na-Deoxycholate, 0.5% N-
lauroylsarcosine. We used the same sonication and wash conditions as
described above.
For TBP, the sonication buffer was 10mM Tris-HCI pH8, 100mM NaCl,
1mM EDTA, 0.5 mM EGTA, 0.1% Na-Deoxycholate and 0.5% N-
lauroylsarcosine. We used a Misonix Sonicator 3000 and sonicated at
approximately 24 watts for 10 x 30 second pulses (60 second pause between
pulses). After Sonication, 10% Triton-X was added. After immunoprecipitation,
beads were washed 4X with the RIPA buffer (50 mM Hepes-KOH pH 7.6, 500
mM LiCI, 1 mM EDTA, 1% NP40 and 0.7% Na-Deoxycholate) and 1X with TE
containing 50 mM NaCl.
Bound complexes were eluted from the beads (50 mM Tris-Hcl, pH 8.0, 10
mM EDTA and 1 % SDS) by heating at 650C for 1 hour with occasional vortexing
and crosslinking was reversed by overnight incubation at 650C. Whole cell
extract DNA reserved from the sonication step was also treated for crosslink
reversal.
ChIP-Seq Sample Preparation and Analysis
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All protocols for Illumina/Solexa sequence preparation, sequencing and quality
control are provided by Illumina (http://www.illumina.com/pages.ilmn?ID=203). A
brief summary of the technique and minor protocol modifications are described
below.
Sample Preparation
DNA was prepared for sequencing according to a modified version of the
Illumina/Solexa Genomic DNA protocol. Fragmented DNA was prepared for
ligation of Solexa linkers by repairing the ends and adding a single adenine
nucleotide overhang to allow for directional ligation. A 1:100 dilution of the
Adaptor Oligo Mix (Illumina) was used in the ligation step. A subsequent PCR
step with limited (18) amplification cycles added additional linker sequence to the
fragments to prepare them for annealing to the Genome Analyzer flow-cell. After
amplification, a narrow range of fragment sizes was selected by separation on a
2% agarose gel and excision of a band between 150-350 bp (representing shear
fragments between 50 and 250nt in length and -100bp of primer sequence). The
DNA was purified from the agarose and diluted to 10 nM for loading on the flow
cell.
Polony Generation and Sequencing
The DNA library (2-4 pM) was applied to the flow-cell (8 samples per flow-cell)
using the Cluster Station device from Illumina. The concentration of library
applied to the flow-cell was calibrated such that polonies generated in the bridge
amplification step originate from single strands of DNA. Multiple rounds of
amplification reagents were flowed across the cell in the bridge amplification step
to generate polonies of approximately 1,000 strands in 1 pm diameter spots.
Double stranded polonies were visually checked for density and morphology by
staining with a 1:5000 dilution of SYBR Green I (Invitrogen) and visualizing with a
microscope under fluorescent illumination. Validated flow-cells were stored at
40C until sequencing.
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Flow-cells were removed from storage and subjected to linearization and
annealing of sequencing primer on the Cluster Station. Primed flow-cells were
loaded into the Illumina Genome Analyzer 1G. After the first base was
incorporated in the Sequencing-by-Synthesis reaction the process was paused
for a key quality control checkpoint. A small section of each lane was imaged and
the average intensity value for all four bases was compared to minimum
thresholds. Flow-cells with low first base intensities were re-primed and if signal
was not recovered the flow-cell was aborted. Flow-cells with signal intensities
meeting the minimum thresholds were resumed and sequenced for 26 or 32
cycles.
ChIP-Seq Data Analysis
Images acquired from the Illumina/Solexa sequencer were processed through
the bundled Solexa image extraction pipeline which identified polony positions,
performed base-calling and generated QC statistics. Sequences were aligned
using ELAND software to NCBI Build 36 (UCSC mm8) of the mouse genome.
Only sequences that mapped uniquely to the genome with zero or one mismatch
were used for further analysis. When multiple reads mapped to the same
genomic position, a maximum of two reads mapping to the same position were
used. A summary of the total number of ChIP-Seq reads that were used in each
experiment is provided (Table S7). ChIP-Seq datasets profiling the genomic
occupancy of H3K79me2 (Marson et al., 2008), Oct4 (Marson et al., 2008), Sox2
(Marson et al., 2008), Nanog (Marson et al., 2008), RNA polymerase II (Seila et
al., 2008) and CTCF (Chen et al., 2008) in mES cells were obtained from
previous publications and reanalyzed using the methods described below.
Analysis methods were derived from previously published methods
(Guenther et al., 2008; Johnson et al., 2007; Marson et al., 2008; Mikkelsen et
al., 2007). Sequence reads from multiple flow cells for each IP target and/or
biological replicates were combined. For all datasets, excluding Pol2 and
H3K79me2, each read was extended 200bp, towards the interior of the
sequenced fragment, based on the strand of the alignment. For Pol2 and
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H3K79me2 datasets, each read was extended 600bp towards the interior and
400bp towards the exterior of the sequenced fragment, based on the strand of
the alignment. Across the genome, in 25 bp bins, the number of extended ChIP-
Seq reads was tabulated. The 25bp genomic bins that contained statistically
significant ChIP-Seq enrichment were identified by comparison to a Poissonian
background model. Assuming background reads are spread randomly
throughout the genome, the probability of observing a given number of reads in a
1 kb window can be modeled as a Poisson process in which the expectation can
be estimated as the number of mapped reads multiplied by the number of bins
(40) into which each read maps, divided by the total number of bins available (we
estimated 70%). Enriched bins within 200bp of one another were combined into
regions.
The Poissonian background model assumes a random distribution of
background reads, however we have observed significant deviations from this
expectation. Some of these non-random events can be detected as sites. of
apparent enrichment in negative control DNA samples and can create many false
positives in ChIP-Seq experiments. To remove these regions, we compared
genomic bins and regions that meet the statistical threshold for enrichment to a
set of reads obtained from Solexa sequencing of DNA from whole cell extract
(WCE) in matched cell samples. We required that enriched bins and enriched
regions have five-fold greater ChIP-Seq density in the specific IP sample,
compared with the control sample, normalized to the total number of reads in
each dataset. This served to filter out genomic regions that are biased to having
a greater than expected background density of ChIP-Seq reads. A summary of
the bound regions and genes for each antibody is provided (Table S4 and S5).
ChIP-Seq Density Maps (Figure 2A and 6A)
Selected genes were aligned with each other according to the position and
direction of their transcription start site. For each experiment, the ChIP-Seq
density profiles were normalized to the density per million total reads. Genes
were sorted as indicated.
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ChIP-Seq Enriched Region Maps (Figure 2D; Figure 6D; Figure 7A and 7B)
The visualizations in Figure 2D, Figure 6D, Figure 7A and Figure 7B show the
location of enriched regions in a collection of datasets (query datasets, indicated
on the top) in relation to the enriched regions of another dataset (base dataset,
indicated on the y-axis). For each of the enriched regions in the base dataset,
corresponding genomic regions were calculated as +/- 5kb from the center of that
enriched region (one genomic region per enriched region, row). For each of
these genomic regions, the location and length of any enriched regions in the
query datasets were drawn.
Assigning ChIP-Seq Enriched Regions to Genes (Table S5)
The complete set of RefSeq genes was downloaded from the UCSC table
browser (http://genome.ucsc.edu/cgi-bin/hqTables?command=start) on
December 20, 2008. For all datasets, excluding Pol2 and H3K79me2, genes with
enriched regions within 10kb of their transcription start site, or within the gene
body were called bound. For Pol2 and H3K79me2 datasets, genes with enriched
regions within the gene body were called bound (Table S5).
Calculations of Med12 and Smc3 Reduction at Oct4 co-occupied sites or Smc3
reduction at CTCF/Smc3 sites (Figure 3)
To determine if there was a reduction in occupancy of Med12 or Smc3 at Oct4,
Med12 and Smc3 co-bound regions following the loss of Oct4, we compared the
normalized peak binding density (in reads/million) of each factor in each co-
occupied region across the genome. For each region co-occupied by Oct4,
Med12 and Smc3 in ES cells, the log2 ratio of the normalized peak heights
between ES cells and Oct4 shutdown cells was calculated. Peak heights were
normalized for each factor (Med12 or Smc3) such that the average peak height
(in reads/million) in enriched regions was the same in ES cells and Oct4
shutdown cells for that factor. This normalization was done to correct for any bias
due to differing qualities of IPs which would effect the perceived density of
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binding in reads/million. The calculation for change in Smc3 in CTCF/Smc3 co-
occupied regions was calculated similarly, except the regions analyzed were
those defined by the overlap between CTCF/Smc3 in ES cells. The log2 ratio of
Med12 and Smc3 for each Oct4/Medl2/Smc3 co-occupied region, and the log2
ratio of Smc3 for each CTCF/Smc3 co-occupied region is shown in Table S6.
Note regarding Bound Gene Table (Table S5)
Table S5 provides binding information on every entry in the RefSeq table
downloaded on December 20, 2008 (See ChIP-Seq analysis above) and the
bound gene numbers reflect counts of these entries. It should be noted however,
that some of the gene names are not unique and thus the density maps in Figure
2A and 6A may have fewer rows than there are entries in Table S5.
Note Regarding Calculation of Co-occupied Regions
Table S4 contains the genomic coordinates of enriched regions co-occupied by
the indicated pair of factors. These coordinates are the union of all overlapping
enriched regions of the two factors. It is possible for an enriched region of one
factor to span, or bridge a gap between, two separate enriched regions of the
other factor, in those cases, only one enriched region would be reported and it
would be the union of all three enriched regions. This will cause the number of
reported co-bound regions to be less than the number of strictly overlapping sites
reported in the Venn diagrams of Figure 2C and 6C. The Venn diagrams are
strictly the number of Smcl sites that are partially overlapped by either CTCF or
Mediator.
Gene Specific ChlPs
Gene specific ChlPs were performed in the indicated cell type following the
protocol outlined in ChIP-Seq Sample Preparation. For the Gene specific ChlPs
carried out in the knockdown cells, approximately 8x10 6 ES cells in 5 x 10cm
tissue culture plates were infected with the indicated shRNA as described
(Validation of shRNAs). Syber Green real-time qPCR was carried out on the
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7000 ABI Detection System according to the manufacturer protocol (Applied
Biosystems). Data was normalized to the whole cell extract and control regions.
Primers to the genes tested and control regions are listed below.
Gnai2
5'- ACAGAGCGATACGGCTCAGCAA-3'
5'-AAGTGGTAGCCGAAGGCAAGTGAA-3'
Vpsl8
5'-TCCTAGCGCCAACATGAGGAACT-3'
5'-TTTCAGCCGCGAGTGTTAACTGGA-3'
Phc1
5'-TTTGCTCTGCGTGACACTGAAGGT-3'
5'-AAATCCCAGCGCTTCTAGACGTAG-3'
BCO0199443
5'-TGCCCACGTCGTAACAAGGTTT-3'
5'-AAGGCCGATCCTTTCTGGTTCA-3'
Nanog
5'-ATAGGGGGTGGGTAGGGTAG-3'
5'-CCCACAGAAAGAGCAAGACA-3'
Oct4
5'-TTGAACTGTGGTGGAGAGTGCT-3'
5'-TGCACCTTTGTTATGCATCTGCCG-3'
Ybx1
5'-AGATCCTGGACCGACTTCC-3'
5'-GTTCCCAAAACCTTCGTTG-3'
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Nol5
5'-GGCTCCGAAAAGATGTGAA-3'
5'-AGCAGAGGTCGCCCTAAAT-3'
Ctrl
5'-TGGGTGCCGTATGCCACATTAT-3'
5'-TTTCTGGCCATCCGCACCTTAT-3'
ChIP-Western, Co-Immunoprecipitation and DNase I Treatment
ChIP-Western and Co-Immunoprecipitation
For ChIP-Western, same conditions as for ChIP-Seq were used. For co-
immunoprecipitation, murine ES cells were harvested in cold PBS and extracted
for 30 min at 40C in TNEN250 (50 mM Tris pH 7.5, 5 mM EDTA, 250 mM NaCI,
0.1% NP-40) with protease inhibitors. After centrifugation, supernatant was
mixed to 2 volumes of TNENG (50 mM Tris pH 7.5, 5 mM EDTA, 100 mM NaCI,
0.1% NP-40, 10% glycerol). Protein complexes were immunoprecipitated
overnight at 4*C using 5ug of Med1 (Bethyl, A300-793A), Med12 (Bethyl, A300-
774A), Nipbl (Bethyl, A301-778A), Smcl (Bethyl, A300-055A), Smc3 (Abcam,
Ab9236) or Rabbit IgG (Upstate, 12-370) bound to 50ul of Dynabeads@.
Immunoprecipitates were washed three times with TNEN125 (50 mM Tris pH 7.5,
5 mM EDTA, 125 mM NaCI, 0.1% NP-40). For both ChIP-Western and co-
immunoprecipitation, beads were boiled for 10 minutes in XT buffer (Biorad)
containing 100mM DTT to elute proteins. After SDS-PAGE, Western blots were
revealed with antibodies against Med23 (Bethyl, A300-425A), Oct4 (Santa Cruz,
sc-5279), Smcl (Bethyl, A300-055A), Smc3 (Abcam, Ab9236) and Nipbl (Bethyl,
A301-778A).
Co-Immunoprecipitation Following DNase I treatment
Murine ES cells were harvested in cold PBS and lysed with 20 mM Tris-HCI pH
8.0, 150 mM NaCI, 10% Glycerol, 1% NP-40, 2 mM MgCl 2 and protease
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inhibitors. After centrifugation, lysates were mock treated or treated with DNase I
(Sigma, AMP-D1) at room temperature for 45 minutes. Protein complexes were
immunoprecipitated overnight at 40C using 2ug of Smcl (A300-055A, Bethly) or
Rabbit IgG (Upstate, 12-370) bound to 20ul of Dynabeads@. Immunoprecipitates
were washed four times with the lyses buffer, proteins were separated by SDS-
PAGE and Western blots were revealed with antibodies against Med23 (Bethyl,
A300-425A) and Smcl (Bethyl, A300-055A). Post DNase I treatment, DNA from
5% of the mock and DNase I treated lysates were isolated by phenol:chloroform
extraction following RNase A (0.2 mg/ml, 2 hours, 370C) and Proteinase K (0.2
mg/ml, 2 hours, 550C) treatment.
Protein Extraction and Western Blot Analysis
ES and MEF cells were lysed with CelLytic Reagent (Sigma, C2978-50ml)
containing protease inhibitors (Roche). After SDS-PAGE, Western blots were
revealed with antibodies against Med1 (Bethyl, A300-793A), Med12 (Bethyl,
A300-774A), Smcl (Bethyl, A300-055A), Smc3 (Abcam, ab9263) or Gapdh
(Abcam, ab9484).
Mediator Affinity Purification
ES Cells
The Mediator complex was purified from mES cell nuclear extracts using
immobilized GST-SREBP-1a (residues 1-50). Bound material washed 4x with 20
column volumes of 0.5M KCI HEGN (20mM Hepes, 0.1mM EDTA, 10% Glycerol,
0.1% NP-40 & 0.5M KCI) buffer, 2x with 0.15M KCI HEGN buffer, and eluted.
The eluted sample was further purified with a CDK8 antibody. After binding, this
resin was washed 4x with 50 column volumes of 0.5M KCI HEGN buffer, 2x with
0.1M KCI HEGN buffer and eluted with 0.1M Glycine, pH 2.75. Western blot
analysis was conducted with Smc3 (Abcam ab9263-50), Med15 (Taatjes Lab
stock), Med12 (Bethyl A300-77A) or Nipbl (Bethyl A301-778A) antibodies.
HeLa Cells
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GST-SREBP-la (residues 1-50) was immobilized to GSH-Sepharose beads (GE
Lifesciences) and used as bait for overnight pull downs (40C) from an ES cell or
HeLa cell nuclear extract. Bound material was washed with 4x with 20 column
volumes of 0.5M KCI HEGN (20mM Hepes, 0.1mM EDTA, 10% Glycerol, 0.1%
NP-40 & 0.5M KCI) and 2x with 20 column volumes of 0.15M KCI HEGN. Bound
material was eluted with 30mM GSH in elution buffer (80mM Tris, 0.1mM EDTA,
10% Glycerol, 0.02% NP-40, 100mM KCI). GSH elutions were
immunoprecipitated with CKD8 (Santa Cruz Biotechnology C-19) or MED1
(Santa Cruz Biotechnology M-255) antibodies immobilized to Protein A/G-
Sepharose beads (GE Lifesciences), washed with 3x 20 column volumes 0.5M
KCI HEGN and eluted with 0.1M Glycine, pH 2.75. Western blot analysis was
conducted with Smc3 (Abcam, ab9263-50), Med15 (Taatjes lab stock), Med12
(Bethyl, A300-774A) and Nipbl (Bethyl, A301-778A) antibodies.
Chromosome Conformation Capture (30)
3C analysis was performed essentially as described by Miele et al. (Miele et al.,
2009) with a few modifications. 108 mES or MEF cells were crosslinked as
described (ChIP-Seq Sample Preparation and Analysis). Cells were lysed and
chromatin was digested with 1000 units Haelll (NEB) for the Nanog and Oct4 loci
or 2000 units Mspl (NEB) for the Phc and Leftyl loci. Crosslinked fragments
were subsequently ligated with 50 units T4 DNA ligase (Invitrogen) for 4 hours at
160C. A control template was generated using a BAC clone (RP23-474F18)
covering the Nanog locus, a BAC clone (RP24-352013) covering the Phc1 locus,
a BAC clone (RP23-438H19) covering the Oct4 locus and a BAC clone (RP23-
230B21) covering the Leftyl locus. Ten [tg of BAC DNA was digested with 2000
units Haelll or 1800 units Mspl. Random ligation of the fragments was done with
5 units T4 DNA ligase in a total volume of 60 microliters. 3C primers were
designed for fragments both upstream and downstream of the transcription start
site within Haelll or Mspl fragments. Primers Nanog 20, Phc1 48, Oct4 346 and
Leftyl 5 were used as the anchor points (Table S8). 3C analysis was done, in
which every PCR for a primer pair was done in triplicate and quantified. Each
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data point was first corrected for PCR bias by dividing the average of three PCR
signals by the average signal in the BAC control template. Data from ES cells
and MEFs were normalized to each other using the interaction frequencies
between fragments in the control regions with the following primer pairs for the
Nanog locus (Biological Replicate 1 and 2); Acta2 11 and Acta2 16, Acta2 48 and
Acta2 52, Gapdh 17 and Gapdh 19, Gapdh 17 and Gapdh 21, Gapdh 17 and
Gapdh 32, Gapdh 21 and Gapdh 39, Gene Desert 5 and Gene Desert 6, Gene
Desert 12 and Gene Desert 14, Gene Desert 25 and Gene Desert 26, Gene
Desert 12 and Gene Desert 26. The following primer pairs were used for
normalization between ES cells and MEFs for the Phc1 locus (Biological
Replicate 1); Gene Desert 0 and Gene Desert 1, Gene Desert 0 and Gene
Desert 2, Gene Desert 27 and Gene Desert 28, Phc1 47 and Phc1 48, Phc1 48
and Phc1 49. The following primer pairs were used for normalization between ES
cells and MEFs for the Phc1 locus (Biological Replicate 2); Gene Desert 0 and
Gene Desert 1, Gene Desert 0 and Gene Desert 2, Gene Desert 27 and Gene
Desert 28, Acta2 0 and Acta2 1, Acta2 2 and Acta2 7, Acta2 8 and Acta2 9,
Acta2 0 and Acta2 13, Gapdh 0 and Gapdh 2, Gapdh 7 and Gapdh 8, Gapdh 9
and Gapdh 12, Gapdh 4 and Gapdh 12. The following primer pairs were used for
normalization between ES cells and MEFs for the Oct4 locus (Biological
Replicate 1); Acta2 11 and Acta2 16, Gapdh 17 and Gapdh 19, Gapdh 17 and
Gapdh 21, Gapdh 21 and Gapdh 39, Gene Desert 5 and Gene Desert 6, Gene
Desert 12 and Gene Desert 14, Gene Desert 25 and Gene Desert 26, Oct4 346
and Oct4 344, Oct4 346 and Oct4 348. The following primer pairs were used for
normalization between ES cells and MEFs for the Oct4 locus (Biological
Replicate 2); Gapdh 17 and Gapdh 19, Gapdh 17 and Gapdh 21, Gapdh 21 and
Gapdh 39, Gene Desert 5 and Gene Desert 6, Gene Desert 12 and Gene Desert
14, Gene Desert 25 and Gene Desert 26, Oct4 346 and Oct4 344, Oct4 346 and
Oct4 348. The following primer pairs were used for normalization between ES
cells and MEFs for the Leftyl locus; Gene Desert 0 and Gene Desert 1, Gene
Desert 0 and Gene Desert 2, Gene Desert 27 and Gene Desert 28, Acta2 0 and
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Acta2 1, Acta2 8 and Acta2 9, Acta2 0 and Acta2 13, Gapdh 0 and Gapdh 2,
Gapdh 7 and Gapdh 8, Gapdh 9 and Gapdh 12, Gapdh 4 and Gapdh 12.
A normalization factor was determined by calculating the log ratio of each
interaction frequency within the control region in mES over MEFs, followed by
calculating the average of all log ratios. The raw interaction frequencies in mES
were subsequently normalized to MEFs using this factor.
Microarray Analysis
Cell Culture and RNA isolation
For ES cell knockdown expression analysis, ES cells were split off MEFs, placed
in a tissue culture dish for 45 minutes to selectively remove the MEFs and plated
in 6-well plates. The following day cells were infected with lentiviral shRNAs
targeting GFP, Smcla #1 or Med12 #1 (See Validation of shRNAs) in ESC
media containing 8 Rg/ml polybrene (Sigma, H9268-10G). After 24 hours the
media was removed and replaced with ESC media containing 3.5 [tg/mL
puromycin (Sigma, P8833). Five days post infection RNA was isolated with
TRIzol (Invitrogen, 15596-026), further purified with RNeasy columns (Qiagen,
74104) and DNase treated on column (Qiagen, 79254) following the
manufacturer's protocols. RNA from two biological replicates were used for
duplicate microarray expression analysis, except for the day 3 knockdown
expression data (Figure S4B) which is a singlicate data set.
For MEF knockdown expression analysis, MEFs were cultured in 6-well
plates and infected as described for the ES cells except that 2.0 [ig/mL
puromycin (Sigma, P8833) was used for selection. RNA was isolated and
treated as described above.
Micorarray hybridization and Analysis
For microarray analysis, Cy3 and Cy5 labeled cRNA samples were prepared
using Agilent's QuickAmp sample labeling kit starting with 1 tg total RNA. Briefly,
double-stranded cDNA was generated using MMLV-RT enzyme and an oligo-dT
based primer. In vitro transcription was performed using T7 RNA polymerase and
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either Cy3-CTP or Cy5-CTP, directly incorporating dye into the cRNA.
Agilent mouse 4x44k expression arrays were hybridized according to our
laboratory's standard method, which differs slightly from the standard protocol
provided by Agilent. The hybridization cocktail consisted of 825 ng cy-dye labeled
cRNA for each sample, Agilent hybridization blocking components, and
fragmentation buffer. The hybridization cocktails were fragmented at 600C for 30
minutes, and then Agilent 2X hybridization buffer was added to the cocktail prior
to application to the array. The arrays were hybridized for 16 hours at 600C in an
Agilent rotor oven set to maximum speed. The arrays were treated with Wash
Buffer #1 (6X SSPE / 0.005% n-laurylsarcosine) on a shaking platform at room
temperature for 2 minutes, and then Wash Buffer #2 (0.06X SSPE) for 2 minutes
at room temperature. The arrays were then dipped briefly in acetonitrile before a
final 30 second wash in Agilent Wash 3 Stabilization and Drying Solution, using a
stir plate and stir bar at room temperature.
Arrays were scanned using an Agilent DNA microarray scanner. Array
images were quantified and statistical significance of differential expression for
each hybridization was calculated using Agilent's Feature Extraction Image
Analysis software with the default two-color gene expression protocol. To
calculate an average dataset from the biological replicates the loglO ratio values
for each feature were averaged and the log ratio p-values were multiplied. For
each gene in our RefSeq set (see ChIP-Seq analysis section), we selected the
feature with the best average p-value that was annotated to that gene. Genes
with no annotated features were reported as NA (Table S3). Heatmaps were
generated using the log ratio values according to the provided color scale.
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